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Abstract 
 
Maintaining adequate and stable blood oxygen level is important for preterm 
babies to avoid the risk of brain, lung and retinal injury such as retinopathy of 
prematurity (ROP). However, wide disparities in policies and practices of 
oxygenation in preterm babies exist among neonatal care providers as it is still unclear 
which best method of monitoring and what features of oxygen measurements are 
important to clinician’s interpretations for assessing preterm babies at risk of 
developing severe ROP or unstable health condition. This thesis consists of two 
projects: NZ-ROP that examines multiple factors of severe ROP including summary 
statistics (mean, standard deviation (SD), coefficient of variation (CV) and 
desaturation) for oxygen saturation (OS) features in very extreme preterm babies, and 
NZ-LP that investigates the efficacy of some of these statistics for health monitoring 
of late preterm babies.  
The OS data in NZ-ROP were recorded using modified oximeters that have 
offsets and inherent software artefact, both of which mask the actual saturation for 
certain OS ranges and may complicate the choice of methods in the analyses. 
Therefore, novel algorithms involving linear and quadratic interpolations are 
developed, implemented on the New Zealand data, and validated using the data of a 
UK preterm baby, as recorded from offsets and non-offsets oximeters. For all data 
sets, the algorithms produced saturation distributions that were very close to those 
obtained from the non-offset oximeter. The algorithms perform within the 
recommended standards of commercial oximeters currently used in the clinical 
practice.  
ROP is a multifactorial disease, with oxygenation fluctuations as one of the 
key contributors. The all-subsets logistic regression, robust and generalised additive 
statistical modelling, along with a model averaging approach, are applied in NZ-ROP 
to determine the relationship of variability and level of OS with severe ROP, and the 
extent of contribution of various clinical predictors to the severity of this eye disease. 
Desaturation, as a measure of OS variability, has the strongest association with severe 
ROP among all OS statistics, in particular, the risk of severe ROP is almost three 
times higher in babies that exhibit greater occurrences of desaturation episodes. 
Additionally, this study identifies longer periods of ventilation support, frequent 
desaturation events, extreme prematurity and low birth weight as the most important 
factors that substantially exacerbate the severity of ROP, and therefore signify babies’ 
underlying condition of being severely ill.  
Persistent cardiorespiratory instabilities prior to hospital discharge may expose 
preterm babies to a greater risk of neuro-developmental impairments. In NZ-LP, the 
statistical summaries of mean, SD and CV are computed from the OS measurements 
of healthy stable and unstable babies, and the performance of these statistics in 
detecting the unstable babies is evaluated using an extremeness index for outlying 
data and a hierarchical clustering technique. With SD and CV, the clinically unstable 
babies were very well separated from the group of stable babies, wherein, the 
separation was even more apparent with the use of CV. These suggest that measures 
of variability could be better than saturation level for highlighting babies’ underlying 
instability due to immature physiological systems, but the combination of variability 
and level through the CV are believed to be even better.  
Identification and summarisation of useful OS features quantitatively hold 
great promise for improved monitoring of oxygenation instability and diagnosis of 
severe ROP for preterm babies. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Neonatal oxygenation  
Preterm babies are at an increased risk of morbidity, mortality, and hospital re-
admissions than term babies (Petrini et al., 2009; Darlow et al., 1997). Each year, 
around 4,800 babies who are born within the period of less than 37 completed weeks 
gestation are admitted to neonatal intensive care units (NICUs) in New Zealand. Of 
these, about 4% or 200 are extremely preterm babies born before 28 weeks gestation 
and out of this figure, nearly 80% are discharged home alive (Cust et al., 2003). 
However, these babies do have considerably higher risk of poor growth, respiratory 
illness, visual deficits, cerebral palsy, sensori-neural and cognitive disabilities, 
educational and behavioural impairment than term babies (Darlow et al., 1997).  
 
The condition of premature babies is characterised by physiological adaptation 
to extra-uterine life. Sudden unpredictable physiological instabilities, such as 
variations of blood oxygen level, heart rate, or respiratory patterns are common in 
preterm babies (Baird, 2004). Frequently, these conditions resulted from a complex 
combination of neonatal illnesses, immaturity of organ development and function, 
iatrogenic factors arising from parental handling and hospital procedures (Murdoch 
and Darlow, 1984), and environmental factors (Hay, 1969)  such as room temperature, 
light, and noise. Hence, physiological variability is partly intrinsic to the baby and 
equally induced by external factors. This poses a challenge to clinicians of how best to 
treat the preterm babies prudently without inflicting unnecessary harm.  
 
Now, modern intensive care has given hope in enabling many preterm babies 
to survive. One of the most important aspects of this care is help with the breathing 
and monitoring of the blood oxygen level because they have very immature lungs. 
Preterm babies frequently have breathing difficulties and require treatment with 
supplementary oxygen to improve the lung perfusion and the oxygen content, which 
changes every few seconds and is difficult to be controlled exactly. Oxygen content, 
however, should be maintained sufficiently high as insufficient blood flow or low 
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oxygen content in the blood (hypoxaemia) and excess of oxygen content 
(hyperoxaemia) do have adverse effects on the tissue oxygenation (Silverman, 2004). 
This, in turn, can lead to complications of prematurity or could trigger a cascade of 
respiratory events.  It is extremely important that the oxygen level is monitored so as 
to ensure that oxygen content is adequate when caring for the babies.  
 
1.1.1 Complications of prematurity 
The process of blood flow and maintaining of oxygen content at certain level 
are integrated to meet the metabolic needs of tissues for ensuring a healthy human 
body. During breathing in a natural environment, molecules of oxygen are transported 
by the blood to the tissues of the body. Most of the molecules consumed by the tissue 
are metabolised. A small fraction of the consumption, however, is constantly 
converted to oxygen free radicals and reactive oxygen species. However, when overly 
produced, these by-products overwhelm the body’s natural defence system and may, 
at least partly, play a role in development of tissue injury in preterm babies (Saugstad, 
1998).  
 
An inappropriate amount of oxygen content in the blood or inspired air may be 
harmful to preterm babies due to their under-developed biological systems. 
Oxygenation of the tissues depends on lung perfusion, which needs to adequately 
match the ventilation areas of blood capillaries. A ventilation-perfusion mismatch 
may cause hyperoxaemia and hypoxaemia, both of which have been implicated in 
diverse organ injury such as lung (Jobe & Bancalari, 2001), brain (McDonald, 1964) 
and retinal injury in preterm babies (Askie et al., 2009). On occasions when the 
amount of oxygen used exceeds what is needed, free radicals and reactive oxygen 
species are increased in hyperoxaemia and in re-oxygenation after hypoxaemia, which 
invariably lead to oxidative stress. However, according to Saugstad (1998), preterm 
babies are vulnerable to oxidative stress due to inadequate antioxidant protection, and 
this may expose the babies to oxidant-related morbidities such as bronchopulmonary 
dysplasia (chronic neonatal lung disease), retinopathy of prematurity (ROP) and 
periventricular haemorrhage. 
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1.1.2 Maturation of physiological systems 
Physiological systems in preterm babies continue to develop after birth. 
Nevertheless, a delay in the maturation progress could place a baby at a greater risk of 
severe cardiorespiratory events (Gaultier, 1995), which are reflected by patterns of 
periodic breathing and apnea (a pause in the regular breathing), bradycardia (a slow 
heart rate) and hypoxaemia of oxygenation (Henderson-Smart et al., 1986). Some of 
the observed patterns are thought to be mediated through a sensory nervous system in 
blood vessels, also known as peripheral chemoreceptor reflex, which monitors 
chemical concentrations in blood with advancing gestation and postnatal age (Rigatto 
et al., 1975). It is common for apnea, bradycardia and hypoxemia to occur 
concurrently, with early onset of bradycardia during apnea being pre-mediated by 
hypoxaemia (Henderson-Smart et al., 1986). Of particular concern, persistent events, 
even if subtle, may cause delayed mental, motor and poorer language development at 
later years in preterm babies (Mattia and deRegnier, 1998). These ramifications, 
however, would largely depend on the ability of babies to recover from any single 
events, and to stabilise after being given appropriate interventions (Balfour-Lynn et 
al., 2009).  
    
1.2 Previous research of oxygenation studies  
Numerous studies have been conducted to differentiate instability arising from 
physiological immaturity or complications of prematurity so as to decrease mortality 
and improve morbidity in this high-risk group during postnatal period. Research has 
found that illnesses such as respiratory distress, anaemia of prematurity and gastro-
oesophageal reflux may contribute to variations in heart rate and breathing patterns 
(Baird, 2004). The investigation and treatment for some of these complications have 
been initiated using physiologic data from electronic monitors, for instance, by 
utilising heart rate variability analysis that quantifies the oscillations in the ECG 
signals (Malik et al., 1996). Existing use of heart rate and respiratory rate variability 
suggests potential for predicting outcome therefore permitting timely intervention. 
Changes in heart rate variability have been found to be able to predict morbidity and 
mortality in fetal (Yum & Kim, 2003) and neonatal patients (Griffin et al., 2007) 
based on heart rate characteristics. Measures of respiratory rate variability and 
severity indices have been developed to study prolonged ventilation in adult patients 
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(Seely et al., 2014) and to describe pulmonary status in ventilated preterm patients 
(Madan et al., 2005). 
 
 Establishing evidence-based information on the links between varying oxygen 
levels and the development of neonatal organs, however, remains a challenge to the 
clinicians because an appropriate range of oxygen levels that would not cause 
hyperoxic (abnormal increase of oxygen supply to the organs and tissues) or hypoxic 
(insufficient oxygen supply to the organs and tissues) injury is still unknown (Higgins 
et al., 2007; Askie, 2013). Results from several randomised control trials (BOOST II 
Group, 2013; SUPPORT Study Group, 2010) have found that high oxygen saturation 
(OS) levels predispose to ROP, which is the leading cause of blindness and visual 
disability in newborns, while high inspired oxygen concentrations exacerbate neonatal 
chronic lung disease, which is associated with poor growth, neuro-developmental 
impairment and long term respiratory morbidity (Jobe & Bancalari, 2001). However, 
insufficient oxygen also leads to poor growth and neuro-developmental impairment 
due to brain damage (McDonald, 1964), and mortality due to hypoxic respiratory 
failure (BOOST II Group, 2013). These studies showed that there is a crucial need to 
seek “safe” OS ranges for the most vulnerable premature babies. In a 2004 editorial in 
Pediatrics (Silverman, 2004), Dr William Silverman, formerly of Columbia 
University, stated, “…there has never been a shred of convincing evidence to guide 
limits for the rational use of supplemental oxygen in the care of extremely premature 
infants. For decades, the optimum range of oxygenation (to balance four competing 
risks: mortality, ROP-blindness, chronic lung disease and brain damage) was, and 
remains to this day, unknown”. 
 
 Oxygen mediated retinal injury is one of the critical areas in need of urgent 
study (Cole, 2010). A major area of concern is investigating various possible oxygen-
related determinants that contribute to the development and progression of ROP. 
Early findings of the role of oxygen in inducing ROP were conducted using 
transcutaneous electrodes for measuring transcutaneous oxygen or umbilical catheters 
for measuring oxygen tension in arterial blood gases; these technologies were later 
replaced by OS monitoring of pulse oximeters. Nevertheless, oxygenation monitoring 
using these methods has been shown not to improve ROP outcome in preterm babies 
requiring intensive care (Flynn et al., 1987; Kinsey et al., 1977; Quine and Stenson, 
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2008). Times series data generated by the monitors, however, could be more useful as 
the source data for more complex analysis by mathematical or statistical modelling. 
Studies using regression models have found that standard deviation (SD) of 
transcutaneous oxygen in the first 2 weeks of life was a significant predictor of severe 
ROP (Cunningham, et al., 1995); increased fluctuations in arterial oxygen tension, as 
quantified by coefficient of variation (CV), imposed a higher risk of developing 
threshold ROP in very-low-birth-weight premature babies (York, et al., 2004; Saito et 
al., 1993); and desaturation episodes (intermittent falls in oxygen levels) of OS were 
higher in babies with severe ROP (Di Fiore et al., 2010). Until now, comparative 
studies have not been done to evaluate which measures of oxygen could possibly 
provide better insight in describing the link between oxygenation fluctuations and 
ROP.  
 
 Several early clinical trials (1951-1969) that investigated the effects of 
restricted versus unrestricted oxygen concentrations on ROP and mortality had 
reported that severity of ROP was reduced with the restriction of oxygen (Askie et al., 
2009). Nonetheless, it was observed that some babies in the restricted oxygen group 
still developed ROP whilst many babies never developed ROP in the unrestricted 
oxygen group. This indicates that oxygen is not the only independent risk factor of 
ROP, and that there are other factors that also contribute to the cause of ROP. For 
instance, lower birth weight and younger gestational age (GA) at birth (Darlow et al., 
2004; McColm & Fleck, 2001; Good et al., 2005) have been identified as having the 
greatest association with the risk of ROP. Male gender (Jacobson et al., 2009; Darlow 
et al., 2004); greater illness severity (Hagadorn et al., 2007) measured by the Score for 
Neonatal Acute Physiology (Richardson et al., 1993); clinical oxygen (Kinsey et al., 
1956; Lala-Gitteau et al., 2007); and upregulation of vascular growth factor (Chen and 
Smith, 2007) are amongst other important contributors of this eye disorder. ROP may 
also relate to poor postnatal growth (Wikstrand et al., 2011; Hellstrom et al., 2009), 
postnatal steroid exposure (Halliday et al., 2003) and oxidative stress (Saugstad, 
1998). 
  
Monitoring the development of physiological systems in preterm babies is an 
area in need of additional study (Raju et al., 2006). Several studies were set up to 
investigate symptoms of delayed maturation in babies born less than 35 weeks GA, of 
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whom occurrences of apnea, bradycardia, hyperoxemia and hypoxemia events were 
recorded longitudinally for six months (Hunt et al., 1996; Hunt et al., 2011).  The risk 
for these events was highest at 36 weeks post-menstrual age (PMA) but declined with 
age at 44 weeks PMA. Further, such events that occurred more than four times (Hunt 
et al., 2004) and prolonged beyond 40 weeks PMA (Poets et al., 1991) were found to 
be associated with poor performance of gross and fine motor skills, and cognitive 
ability. The extent of morbidity in relation to the cardiorespiratory events may explain 
the concern on whether some preterm babies, particularly the late-preterm ones 
(babies of 33 to 36 weeks gestation), are clinically ready for NICU discharge (Engle 
et al., 2007) when their physiological systems are still immature. It is, therefore, 
important to detect pre-discharged babies with suspected unstable health conditions to 
ensure necessary treatments could be provided with the aim of improving the babies’ 
outcome.   
 
Whereas pre-discharge criteria have been established for respiratory and heart 
rates to guide interventions during neonatal transition prior to hospital discharge 
(American Academy of Pediatrics, 2004), evidence-based guidelines have been 
difficult to be obtained for oxygenation of a preterm baby (Higgins et al., 2007; Askie, 
2013). Nevertheless, there have been several observational studies describing the 
oxygenation patterns and typical values of OS during the first days and months after 
birth in preterm babies. Most of these studies have considerable interest in saturation 
level (Rhein et al., 2014; Harigopal et al., 2011; Hunt et al., 2011; Beresford et al., 
2005; Ng et al., 1998; Poets et al., 1992), and some common summary statistics that 
have been used are mean, median, percentiles, and median baseline (median of the 
means). These studies focus on OS level and not on variability in OS.  
 
Some clinicians believe that information about the health state of preterm 
babies is contained in the variability of physiological systems. Studies have found that 
preterm babies with very low birth weight and/ or complications are more likely to 
exhibit lower level or higher variability of blood oxygen. For example, babies with 
severe ROP that require retinal surgery have higher oxygen variability (York et al., 
2004; Saito et al., 1993); babies with chronic lung disease have greater number of 
desaturation episodes (Durand at al., 1992); and babies with infection have increased 
hypoxaemia and apnoea incidences (Hofstetter et al., 2007). A statistic that is often 
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used to represent variability in OS data is SD (Cunningham et al., 1995; DiPietro et 
al., 1994). An alternative but infrequently used measure to quantify OS is CV (Grove 
et al., 2005; York et al., 2004; Saito et al., 1993), which quantifies the variability of 
OS relative to the mean level. 
  
 Appropriate measures of blood oxygen need to be identified for distinguishing 
preterm babies at high risk of ROP or babies with unstable oxygenation. This would 
be a daunting task since the definition for optimal high and low limits for OS to guide 
oxygenation monitoring in either healthy or oxygen supplemented preterm babies is 
still not clearly defined, which in part, could be due to the absence of clarity on how 
often and/or what length and duration of an apneic episode and hypoxemia is safe 
(Cole et al., 2003; Silvestri et al., 2002), and lack of knowledge on what suitable 
measures can sufficiently summarise the instability in blood oxygen. That this 
knowledge has not been forthcoming is due to the complexity and multitude of 
information involved, which precludes most medical researchers from examining the 
physiology as the interrelated system that it is. Much existing research in this area has 
examined individual measures of oxygenation, but not all of them together, which is 
specifically what is being sought in this thesis. Such measures need to be carefully 
chosen to ensure that they possess blood oxygen features that reflect the instability of 
oxygenation in a baby. 
 
1.3 Thesis objectives 
There exist wide disparities in current policies and practices of oxygenation in 
preterm babies among neonatal care providers due to limitations in current knowledge 
on how to appropriately manage the oxygen for newborn babies. There is a need to 
determine useful measures of OS for saturation monitoring, to better understand the 
links between OS and retinal injury (Cole et al., 2003), and to investigate whether 
some indication of health status of preterm babies could be determined from certain 
measures of routinely collected OS data. These are the motivations for this research, 
which is structured as two studies, New Zealand Retinopathy of Prematurity (NZ-
ROP) and New Zealand Late Preterm Babies (NZ-LP), with separate groups of 
babies.  
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The goal of NZ-ROP and NZ-LP studies is to provide some information on 
several aspects of oxygenation that could support the clinician’s assessment when 
evaluating the risk of severe ROP and health status of preterm babies in NICUs. 
Oximeter OS data and other clinical information are utilised in the two studies for 
detailed statistical modelling and various techniques. Some statistical measures based 
on the continuously collected saturation data are then identified to provide additional 
insights into physiologic conditions in unstable premature babies and pathologic 
conditions in sick babies. 
 
Altogether, there are three specific aims in this thesis, two of which are the 
aims of NZ-ROP and the other is the aim of NZ-LP. Specifically, the aims of NZ-
ROP are: 
1. to determine any plausible relationships between saturation levels, three 
measures of variability of OS (specifically SD, CV and desaturation), and 
severe ROP and 
2. to identify dominant predictors that have stronger relationship with severe 
ROP. 
 
The aim of NZ-LP is to determine whether three statistical summaries (mean, SD and 
CV) of the OS recordings are potentially useful in the clinical care of late preterm 
babies. 
 
1.4 Study method 
Various methods have been identified to achieve the research objectives of 
NZ-ROP and NZ-LP. With respect to the first two objectives, the study of NZ-ROP is 
carried out in two phases. The first phase involves pre-processing of OS data to render 
them suitable for analysis. The data were recorded from the Masimo SET oximeters 
and were obtained from the BOOST-NZ trial. This was a double-blind randomised 
trial (Darlow et al., 2014) with its own objectives in investigating OS targeting in two 
groups of preterm babies, of whom each baby was randomly allocated with one of two 
types of oximeters. The oximeters had two features: trial-imposed offsets of either 
+3% or -3% in the OS range 85-95% that masked the trial intervention, and machine 
artefact inherent in the oximeters. Both of these features influenced the OS readings. 
Part of the pre-processing includes identifying the type of oximeter used for each 
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baby, removal of the offsets and correction of the artefact. Novel algorithms through 
interpolation techniques are developed, implemented, and validated to adjust for these 
features. Subsequently, an appropriate period for summarising the OS data has to be 
determined. For this, some clinical factors such as the onset of ROP (Palmer, 2006) 
and age of the babies are taken into consideration. 
 
The second phase of NZ-ROP involves the analysis of predictors that could 
contribute to the development of severe ROP. This includes identifying whether some 
measures of saturation levels or variability of OS are related to severe ROP. As 
opposed to previous research that had studied measures of oxygen fluctuations 
separately based on older technology, this research considers four summary statistics 
of OS readings of non-invasive oximeters: mean for measuring saturation level; SD 
for measuring saturation variability; CV as a composite measure of variability relative 
to the mean level, and desaturation as another variability measure. By doing so, the 
degree of relationship between each measure of OS and severe ROP could be 
evaluated. These statistics are computed from the OS readings and are analysed as 
part of the predictors in the regression analysis for predicting risk of severe ROP in 
very young preterm babies less than 28 weeks GA. The all-subsets logistic regression, 
which produced models with all possible combinations of predictors, is employed. 
During the model verification stage, identification of outlying observations and 
appropriate functional forms for the continuous predictors is checked using 
conventional, robust (Cantoni & Ronchetti, 2001) and generalised additive statistical 
modelling (Hastie and Tibshirani, 1990). The performance of the models is measured 
by the area under the receiver operating characteristic (ROC) curve (AUC), and 
validated using a repeat-stratified 10-fold cross-validation technique (Kohavi, 1995; 
Refaeilzadeh et al., 2009). Single-, multi-predictor, and model averaging approaches 
are used to assess the relationships between the OS statistics, seven other clinical 
predictors, and severe ROP, as well as to identify dominant predictors that are 
strongly related to the diagnosis of severe ROP. The analysis by the model averaging 
approach is based on several measures computed by averaging over all models. 
 
Data for NZ-LP were obtained from the Christchurch Women’s Hospital. 
These data consisted of OS readings of 31 preterm babies that were recorded from the 
Masimo Radical oximeters. Except for one baby, most of the recordings were 
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conducted when the babies were 34 to 36 weeks PMA. The babies were clinically 
well at the time of enrolment for the study, however, two babies were soon identified 
as being clinically mildly unstable. Using these data, some measures of OS features 
are evaluated whether they could be informative to the clinicians when monitoring 
late preterm babies potentially with unstable health conditions. To address this issue, 
statistical summaries of mean, SD and CV of OS are evaluated in a two-phase 
analysis. In the first phase, all suspected erroneous data are identified and assigned 
with a lesser weight through the use of an appropriate weighting function. In the 
second phase, the distribution of saturations for several stable and unstable babies is 
assessed using nonparametric kernel density technique (Wand & Jones, 1995). 
Subsequently, the OS readings of each baby are summarised using the three statistical 
measures, and the ability of these measures to distinguish the unstable babies is 
investigated. This could be done in two ways. One is through the use of graphical 
approach, i.e. by assessing the capability of each measure in identifying the two 
babies as outlying data points as well as quantifying the level of extremeness of these 
outliers from the main data set. Clustering technique is another approach that can be 
considered, i.e. each measure is used to group the babies into clusters, such that babies 
within a cluster looked more “similar” with respect to the measure than babies from 
different clusters. This is performed using the hierarchical clustering method (Sneath, 
1973) in conjunction with a dendogram and a clustering performance index (Calinski 
& Harabasz, 1974) to assess the overall results.  
 
1.5  Contributions and significance of research 
Oxygen has been established as one of the key factors of ROP (Cole, 2010). 
However, more information is required pertaining to the relationships between 
oxygenation fluctuations and ROP, particularly so with respect to GA, timeline of the 
onset, or relationship with other risk factors (Cole et al., 2003). Studies have been 
done to improve the understanding of the origin and mechanism of ROP, but not 
without limitations. There is a subjective interpretation of outcome due to the different 
oxygen monitoring devices used, a lack of knowledge of whether and which measures 
of OS are related to the severity of ROP, and a lack of understanding on the 
relationships between oxygenation, other clinical and postnatal factors, and severe 
ROP. These issues underscore the importance of conducting a detailed and 
comprehensive analysis in understanding the development (or healing) of severe ROP, 
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and these are addressed in NZ-ROP. It is a study that investigates multiple 
determinants, including four OS measures, of severe ROP in extremely low GA (<28 
weeks GA) babies. 
 
 Defining the “appropriate” blood oxygen levels or dose of supplemental 
oxygen in preterm babies is one of the primary interests in the perinatal and neonatal 
medical community. However, this goal has been hindered as to which best method of 
monitoring and what features of the oxygen readings to analyse are still debated. 
Previous studies have attempted to address these issues by suggesting several typical 
measures of the saturation levels when investigating babies’ oxygenation during the 
early life. In NZ-LP, three summary statistics based on OS variability and levels are 
considered and assessed for saturation monitoring of late preterm babies. 
 
The contributions of NZ-ROP and NZ-LP are the identification of OS 
measures of variability as the useful features of blood oxygen for examining and 
detecting babies who may be at future risk for severe ROP and babies that may have 
unstable health conditions prior to hospital discharge. Specifically in NZ-LP, 
measures of SD and CV perform better than mean for separating mildly unstable 
babies in one group and all stable babies in another group. In NZ-ROP, a measure for 
desaturation events is found to be strongly associated with severe ROP. Additionally, 
the study demonstrates that a combined impact of four factors: frequent episodes of 
desaturation, longer duration of ventilation support, extremely low birth weight and 
high degree of immaturity is substantial on the development of ROP sufficiently 
severe to require retinal surgery.  
 
Influential evidence on the relationships between oxygen and ROP 
occurrences are now emerging, with past studies showing that fluctuations of 
oxygenation (Cole, 2010) and treatment of oxygen therapy (Kinsey et al., 1977) have 
a role in this neonatal complication. The data from the BOOST-NZ oxygen targeting 
trial could be used to investigate the risk factors of severe ROP. However, these are 
new data sets and have not been analysed in any other studies. In particular, the OS 
readings are influenced by the trial-imposed offsets and software artefact of the 
oximeter, and the oximeter’s type for each baby is masked from the parents and 
neonatal care providers. As such, these hinder the OS data to be directly used for NZ-
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ROP. Substantial efforts are carried out to manage and process the NZ-ROP data set 
so as to ensure that the oximeter’s type is identified and the affected OS values are 
adjusted using novel algorithms to reflect the actual readings. 
 
Implementation of the algorithms is also essential for other studies on preterm 
babies. The OS data could be useful to study patients of neonatal morbidities 
associated with the use of oxygen such as bronchopulmonary dysplasia (Askie et al., 
2003) and damage to the postnatal growth of length, weight, and head circumference 
(Tin et al., 2001). The presence of the offsets and artefact in the data, however, could 
mask certain borderline threshold of saturations for each morbidity; thereby, could 
result in failure to identify babies with potentially severe outcomes. 
 
The research outcomes of NZ-ROP and NZ-LP are important to the health 
care providers and academia. The knowledge that the research seeks will contribute to 
the wider neonatal community (neonatologists, paediatricians, ophthalmologists, and 
neonatal nurses) and towards better understanding of oxygen instability and its 
monitoring, and management of high-risk babies within and across the population of 
New Zealand preterm babies. This information would increase awareness in 
enhancing the care of high-risk newborn babies and stimulate ideas to develop 
evidence-based preventive and corrective strategies for future neonatal treatment. The 
research can also be important for academia as it provides a thorough description of 
the projects, which can be analysed and critiqued from different angles, for instance, 
using the regression analysis for NZ-ROP. The investigation of ROP determinants, 
which includes measures of oxygenation fluctuations and other clinical predictors, 
may confer better understanding on the extent of their relationship with severity of 
ROP. Consequently, the outcomes of predictive models for ROP may be of use to 
clinicians when evaluating vulnerable young babies at risk of the sight-threatening 
disease.  
 
Continuous oxygen monitoring plays an important role in assessing the health 
of preterm babies. In the clinical care of these vulnerable babies, appropriate tools are 
required for identifying medical complications (Higgins et al., 2007; Raju et al., 
2006). Successful identification of OS measures is therefore important for monitoring 
the oxygenation status of premature babies during their early weeks of life. This 
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would allow the clinicians to control and reduce factors that aggravate oxygen lability, 
and evaluate current care practices for oxygen supplemental administration.  
 
As well as contributing to health care provision, all New Zealand high-risk 
babies will benefit from up-to-date evidence-based research from the two studies, 
with the goal to reduce the likelihood of developing neuro-developmental disability or 
ROP sufficiently severe to require laser therapy. The reduction in such morbidities 
and financial burden would enhance their quality of life and benefit their family and 
the society (Saigal and Doyle, 2008).  
 
Overall prematurity accounts for much of the cost and disability from NICU 
care. Preterm babies contribute disproportionately to the work loads of neonatal 
intensive care units (Cust et al., 2003). According to Darlow and colleagues (2007), 
these babies have increased morbidity across a range of health and developmental 
outcomes at two years of age compared with healthy controls. The outcomes from the 
studies could be essential to reduce the burden of disability on health service 
resources in the community, in terms of time commitments and workloads of the 
NICUs medical team and specialist visit. In turn, these could reduce the long-term 
costs to New Zealand’s health system and social services. The exact size of this cost 
saving, however, can only be estimated accurately by a formal economic evaluation. 
 
1.6 Overview of the thesis 
 The structure of the thesis is as follows. Consequences and issues related to 
instability in blood oxygen level as well as the current challenges in managing these 
concerns are addressed in Chapter 1. NZ-ROP is described in Chapter 2 until Chapter 
5; Chapter 3 and Chapter 5 form the main parts of the thesis. NZ-LP is discussed in 
Chapter 6.  
 
Chapter 2 reviews on the pathological details and risk factors of ROP, 
motivation and relevant background of NZ-ROP. Description is also given for the 
three main components (OS readings, diagnosis of ROP status, and clinical and 
postnatal information) of data that are used in the analysis.  
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Chapter 3 concentrates on the pre-processing of OS data that were recorded 
using Masimo SET oximeters. Some of the challenges faced in processing these data 
include unmasking the oximeter’s type for each baby involved in the study, and 
removing the effects of artefact and trial-imposed offsets from the OS readings. An 
outline of procedure for identifying the type of oximeter, and description for 
development and implementation of two novel algorithms for adjusting the two 
features are provided in this chapter. These steps are important to render the data 
suitable for use in the regression modelling, which is the focus of Chapter 4 and 5.  
Additionally, validation of the algorithms is also demonstrated using the offset and 
non-offset data of a UK preterm baby.  
 
Chapter 4 provides the background material of statistical techniques used for 
analysing plausible relationships between four measures of OS, seven other 
predictors, and severe ROP. These relationships are examined simultaneously using 
all-subsets regression. The approaches that are used here extend the work of previous 
studies, which have mainly focused on single regression model and single measure of 
oxygen, and utilised older technology of blood oxygen monitoring.  
 
The results and discussion of NZ-ROP are presented in Chapter 5. Various 
ideas are forwarded in this chapter when analysing the OS features (saturation level 
and variability) and other predictors for severe ROP diagnosis. For instance, using 
subtle patterns in the oxygenation of babies with and without ROP to locate a suitable 
period for summarising the OS measures; fitting regression models with one predictor 
from each group of common predictors that are highly correlated for handling 
multicollinearity; and grouping of common predictors of similar risk factor groups for 
examining the relative importance of ROP’s predictors with respect to their 
relationship with this eye disorder.  
 
Chapter 6 describes the investigation of NZ-LP. A review is presented on the 
previous works of obtaining some typical measures of saturation levels as the 
common values for oxygenation monitoring. Treatments are outlined for missing or 
unreliable OS readings and description of techniques is given to evaluate the ability of 
three statistical summaries: mean, SD, and CV of OS. The results of the analysis are 
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illustrated using an extremeness index of the box plots, and a hierarchical clustering 
method.  
 
Concluding remarks for the thesis and recommendations for future direction of 
research are given in Chapter 7. 
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CHAPTER 2 
NZ-ROP STUDY-BACKGROUND 
 
2.1 Introduction  
This chapter reviews the background of ROP, which includes the historical 
aspect, pathophysiology or development in the developing retina, classification and 
treatment of ROP severity as well as the group of babies at risk and related risk 
factors.  Previous and recent developments in ROP studies are also discussed. For 
instance, the guidelines for safe OS monitoring in clinical practice, investigations on 
the relationship between arterial oxygen tension, transcutaneous oxygen and OS, and 
on oxygenation fluctuations and ROP. A brief description of a study on ROP 
predictors is given in the final section. 
 
2.1.1 ROP in preterm babies  
 ROP is an abnormality of the retina and disorder of immature retinal blood 
vessels in babies born prematurely. The incomplete formation of the retina is due to 
failure of retinal blood vessels to develop normally and to grow to the entire retina. In 
the absence of timely and appropriate treatment, it can progress aggressively to retinal 
detachment leading to visual loss. ROP is a visual impairment threat to babies in 
various parts of the world, particularly so in countries with access to neonatal care of 
resuscitation (Gilbert et al., 2005).  
 
Oxygen therapy for neonatal treatment was introduced in the 1930s in the US 
and soon, it became widespread to other industrialised countries. As proper devices 
for measuring blood oxygen levels were unavailable, clinicians found it difficult to 
target supplemental oxygen that meets each baby’s need. The first epidemic of ROP 
was first reported in 1942 (Kinsey et al., 1956) and by 1950s, the role of breathing 
unrestricted supplemental oxygen as the major cause was discovered by three 
randomised control trials. As a result of these trials, the use of oxygen in nurseries 
was drastically curtailed, where the babies were often administered with less than 
40% of supplemental oxygen. Such a restriction resulted in a decrease in blinding 
ROP, but there were also increased mortality and morbidity rates (Cross, 1973). The 
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second epidemic occurred in the 1970s, in which advances in health systems for both 
antenatal and neonatal care have contributed to the survival of a greater proportion of 
high-risk babies. Extreme prematurity, with some cases as young as 23 weeks GA, 
was the driving force for this epidemic to persist (Slidsborg et al., 2008; Zin and Gole, 
2013); thus, stimulating clinicians to develop methods for preventing and detecting 
potentially blinding ROP. In the last decade or so, the rate of children who develop 
blinding ROP has been increasing in newly industrialising and developing countries 
(Gilbert et al., 2005). This is termed as the third epidemic.  
   
2.1.2 Severe ROP worldwide 
ROP is one of the three leading causes of childhood blindness in the world for 
the past 10 years (Kong et al., 2012). In 2010, it was estimated that nearly 22% or 
184,700 of surviving preterm babies had some degree of ROP. Of these, almost 6.7% 
or 12,300 babies developed mild or moderate visual impairment and a further 10.8% 
progressed to severe impairment or become blind (Bleincowe et al., 2013). Incidence 
for ROP, however, differs enormously per country as it depends on the standards of 
health care and socioeconomic development. ROP was once considered as a disease 
that mostly occurred in developed countries; nonetheless, incidence of ROP has been 
emerging in middle-income countries and urban areas of low income countries, in 
which these account for 65% of visual impairment in children. Lowest income 
regions, however, have very low percentage of ROP cases with mortality among 
premature babies as high as 50% due to lack of good quality health care facilities for 
babies and pregnant women (Gilbert et al., 2005).  
 
More ROP incidences are now being reported for severe ROP. This generally 
refers to sight threatening ROP at advanced stages for which treatment will be 
offered. The incidence of severe ROP in several high-, middle-, and low-income 
countries over the past two decades (Zin and Gole, 2013) is summarised in Table 2.1. 
It can be seen that severe ROP is emerging as a major cause of blindness in middle-
income nation such as China, and regions such as Southeast and South Asia, Latin 
America and parts of Eastern Europe. In these places, many of the cases have been 
reported to occur in more mature (32-36 weeks of GAs) and larger (>1500g of birth 
weights) babies. Such a phenomenon could be due to the rapid improvement in the 
maternal and neonatal facilities, which in part, has induced delivery of moderately to 
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late premature babies for non-medical reasons (Zin and Gole, 2013). In high-income 
countries, incidences of ROP are widely ranged from nearly 4% to 35% (Table 2.1). 
However, blindness and severe visual impairment is more prevalent among newborns 
with low GAs <28 weeks or extremely low birth weights <1000g (Horbar et al., 
2012).   
 
Table 2.1: Severe ROP incidence in some high-, middle-, and low-income 
countries (adapted with permission from Zin and Gole, 2013) 
Country 
Country group 
by income 
 Period 
Number of 
babies 
Incidence 
(%) 
United States High  2003-2007 6866 16.0  
United Kingdom High  1987-1998 484 5.2  
Australia  High  1992-2009 373 15.0  
Canada High  2006-2007 1866 3.9  
Germany High  1993-2007 1473 14.8  
Sweden High  2007-2009 506 34.8  
Argentina Upper middle  2008-2010 1169 13.4  
Brazil Upper middle  2004-2006 3437 3.4  
China Upper middle  2009-2010 2185 13.1  
Romania Upper middle  2002-2007 1783 15.2  
India Lower middle  1999-2002 1083 11.0  
Pakistan Lower middle  2003-2006 68 20.6  
Vietnam Lower middle  2001 225 9.3  
Bangladesh Low  1998-2003 114 4.4  
  
2.1.3 Significance of ROP problem 
ROP is a public health issue with economic and social implications. Premature 
babies with ROP face visual impairment including blindness. The impact on these 
survivors of prematurity when entering the society with potential life-long blindness is 
particularly tragic. They may have more difficulty in securing employment; therefore, 
hindering them from producing economic benefits to the society and in turn, requires 
aid from their families or social services. Blindness due to severe ROP also negatively 
affects neuro-developmental function. Babies with unfavourable visual acuity fare 
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worse functional outcomes, with 77% have self-care disability, 50% continence 
disability, 43% motor disability, and 66% social cognitive disability (Msall et al., 
2000). The adverse sequels resulting from these disabilities affect the quality of life of 
the children and inflict a long-term burden on their families, society, and health care 
resources (Saigal and Doyle, 2008).  
 
Disabilities impose great strains on the family. Many parents with a disable 
child have reported additional pressures and stresses on their other children, health 
and marriage when coping with their child's disabilities. Also, these parents are less 
likely to be engaged in full-time employment; hence, they tend to have lower 
household incomes and savings (Saigal and Doyle, 2008).  
 
Caring for the severely disabled individuals entails considerable utilisation and 
cost of health care resources. According to Tommiska and colleagues (2003), who 
studied the costs of caring extremely low birth weight babies in Finland for the period 
1996-1997, the average health care cost of raising severely disabled babies in the first 
two years is 68-fold compared to normal healthy babies. The higher costs are related 
to the treatments received during hospitalisation, specialist consultation, other health 
care services, and parents’ travel, accommodation and loss of earnings. 
 
High incidence of severe ROP, associated with disability and rising cost of 
health services, represents a significant health impact in all countries. With recent 
developments showing improved survival rates of premature babies (Horbar et al., 
2012) and large numbers of ROP babies entering the society (Blencowe et al., 2013), 
ROP remains an ongoing concern. Eradicating ROP would enhance the quality of life 
of these babies and benefit their family and the community.  
 
2.1.4 Assessment, classification and treatment of ROP 
With vast improvements in the medical care, it is now possible to diagnose 
ROP through retinal examination by an ophthalmologist. Currently, more hospitals in 
many countries are starting to impose a regulation that all babies at risk of sight-
threatening ROP should be examined in screening programs. Guidelines for 
examining and classifying of ROP were first developed in 1984 by an international 
group of pediatric ophthalmologists and retinal specialists (Committee for the 
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Classification of Retinopathy of Prematurity, 1984). These guidelines were updated 
recently, which recommended that the first eye examination needs to be performed as 
early as 31 weeks PMA for babies born <28 weeks GA, and at four weeks after birth 
for more mature babies (Fierson et al., 2013). When no ROP is detected during the 
first visit, follow-up exams are needed every one to three weeks until the eyes are 
fully vascularised or worsening condition is found. As proper screening programs are 
not properly established in the less and moderate developing countries, some 
ophthalmologists follow the US guidelines, i.e. birth weight ≤1500 g or ≤30 weeks 
GA, or 1500 g - 2000 g or >30 weeks GA for high risk babies (American Association 
for Pediatric Ophthalmology, 2006), and some follow the UK guidelines, i.e. birth 
weight <1500 g and/ or <32 weeks GA (Wilkinson and Royal College of 
Ophthalmologists of the United Kingdom, 2008). However, according to Gilbert and 
colleagues (2005), these guidelines from two highly developed countries may not suit 
countries such as India, China, Latin America, and Eastern Europe, in which larger 
and more mature babies are developing threshold ROP. The researchers then 
suggested that wider screening criteria and appropriate timing of examination be 
adopted according to the local data.  
 
Classification 
By convention of the current guidelines (Fierson et al., 2013; American 
Association for Pediatric Ophthalmology, 2006; Wilkinson and Royal College of 
Ophthalmologists of the United Kingdom, 2008), the overall ROP status of an eye is 
indicated by the worst stage of retinopathy. ROP is graded into five stages of 
increasing severity (stages 1-5). In the early stages 1 and 2, the eyes could get better 
on their own or in some cases, they progress to stage 3. If untreated, the eyes are 
exposed to the risk of potentially blinding stages 4 and 5. The schematic view of 
retina in Figure 2.1 illustrates the progression of ROP from normal to mild ROP of 
stages 1 and 2, to severe ROP of stage 3. The quadrant labelled A shows the retinal 
pattern of premature blood vessels. Quadrant B shows the first stage of ROP. The 
blood vessels have stopped developing and the normal retina is now separated from 
the premature retina by a sharp line. Stage 2 ROP, as shown in quadrant C, occurs 
when the line of separation advances to an elevated ridge of tissue. In quadrant D, 
more serious stage 3 ROP is present when new blood vessels extend from the ridge 
toward the center of the eye. As stage 3 advances, the separation between the retina 
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that has blood vessels in the back of the eye, and the retina that does not have blood 
vessels in the front of the eye becomes even clearer. Treatment is then required to 
destroy the retina without the blood vessels. After the treatment, ROP could either 
subsides on its own or continues to affect the retina to detach partially (stage 4) or 
totally (stage 5). 
 
 
UK Retinopathy of Prematurity Guideline, 2008 
 
2.2 Risk factors of ROP  
Figure 2.1: Stages of retinopathy based on a diagrammatic view of retina. The white 
area in the centre is the optic nerve, the grey lines are the arteries, and the black lines 
are the veins. (Reprinted from “UK Retinopathy of Prematurity Guideline 2008” 
(Wilkinson et al., 2008) with permission of the Royal College of Paediatrics and Child 
Health). 
  
Treatment of established ROP 
A majority of extremely preterm babies will show some degree of ROP, which 
sometimes resolves naturally without treatment. A small proportion, however, go on 
A 
Normal retina 
D 
Stage 3 ROP 
 
C 
Stage 2 ROP 
B 
Stage 1 ROP 
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to develop severe ROP in one or both eyes that progress to serious vision impairment 
when untreated. To prevent the adverse effects, treatments such as cryotherapy and 
laser therapy are used. The latter is often used as the current standard of care as laser-
treated eyes have been reported to have better structural and visual acuity than 
cryotherapy (Ng et al., 2002). Recently, bevacizumab drug (Mintz-Hittner et al., 
2011) was introduced in lieu of or in addition to laser treatment. The treatment of 
ROP with bevacizumab, however, is still at an experimental stage with patterns of 
recurrence and long term side effects remain to be further investigated. More evidence 
through randomised trials is needed to determine its safe and effective dose, and 
whether it is superior to laser (Darlow et al., 2013). 
 
2.2 Pathophysiology of ROP   
 The development of ROP is surrounded by intricate connections with many 
factors including premature lung function (Askie et al., 2003), immature retinal tissue 
(Smith, 2005), variable tissue oxygenation (Cole, 2010) as well as demographic and 
postnatal factors (Darlow et al, 2005). Most recently, the role and impacts of vascular 
endothelial growth factor (VEGF) on the development of ROP have been explored 
(Chen and Smith, 2007). VEGF is excreted following from the deficiency of oxygen 
in the tissue and it is associated with the development of new blood vessels.  
 
An adequate balance between oxygenation and regulation of VEGF is 
important for normal retinal formation (Chen and Smith, 2007; Pierce, 1996). A 
perturbation in oxygenation, however, will alter the delicate balance of the growth 
factor regulation and inevitably leads to the progression of clinical retinopathy. In 
early fetal life, the retina is devoid of blood vessels. After premature birth, treatment 
with supplemental oxygen may flood the immature retina with oxygen, resulting in 
higher exposure of the baby to oxygen concentration. This hyperoxia interrupts the 
natural hypoxia process in the retina. This leads to the downregulation of VEGF 
production and causes cessation of existing vessels growth. When the oxygen 
treatment stops, the retina becomes severely hypoxic, causing high secretion of 
VEGF. Such an overproduction stimulates new vessels to grow abnormally, extending 
from the ridge in the retina toward the center of the eye. These vessels are weak and 
prone to haemorrhage, scarring and contraction; thus, leading to detachments of retina 
and loss of vision. 
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2.3 Previous and current research in ROP 
2.3.1 Guidelines for blood oxygen levels to minimise the risk of ROP 
Monitoring blood oxygen levels is vital in neonatal care. Since 1970s and 
1980s, three types of devices have been used to assess a baby’s oxygenation status. 
These include transcutaneous oxygen electrode that requires regular calibration and 
can cause skin burns from prolonged use, and umbilical arterial catheter that has been 
considered as the optimum method for estimating blood oxygen levels. However, the 
latter is invasive and mostly limited to intermittent monitoring. A non-invasive pulse 
oximeter may be utilised to measure OS continuously. Its relative convenience of 
usage, which consists of a sensor that could be placed on the finger or toe of a patient, 
has made it as the predominant method of monitoring oxygenation in many NICUs. 
 
Studies have found that arterial oxygen tension (PaO2), transcutaneous oxygen 
(PtcO2), and OS do not correspond linearly (Hintz et al., 2002). Hence, care must be 
taken when using the relationships between these measurements to interpret the 
readings. In particular, lower OS levels of less than 70% generally are less accurate 
(Giuliano and Higgins, 2005) whilst higher OS levels of 97-100% can correspond to a 
wide range of PaO2 values starting from 60 mmHg to as high as 400 mmHg, or higher 
when a baby breathes supplemental oxygen. Likewise, a decreasing accuracy of linear 
relationship between PaO2 and PtcO2 has been observed at lower and higher readings 
of PaO2. For instance, a PtcO2 of 45 mmHg may correspond to a PaO2 of 50 mmHg or 
higher than 80 mmHg. As readings between these instruments differ, it remains a 
challenge to ascertain episodes of hypoxaemia, hyperoxaemia and desaturation in the 
oxygenation monitoring of preterm babies.  
 
Reliable detection of the three events, as mentioned above, is crucial for 
avoidance of oxygen-related diseases such as ROP (Di Fiore et al., 2010) and chronic 
lung disease (American Academy of Pediatrics, 2002). Values of PaO2 ranging from 
<40-50 mmHg have been considered to be the thresholds for defining episodes of 
hypoxaemia (Bohnhorst et al., 2000; Poets & Southhall, 1994) whilst an upper limit of 
80 mmHg has been shown to have sufficient sensitivity to detect hyperoxaemia 
(Bohnhorst et al., 2002). Desaturation is the frequency of intermittent falls in OS. 
According to Hunt and colleagues (1999), occurrences of desaturation are common 
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either during short respiratory pauses or periodic breathing. OS levels of not more 
than 80% or 85% have been used as thresholds for defining desaturation episodes in 
full term babies (Hunt et al., 1999; Stebbens et al., 1991) and preterm babies (Di 
Fiore, 2004; Poets et al., 1992). A critical range of oxygen tension and OS in preterm 
babies receiving supplemental oxygen is still unknown. Flynn and colleagues (1992) 
later found that ROP occurred more often with oxygen tension above 80 mm Hg and 
thereafter, PaO2 of 50-80 mmHg as a safe range to avoid ROP was accepted by 
professional consensus (American Academy of Pediatrics, 2002). Another study on 
the role of OS in fetal growth reported that normal fetuses develop with OS of 70-
80% in utero (Nicolini, 1990); many clinicians, however, are relying on 85-95% in 
monitoring preterm babies (Cole et al., 2003).  
 
With limited information on the link between oxygen tension and OS, efforts 
have been made to transpose oxygen tension of 50-80mm Hg into equivalent OS 
values. These included targeting a higher range of 90-95% (Vijaykumar, 1997) and a 
lower range of 80-95% (Tin et al., 2001; Anderson et al., 2004; Sun et al., 2002; 
Chow et al., 2003) shortly after birth. Outcomes from these observational studies 
suggested that retinal surgery may reduce by 61-100% if a lower range of OS policy is 
adopted. Such a recommendation, however, was met with a concern because lower 
saturation ranges may compromise neuro-developmental and survival outcomes (Cole 
et al., 2003). To guide future clinical practice in the administration of supplemental 
oxygen to newborn babies, a group of collaborated randomised control trials from 
nine countries are studying the effects of two different ranges of OS levels on the 
health of very preterm babies less than 28 weeks GA (Cole et al., 2003; Askie et al., 
2011). Recent results from these trials suggested that incidence of severe ROP was 
reduced with lower saturation ranges below 90%; however, the risk of mortality was 
increased (SUPPORT Group, 2010; Vaucher et al., 2012; Schmidt et al., 2013; 
BOOST II Group, 2013).  
 
2.3.2 Oxygen fluctuations and ROP 
 The role of oxygen fluctuations in the development of ROP was not fully 
understood until animal studies were carried out in the early 1950’s (Ashton et al., 
1954).  Rats, cats, mice and rabbits were often used to study the effects of alternating 
or clustering of oxygen fluctuations on retinal development as their retinal structure at 
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birth is closely comparable to that in preterm babies. Mimicking oxygen-induced 
retinopathy, the newborn animals were exposed to varying concentrations of oxygen 
for continuous or intermittent periods. These studies later gave rise to other animal 
models of retinopathy and studies involving extremely premature babies as young as 
23 weeks GA (Di Fiore et al., 2010).  
 
 Clinical human and animal studies have shown that oxygen fluctuations, 
hypoxia and hyperoxia in the early weeks of life during oxygen therapy increased the 
risk for severe or threshold ROP. PtcO2 variability was reported to be a significant 
predictor of severe ROP in the first two weeks of life (Cunningham et al., 1995), and 
increased fluctuations of PaO2 may expose premature babies to a higher risk of 
developing threshold ROP (Saito et al., 1993; York et al., 2004). In experiments done 
in newborn rats, alternating hypoxia and hyperoxia caused severe retinopathy 
(Werdich et al., 2004; Penn et al., 1994; McColm et al., 2004; Coleman et al., 2008). 
Severity is worsened when fluctuations in oxygen occurred in wider ranges (Penn et 
al., 1995), hypoxic clusters (Coleman et al., 2008), small increments (Werdich et al., 
2004), or repeated hypoxic periods (McColm et al., 2004). These studies illustrate a 
plausible explanation that increased hypoxic episodes may be associated with the 
development of severe ROP, a finding which was later confirmed by Di Fiore and 
colleagues (2010). In their study, the babies in the group of ROP sufficiently severe to 
require laser therapy (LaserROP) had increased frequency of hypoxaemic events as 
well as longer period of supplemental oxygen compared with babies in the 
NoLaserROP group through the first four to five weeks of life. Because longer 
periods on oxygen therapy may subject a baby to greater episodes of hypoxia, 
hyperoxia and oxygenation fluctuations (Tin et al., 2001; Cole, 2010), clinical 
practices accompanied by frequent adjustments of supplemental oxygen need to be 
eradicated.  
 
2.3.3 Postnatal and clinical determinants of ROP 
ROP is a disease of prematurity that was discovered about seven decades ago 
after oxygen therapy was introduced into the newborn nursery. At that time, it was 
also noted that all of the initial patients weighed under 1600 g (Kinsey et al., 1956; 
Kinsey et al., 1977). The use of oxygen is now closely monitored and is no longer 
implicated as the sole or even the primary factor of ROP. Nevertheless, serious 
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retinopathy persists until today, with prematurity (Darlow et al., 2005) and birth 
weight (Good et al., 2005) remain as the dominant risk factors of this vision 
threatening disorder.  
 
Many clinicians believe that events in the postnatal period of premature babies 
may be critical in determining the onset of ROP. A multitude of factors have been 
investigated as having associations with ROP. Whilst prematurity, low birth weight, 
and the use of oxygen therapy (McColm and Fleck, 2001) have been consistently 
found as the strongest risk factors of ROP, recent studies have also suggested that 
there are close relationships between postnatal weight gain (Wikstrand et al., 2011; 
Hellstrom et al., 2009), insulin-like growth factor (IGF-1) (Hellstrom et al., 2003) and 
severe ROP. Using a screening algorithm, these investigators demonstrated that poor 
development in weekly weight gain and IGF-1 serum levels that prolonged provide an 
early indication of babies at high risk of severe ROP. IGF-1 has been shown to be 
important for development of normal retina (Hellstrom et al., 2003), and growth of 
fetal and neonate through regulation of insulin glucose levels (Giudice et al., 1995). 
However, high overall glucose levels during the first month of life were found as a 
predictor of severe ROP (Chavez-Valdez et al., 2011). Infection is another area of 
concern in the neonatal development as it is a major cause of mortality and morbidity 
(Hofstetter et al., 2007; American Academy of Pediatrics, 2002). A meta-review by 
Bharwani and Dhanireddy (2008) showed that systemic infection such as candida 
sepsis is associated with a higher proportion of ROP severe enough to require surgical 
treatment.   
 
There have been other clinical factors that have not been consistently 
confirmed with univocal results or clearly proven in large studies, but have been 
postulated to be associated with ROP. Among factors that have been studied are 
genetic disease, multiple gestation pregnancies, maternal bleeding, intakes of iron, 
vitamins E and A, breast milk feedings, light exposure. There are also several reports 
on the damaging effects of high carbon dioxide levels (Hauspurg et al., 2011) and 
frequent blood transfusions (Romagnoli, 2009) on exacerbating the severity of ROP. 
Although the findings are suggestive, additional investigations are warranted if these 
events persist in the neonatal care.   
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Gender has been identified as one of the risk factors since an early report of 
ROP in 1942, where male babies were noted to be more likely to acquire the disease 
than female babies. Whilst this outcome has been confirmed by several studies in the 
US (Di Fiore et al., 2010; Jacobson et al., 2009) and a large network in Australia and 
New Zealand (Darlow et al., 2005), others found no relationship between male gender 
and severity of ROP (Gunn et al., 2012; Austeng et al., 2010). The finding that male 
babies are prone to the risk of ROP is in accordance with some earlier evidence that 
being male is associated with increased chances of mortality and morbidity at extreme 
prematurity (Synnes et al., 1994). Likewise, babies with prenatal growth restriction 
have been suggested to be more susceptible to these adverse outcomes. Currently, 
many clinicians are starting to study whether restriction in intrauterine growth could 
have contributed towards the development of the eye disease. Consequently, there 
appears to be an increasing inclination to use weight-for-GA rather than birth weight 
as the basis of cohort selection (Qiu et al., 2012; Regev et al., 2003) since the former 
has been shown to provide a clearer relationship between morbidity, GA and birth 
weight (Synnes et al., 1994). The benefit of utilising weight-for-GA over birth weight, 
however, is still debated as not all studies consistently found similar associations, 
which in part, could be due to various criteria being used for defining weight-for-GA 
itself.  
 
The efficacy of steroids on reducing mortality, morbidity and improving lung 
maturation in fetal and preterm babies has been reviewed by Halliday and colleagues 
(2003) based on 21 randomised controlled trials. Both prenatal and postnatal steroids 
appear to be associated with a reduction in the severity of ROP (Console et al., 1997; 
Jagielska et al., 2008). The protective effect of the latter, however, is demonstrated 
only when administered within 4 days of birth (Halliday et al., 2003), which also 
resulted in adverse side effects of body systems and neuro-developmental impairment. 
Timing of administration again plays an important role when a study reported that any 
late treatments given after three weeks of life or those that prolonged for more than 
two weeks may pose an increased risk of severe ROP in very low birth weight babies 
(Karna et al., 2005). A large multi-center randomised trial has been suggested to gain 
a consensus on recommended timing and dosage for both short and long-term use of 
steroids in clinical practice.  
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2.4 NZ-ROP study 
The influence of clinical determinants of ROP in preterm babies is 
multifaceted (McColm and Fleck, 2001). Many of them are inter-related, and have 
been found to be associated not only with ROP but also with other various 
complication of prematurity. The simultaneous presence of these factors seems to 
indicate babies’ underlying conditions of being more ill from severe disease status. 
  
Reducing the severity of ROP is extremely important in protecting very 
premature babies from the risk of vision impairment or blindness. More studies are 
beginning to shed light on the many factors involved in the disease; in particular, 
fluctuations of blood oxygen levels of PaO2 (York et al., 2004) and PtcO2 
(Cunningham et al., 1995). However, the role of OS, combined with other factors, on 
the development of ROP is still less clear today. A study, NZ-ROP, was then 
undertaken to examine whether some measures of OS could provide some insight on 
the link between fluctuations of OS and severity of ROP. NZ-ROP was analysed 
using a subset of data from the BOOST-NZ trial. 
 
2.4.1 BOOST-NZ trial 
The BOOST-NZ is the New Zealand arm of a group of collaborated 
international randomised controlled trials (described in Section 2.3.1) for investigating 
the optimal range of OS in extreme premature babies being treated with supplemented 
oxygen (Darlow et al., 2014). Specifically, the aim of the trials is to determine 
whether targeting the lower range 85-89% compare to upper range 91-95%, beginning 
within 24 hours of birth until 36 weeks PMA, leads to any difference in outcomes of 
death or survival with neuro-developmental disability diagnosed at two years of age. 
Additionally, postnatal growth and several neonatal illnesses such as ROP are 
investigated as the secondary outcomes.  
 
The trial received approval from the Multi-Region Ethics Committee and 
obtained written consent from all parents. Enrolment of babies started in September 
2006 and ended in December 2009. Recruitment of extremely preterm babies was 
undertaken at five NICUs in New Zealand. Some postnatal data were recorded upon 
enrolment such as gestation age and weight at birth, and gender whilst other variables 
were documented prospectively until the baby reached 36 weeks PMA or had an early 
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discharge, for instance, survival, OS, duration of oxygen therapy and neonatal 
illnesses. To achieve the trial’s objectives, each enrolled baby was randomly assigned 
with a lower-target group with OS target of 85-89% or a higher-target group with OS 
target of 91-95%, and, therefore was allocated with one of two types of pulse 
oximeters to record the OS readings. These oximeters were specially programmed 
such that the readings between 85-95% were offset to either higher or lower than the 
actual saturation to blind the treatment allocation to family, clinical staff and 
outcome-assessors. Details of these offsets are described in Chapter 3, Section 3.3. 
 
NZ-ROP has different objectives from the BOOST-NZ, although the data were 
taken from the latter. Whilst the BOOST-NZ attempted to assess the effect of two 
different OS ranges on the health of preterm babies, NZ-ROP is focused on 
identifying the potential relationships between four statistical summaries of OS, 
several postnatal factors and ROP alone. The differences in these objectives between 
the two studies have some implications on the OS data. Because the readings of the 
oximeters were influenced by the trial-imposed offsets, these effects must be removed 
before the OS data can be used in the NZ-ROP analysis. The procedures to adjust 
these offsets are detailed in Section 3.4.   
   
2.4.2 NZ-ROP data  
There were 340 premature babies that were enrolled in the BOOST-NZ. 
Babies were eligible for inclusion in NZ-ROP if they had been admitted to the NICUs 
between September 2006 and December 2009 with gestation less than 28 weeks, were 
less than 24 hours old, and were alive until 36 weeks PMA. Babies were excluded if 
they had known congenital anomalies affecting oxygenation. A total of 83 of the 
eligible babies did not meet the inclusion criteria for the following reasons: they were 
deceased before 36 weeks PMA, had not reached the end point of the eye 
examination, were still depending on supplemental oxygen, had withdrawn from the 
study before 36 weeks PMA, or had no OS data for at least two weeks after 27 weeks 
PMA. Overall, a total of 257 babies who met the inclusion criteria of NZ-ROP (Figure 
2.2) and had the most complete information were included in the retinopathy study. 
Of these, 38 babies developed at least stage 3 ROP, and another 3 developed stage 2 
ROP but were treated with laser retinal surgery. This resulted in 13.6% (or 41/301) of 
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severe ROP cases. The ROP status, clinical and postnatal information as well as the 
OS data for these 257 babies were utilised in the NZ-ROP analysis.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Flowchart of study population in NZ-ROP and ROP outcome 
 
Oxygen saturation 
The BOOST-NZ trial used specially adjusted and masked Masimo SET pulse 
oximeters (Masimo Corporation, Irvine, CA, United States) for comparing the effects 
of OS targeting in two groups of preterm babies. Within 24 hours after a baby was 
born and parental consent was obtained, randomisation of oximeter was performed 
and the oximeter with labelled serial number was attached to the baby. Data 
39 babies died before 
PMA 36 weeks 
301 babies available for 
ROP screening 
340 babies born with a 
GA < 28 weeks 
11 babies had no OS 
data ≥2 weeks after 27 
weeks of PMA 
1 baby withdrawn before 
PMA 36 weeks  
14 babies still required 
supplemental oxygen 
18 babies still required 
eye examination  
257 babies included in 
NZ-ROP analysis 
219 babies with ROP 
stage 0-2 
 
38 babies with ROP 
stage ≥3 
 
3 babies treated with 
retinal surgery 
 
20 babies treated with 
retinal surgery 
 
18 babies not treated 
with retinal surgery 
 
41 babies with severe 
ROP 
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acquisition commenced once a good waveform was obtained and OS was recorded 
once every 10 seconds for a continuous duration until 36 weeks PMA or discharged, 
whichever occurred earlier. The data was downloaded at least every fortnightly. The 
allocated oximeter must remain with the baby even when the baby is transferred to 
another NICU while still in oxygen. 
 
The OS readings from the oximeter were used as the basis of computation for 
four OS measures that have been chosen as the severe ROP predictors: mean, SD, CV 
and desaturation of OS levels. These measures were computed for each baby after 
adjustments were made on the OS readings to remove the effects of the trial-imposed 
offsets (refer Section 3.4), and a suitable time interval was chosen (refer to Section 4.2 
and Section 5.2). All subsequent analyses for NZ-ROP were based on the adjusted 
data. 
 
Status of ROP 
The babies’ eyes were examined according to the BOOST-NZ protocol by 
experienced ophthalmologists to monitor and detect for any signs of ROP. The stage 
of ROP was recorded during these eye examinations, which started when the babies 
were at the age of four to six weeks after birth, and thereafter fortnightly until the eye 
was considered to be no longer in danger of developing severe ROP. These are when 
the eyes are fully vascularised or the vessels have reached zone III. For this study, the 
status of ROP (denoted as severe or no severe ROP) for each baby was recorded 
according to the most advanced ROP stage observed throughout all visits. Severe 
ROP was defined as stage 3 and above or had undergone laser therapy whilst no 
severe ROP was defined as stage 2 and below including no diagnosis of ROP.  
 
2.6 Summary 
ROP continues to be a significant visual impairment threat in very preterm 
babies. Incidence of ROP is high among the most immature and smaller babies in 
developed nations, but has now emerged among older and bigger babies in middle-
income countries and urban areas of low-income countries (Gilbert et al., 2005). The 
use of supplemental oxygen that was initially implicated as the primary cause of ROP 
is now being closely monitored whilst prematurity and birth weight remain as the 
strongest risk factors of ROP (McColm and Fleck, 2001). There is also a growing 
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evidence of close relationships between ROP and male gender, poor postnatal weight 
gain, prenatal growth retardation, IGF-1 and VEGF (Hellstrom et al., 2003; Hellstrom 
et al., 2009). Guidelines for recommended screening criteria and timing of 
examination according to babies’ birth weight and GA are adopted in various parts of 
the world to detect high-risk babies. Thereby, this would enable them to receive 
appropriate and timely treatment as needed. Eyes that progressed to serious ROP are 
treated with retinal surgery such as cryotherapy or laser therapy (American 
Association for Pediatric Ophthalmology, 2006; Wilkinson and Royal College of 
Ophthalmologists of the United Kingdom, 2008).). 
 
 Recent developments have indicated that stable IGF-1 and VEGF (Hellstrom 
et al., 2003; Hellstrom et al., 2009), reduced fluctuations of blood oxygen levels 
(Cole, 2010), and close monitoring of oxygen therapy (Schmidt et al., 2013; BOOST 
II Group, 2013) in the early neonatal life are important for the development of normal 
retinal formation. Any slight perturbations in oxygenation will alter the delicate 
balance of the growth factors’ regulation and inevitably leads to the progression of 
clinical retinopathy. In animal models of induced retinopathy, varying concentrations 
of oxygen for continuous or intermittent periods in the form of alternating, clusters, 
wider ranges, small increments and repeated episodes exacerbate the severity of ROP. 
However, there is still no clear answer of what range of OS is optimal for newborn 
babies receiving supplemental oxygen. This issue is currently being studied by a 
group of international trials (Askie et al., 2011). 
 
Further studies are also needed to shed light on the link between OS 
fluctuations and ROP. A study (NZ-ROP) was conducted to determine whether 
measures of variability and saturation levels of OS are related to the development of 
severe ROP. This investigation involved 257 babies born <28 weeks GA that were 
enrolled in the BOOST-NZ trial (Darlow et al., 2014). Data consisted of ROP status, 
OS data and postnatal information. The latter includes the age and weight of the 
babies at birth, gender, and details of some treatment for oxygen therapy. The eyes 
examinations were conducted by trained ophthalmologists until the eyes were fully 
vascularised. The status of ROP for each baby was classified as severe ROP or no 
severe ROP, as indicated by the worst stage of ROP observed throughout all visits. 
The OS readings were recorded continuously within 24 hours after birth until 36 
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weeks PMA from Masimo pulse oximeters. The BOOST-NZ, which has its own 
separate objectives from NZ-ROP, had used specially programmed oximeters for 
studying the effects of two types of oxygen intervention. These modifications had 
resulted in the OS readings between certain ranges to be displayed higher or lower 
than the actual saturation. As such, some mechanism is needed to render the data 
suitable for use in NZ-ROP. 
 
High incidence of severe ROP, associated with disability and rising cost of 
health services, represents a significant health impact in all countries. ROP affects the 
quality of life of the children and inflict a long-term burden on their families, society, 
and health care resources (Saigal and Doyle, 2008). Various measures have been 
developed such as providing better antenatal care to reduce the rate of preterm birth. 
There have also been improvements in the neonatal care practices to reduce the risk of 
ROP blindness through adequate human and equipment resources, timely diagnostic 
screening and examinations with appropriate treatment to prevent progression to 
blindness, and identification of criteria for determining babies at high risk of severe 
ROP (Bleincowe at al., 2013; Gilbert et al., 2005). Such interventions in managing 
these most vulnerable patients can contribute significantly to their visual diagnosis. 
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CHAPTER 3 
PRE-PROCESSING OF OXYGEN SATURATION 
DATA FOR NZ-ROP 
 
3.1 Introduction  
Recruitment of babies for the BOOST-NZ trial was completed at the end of 
2009. The data, which were collected from five hospitals, were received in two 
batches - November 2009 and August 2010. There were three main components (refer 
to Chapter 2, Section 2.6) of the data: the clinical data, the ROP status, and the OS 
data from the oximeter. These data were processed before they could be used for 
further analysis. Data checking and verification were conducted for the first two 
components. 
 
The OS data were processed in three stages: data clean-up, data adjustments 
and data summary. The first stage mainly dealt with the inspection and organisation of 
the data, including accounting for signal quality. Data adjustments stage was a crucial 
stage involving the identification of high and low saturation oximeters used for the 
BOOST-NZ trial, removal of the trial-imposed offsets and correction of artefact from 
the Masimo oximeters. In the final stage, summary statistics were computed, which 
formed part of the predictors for the regression analysis in Chapter 5.  
 
3.2 Data clean-up  
 The readings from the oximeter were recorded within 24 hours after birth until 
36 weeks PMA or early discharge from the hospital. They were uploaded about once a 
fortnight to a file, which was named according to the baby’s case number and the 
upload date. The files were checked for consistency in the filename and content. 
Whenever necessary, re-labelling of filenames, organisation of data for each baby, 
and systematic removal of mismatched or duplicated readings were performed. After 
the database was cleaned and properly organised, the quality of the OS values was 
accounted for. Readings with low signal quality indicated by the oximeter, such as 
‘low indicator quality signal’, ‘low perfusion’, or ‘sensor off’ were discarded. Several 
factors could have contributed to the low signal quality, for instance, malpositioning 
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of oximeter’s probe due to a patient movement, low blood flow to the measurement 
site, or unreliable readings during the initial start-up of the oximeter. Upon advice 
from a pediatrician, readings less than 50% were also omitted, as they are unrealistic 
because no preterm baby would normally survive with such low OS. An algorithm 
that removed the noise in the OS readings and assembled all data is provided in 
Appendix A.1. The following flowchart summarises the clean-up process performed 
for each baby. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Flowchart of data clean-up procedure 
 
3.3 Operation of Masimo oximeters for BOOST-NZ  
The oximeters used for the BOOST-NZ trial had two features that were 
addressed before the OS data could be used for the ROP-NZ study. The first was the 
trial-imposed offsets for the OS readings. The oximeters used in the BOOST-NZ trial 
had been altered to read either higher or lower than the true saturation for readings 
between 85-95%. A low saturation oximeter displayed 88-96% when the saturation 
was actually lower at 85-95%, that is, the displayed reading is the true reading plus 
3% but bounded above at 96%. Similarly, a high saturation oximeter displayed 84-
92% when the saturation was actually higher at 85-95%, that is, the displayed reading 
Re-labelling and organisation 
of data 
Removal of mismatched or 
duplicated readings 
Removal of low quality 
readings 
Low IQ signal  
OS values < 50%  
Sensor-off  
Low perfusion 
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is the true reading minus 3% but bounded below at 84%. To prevent unmasking, the 
oximeters displayed a transition from true to offset values and vice versa. The 
transition always occurred incrementally over several seconds, showing intermediate 
values between 85-87% for a low saturation oximeter and between 93-95% for a high 
saturation oximeter. 
 
A second feature of the BOOST-NZ oximeters was an algorithmic artefact that 
made it less likely for OS values between 87-90% to be displayed. Instead, they were 
displayed either as higher or lower (mainly higher) values surrounding the region. As 
a consequence, the true values in the region were moved to either side of the region. 
This, in turn, created a ‘dip’ in the frequencies for the affected region.  
 
As the offsets and the dip region masked the true OS values, it is important 
that the affected values be adjusted to reflect what would have been actually read. 
These adjustments must be made before further analysis can be carried out.  
 
3.4 Adjustments for offsets and dip artefact  
 The algorithms to implement these adjustments were developed in two stages. 
The first stage entailed the identification of the oximeter type (high or low saturation) 
for each baby. In the subsequent stage, adjustments were made for the offsets and the 
dip artefact according to the type of the oximeter. The algorithms for the adjustments 
are described in the next two sub-sections, 3.4.1 and 3.4.2.  
 
3.4.1 Procedure for identifying high or low saturation oximeters  
To unmask the oximeter’s type, the OS readings were summarised as relative 
frequencies and plotted for each baby. Upon careful inspection of the relative 
frequency plots, two distinct patterns for the two types of oximeters were identified. 
For the first type, there was an almost-flat region at saturations 85-87% caused by the 
transition mechanism (Section 3.3), and a notable peak at 96% (Figure 3.2).  
38 
 
 
Figure 3.2: A typical OS pattern for low saturation oximeters: SD(85-87%) is smaller 
than SD(93-95%) and a peak occurs at 96%   
 
For the second type, on the other hand, the almost-flat region occurred at 93-
95% and a peak at 84% (Figure 3.3). From these patterns, it was apparent that the first 
corresponded to low saturation oximeters, and the second to high saturation 
oximeters. These patterns were used to distinguish the oximeter’s type. The resulting 
offset identifications were further verified by checking the serial number of the 
oximeter for each baby. To be consistent, babies using the same oximeter should be 
identified as having the same offset. 
 
 
Figure 3.3: A typical OS pattern for high saturation oximeters: SD(93-95%) is smaller 
than SD(85-87%) and a peak occurs at 84%  
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 The procedure to identify the offsets was summarised as follows: 
 Calculate the standard deviation (SD) of the relative frequencies at saturations 
85-87% and 93-95%. 
 Assign a high saturation oximeter if a peak occurs at 84% saturation and 
SD(85-87%) > SD(93-95%); else assign a low saturation oximeter if a peak 
occurs at 96% saturation and SD(85-87%) < SD(93-95%); else treat as 
unassigned. 
 Ensure consistency of the assigned cases by checking that all babies using the 
same oximeter have the same offset. 
 Assign each of the unassigned cases as high or low by matching its serial 
number with those in the assigned group. Note that there were no unassigned 
cases without matching serial numbers in the assigned group. 
 
3.4.2 Algorithm for adjusting offsets and dip artefact  
 Having identified the type of the oximeter, the next step was to develop and 
implement algorithms for adjusting the offsets and the ‘dip’ artefact. Separate 
algorithms were needed depending on the oximeter type. The details for the two 
algorithms are as follows: 
 
(i) Algorithm for low saturation oximeters (offset is +3%) 
 
 
Figure 3.4: Effects of offset and ‘dip’ artefact, as indicated by the circles, for low 
saturation oximeters 
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 Figure 3.4 depicts the distribution of the OS readings from a baby that was 
assigned to a low saturation oximeter. Recalling how the offset for a low saturation 
oximeter was achieved as well as the ‘dip’ artefact presence in the oximeter, the 
following features are relevant. Firstly, there was a three-point flat region at 
saturations 85-87% due to the transition mechanism (described in Section 3.3). 
Secondly, an unusual peak at 96% was also observed, resulting from true saturations 
of 93-95% being returned as 96% along with the true saturation of 96%. Thirdly, the 
‘dip’ region at 87-90% now occurred at 90-93% because of the offset. Therefore, a 
three-step algorithm was developed to estimate the true readings. Each step consists of 
a linear or quadratic interpolation constrained by two reliable end points, and by an 
appropriate conservation of relative frequencies. Using kr and kr
~  to denote the 
displayed and adjusted relative frequencies, respectively for saturation k. The 
algorithm for low saturation oximeters is outlined as follows: 
 
Step 1: Adjust the three-point flat region. 
Estimate 84
~r  and 85
~r  by quadratic interpolation constrained by true relative frequencies 
at saturations 83% and 86% (i.e. 83r  and 89r  before the offset removal), and 
redistributing the relative frequencies in 88:84r  to 85:84r  (see Figure 3.5(a)). Hence, solve  
,2)8584()8584(
,8686
,8383
22
88
84
2
89
2
83
cbar
cbar
cbar
k
k 




 
(3.1) 
simultaneously for a, b and c, and use them to estimate 84r and 85r : 
.85 ,84,ˆˆˆ~ 2  kcbkakrk  (3.2) 
 
Next, remove the +3% offset to recover the relative frequencies at saturations 86% to 
92% by setting 86:92 89:95r r , (Figure 3.5(b)).  
 
Step 2: Estimate 90:87
~r to adjust for the ‘dip’ artefact. Solve for a and b from equations 
bar
bar


91~
86~
91
86
 (3.3) 
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and use these estimates to interpolate linearly the relative frequencies in the ‘dip’ 
region (Figure 3.5(c)), 
.90 ,...,87,ˆˆ~  kbakrk  (3.4) 
      
Step 3: Adjust the region near the peak at 96%.  
Estimate 96:93
~r by quadratic interpolation constrained by true relative frequencies at 
saturations 92% and 97%, and redistributing the relative frequency in 
96r  to 96:93
~r (see 
Figure 3.5(a)). Hence, solve 
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(3.5) 
 
simultaneously. Use the estimates of a, b and c from the three equations to interpolate 
for 96:93
~r (Figure 3.5(d) and Figure 3.5(e)), 
2 ˆˆ ˆ, 93,...,96.kr k a kb c k     (3.6) 
   
 
       
42 
 
 
Figure 3.5 Corrections for offsets and dip artefact for low saturation oximeters 
 
(ii) Algorithm for high saturation oximeters (offset is -3%).   
 
Figure 3.6: Effects of offsets and ‘dip’ artefact, as indicated by the circles, for high 
saturation oximeters 
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 Similar to the low saturation oximeter, the high saturation oximeter also has 
the peak, ‘dip’ artefact, and the three-point flat region. However, the three features are 
located at different saturations (Figure 3.6). A peak was noted at 84%, resulting from 
true saturations of 85-87% being returned as 84% along with the true saturation of 
84%. This peak corresponds to the true reading of 87%; therefore, comprising part of 
the ‘dip’ region (87-90%). The three-point flat region, which is the effect of masking 
the true saturations, is depicted by the circle at 93-95%. An algorithm to adjust for 
these features is described below along with the results of the implementation (Figure 
3.7). 
 
Figure 3.7: Results of corrections for offsets and dip artefact for high saturation 
oximeters 
 
Step 1: Adjust the three-point flat region. 
Adjustment for the region within the three-point values at 93-95% involves estimating 
95r  and 96r  by quadratic interpolation constrained by true relative frequencies at 
saturations 94% and 97% (i.e. 91r  and 97r before the offset removal), and redistributing 
96:92r  to  96:95
~r  (see Figure 3.7(a)). Hence, solve 
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(3.7) 
 
simultaneously for a, b and c, and use them to estimate 95r  and 96r , 
.96,95,ˆˆ~ 2  kcbkakrk  (3.8) 
       
Next, remove the %3  offset to retrieve the true relative frequencies at saturations 
88% to 94% by setting 91:8594:88
~ rr  , (Figure 3.7(b)).   
    
Step 2: Adjust the region near the peak at 84%.  
Estimate 87:84r  by quadratic interpolation constrained by true relative frequencies at 
saturations 83% and 88%, and redistributing the relative frequency in 84r  to 87:84
~r . 
Hence, solve equations 
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(3.9) 
 
to estimate a, b and c. Use them to interpolate for 87:84
~r  (Figure 3.7(c) and Figure 
3.7(d)), 
.87,...,84,ˆˆ~ 2  kcbkakrk  (3.10) 
  
Step 3: Repeat step 2 from the algorithm for low saturation oximeters to adjust for the 
relative frequencies in ‘dip’ region, i.e. 90:87
~r  (Figure 3.7(e)). 
 
Finally, for both algorithms, normalise all relative frequencies from 84% to 96% 
(Figure 3.5(f)) and Figure 3.7(f)), 
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The MATLAB program for the implementation of the two algorithms is provided in 
Appendix A.2. 
    
3.4.3 Validation of the adjustment method  
 The algorithms were validated using data sets obtained from the United 
Kingdom. These data were OS readings from an extremely preterm baby, who 
received ventilation and supplemental oxygen during the study. The baby was 
monitored for two consecutive periods totaling about 24 hours. In the first period, OS 
readings were taken using a low saturation Masimo oximeter, while in the second 
period, a high saturation Masimo oximeter was used. For both periods, a non-offset 
Siemens oximeter was also used as benchmark. 
 
 Each algorithm (refer Sections 3.4.1 and 3.4.2) was then implemented on the 
corresponding offset Masimo readings, and the results were compared with the 
Siemens recordings. Figures 3.8 and 3.9 show the unadjusted (blue line) and adjusted 
data (red line) alongside the Siemens data (brown line). It can be seen that the 
adjusted data are remarkably close to the Siemens data. Using the algorithms, all of 
the three features – the peak, ‘dip’ artefact, and three-point flat region – that appear in 
the lower and higher saturation target oximeters have been adjusted successfully to 
determine the true OS recordings. 
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Figure 3.8: Comparison of unadjusted and adjusted readings from a Masimo low 
saturation oximeter and a Siemens oximeter  
 
 
Figure 3.9: Comparison of unadjusted and adjusted readings from a Masimo high 
saturation oximeter and a Siemens oximeter  
 
3.5 Summary statistics for the OS data 
 After the preceding pre-processing stages, the adjusted OS readings for each 
baby were checked to ensure that there is adequate data for obtaining OS summary 
statistics. 
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3.5.1 Checking for incomplete data  
 Readings of OS of each baby were recorded once every 10 seconds by a 
Masimo pulse oximeter. Therefore, a complete recording for a week for each baby 
should contain 60,480 data points. However, in reality some data points may be 
missing; this is indeed the case for the NZ-ROP data. Figure 3.10 illustrates that about 
65-80% of the babies have almost complete weekly data (99%), whilst only 5-10% of 
babies have about 50% of weekly data. These results suggest that the occurrence of 
missing data is low and hence should not affect the computation of OS summary 
statistics.  
 
 
Figure 3.10: The relative frequency of infants with percentage of missing points in 
NZ-ROP data  
 
3.5.2 Data summary  
 The last step in the pre-processing procedure was to define statistical 
summaries for the OS readings. Four summary statistics were selected to measure the 
variability and level of OS: mean (meanOS), standard deviation (sdOS), coefficient of 
variation (cvOS), and desaturation (dstOS) of OS. The meanOS served as a measure 
of the OS level, sdOS and dstOS were measures of the OS variability, and cvOS 
measured the OS variability relative to its mean. These statistics are defined as 
follows: 
meanOS = ,~
100
50

k
krk  (3.12) 
  
sdOS = ,meanOS~ 2
100
50
2 
k
krk  (3.13) 
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cvOS ,meanOSsdOS  (3.14) 
and 
dstOS = 
80
50
,k
k
r

  (3.15) 
 
where kr  is assumed to be kr  for k < 84% or k > 96%.  
 
3.6 Summary 
The OS data were obtained from a multi-centre randomised control trial; they 
were recorded using Masimo oximeters. However, these data cannot be used directly 
for the NZ-ROP project due to some features that resulted from the design of the 
oximeters. Therefore, the data were pre-processed in several stages, which included 
data adjustments and data summary. The oximeters had trial-imposed offsets and 
machine artefact, both of which affected the readings displayed on the oximeters; 
thus, resulting in higher or lower saturations readings between 85%-95%. To adjust 
for these two features, algorithms based on linear and quadratic interpolations were 
developed. Subsequently, these algorithms were validated using data sets of an 
extremely preterm baby from the United Kingdom, which consisted of offsets and 
non-offset OS data. The result was satisfactory; the adjusted data were very close to 
the non-offset data; hence, suggesting that the features had been carefully adjusted to 
reflect the true OS readings.  
 
The final pre-processing stage was the computation of the OS summary 
statistics. However, to ensure adequacy of data for the computation, the total record of 
available OS readings in each baby was checked. A close inspection on the data for 
the period of 28 to 35 weeks PMA revealed that at least two-thirds of the babies had 
nearly 99% of weekly data. Nevertheless, there was a small percentage (5-10%) of 
babies, of whom half of their weekly data were missing. The low percentage of 
missing weekly data for each baby should not affect the computation of the OS 
statistics. Four OS statistics were then defined to measure the variability (cvOS, sdOS, 
and dstOS) and level (meanOS) of OS; these statistics were part of the predictors for 
the regression analysis in Chapter 5. 
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CHAPTER 4 
METHODOLOGY FOR NZ-ROP 
 
4.1 Introduction  
The first objective of the NZ-ROP project is to establish whether four OS 
summary statistics are associated with the risk of extremely preterm babies 
developing severe ROP. These measures, as defined in Chapter 3 (Section 3.5.2), 
however, need to be computed upon specification of a time interval. In this chapter, 
the methods used to analyse the NZ-ROP are described, which include the techniques 
for identifying relevant time interval to summarise the OS data, strategy for 
developing predictive models, statistical modelling using logistic regression and 
validation procedure for the models. The chapter is concluded with a detailed 
description of methods for examining the degree of relationship of each predictor with 
severe ROP. 
 
4.2 Time interval to summarise the OS statistics 
 The OS data were electronically sampled every 10 seconds. There were two 
issues with these data that must be addressed before they can be used for the 
calculation of the OS measures: specifying sufficient amount of data and identifying 
time period that could detect the fluctuations of neonatal oxygenation. Previous 
studies were examined to investigate the effects of oxygen fluctuations on preterm 
babies. It was noted that the data were aggregated: five and 10 days of receiving 
oxygen therapy (York, et al., 2004); weekly for three (Cuninngham at al., 1995); four 
(Flynn et al., 1992); and eight (De Fiore at al., 2010; Saito et al., 1993) consecutive 
weeks of postnatal age. Aggregation of one week data is in accord with the guidelines 
for retinal screening of premature babies (Fierson et al., 2013) with the 
recommendation that babies need to be examined from as much as once in three 
weeks down to within one week depending on the categories of risk. This information 
lends support that a week of data was sufficient for quantifying the OS data. In 
Section 3.5.1, it has been demonstrated that the total recording of OS measurements 
for each baby was adequate for weekly data summaries. 
 
50 
 
 For the second issue that is to determine the appropriate time period for the 
calculations of the OS measures, a pediatrician was consulted and the factor of time 
throughout the course of ROP was considered. Over the range of birth weight up to 
1250 gram, ROP has been shown to develop from about 32 to approximately 41.5 
weeks PMA (Good et al., 2005), and progressed to severe ROP at a median of 35 
weeks PMA in preterm babies born less than 25 weeks GA (Coats et al., 2000). The 
development of ROP is characterised by growth of retinal blood vessels (see Section 
2.2) and recent research data have suggested that this disease progresses in two 
distinct phases: the cessation of vessels growth after premature birth and uncontrolled 
growth of vessels that may lead to retinal detachments and blindness (Chen and 
Smith, 2007; Hellstrom et al., 2003). The first phase advances to the second phase at 
about 30–32 weeks PMA. As the timing to intervene medically in the development of 
retinopathy is critical, the pediatrician then recommended that the association between 
the level and variability of OS, and ROP be identified in the earlier weeks of PMA so 
as to curb and prevent more severe ROP cases in very young babies.  
 
Consequently, potential time periods were investigated, which included 
visualising the trend of the group means of the OS measures from 28 until 35 weeks 
PMA. It was necessary to start at 28 weeks PMA since the oldest baby recruited for 
the BOOST-NZ was born at 27 weeks GA. Further, the following was looked into: (i) 
any significant differences between the severe and no severe ROP groups using the 
two-sample t-test, and (ii) the biggest drop or highest peak of the group means in a 
particular week. After evaluating the results across the eight successive weeks, 29 
weeks PMA was used. The justification for choosing this particular PMA is discussed 
in Chapter 5 together with the results of the logistic regression when applied to the 
chosen PMA. 
 
4.3 Logistic regression modelling 
4.3.1 The model 
The logistic regression model is one case of the broader class of generalised 
linear models (GLMs) introduced by Nelder and Wedderburn (1972). A GLM is 
specified by two components: 
 a response variable y that follows one of the exponential family 
distributions, and 
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 a link function, g, which links the conditional mean of the response to a 
linear combination of predictors, that is  Xg )( , where X is a row 
vector of predictors (with 1 as the first element of X when an intercept 
is included), β is a column vector of parameters, and )( XyE .                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 
For a binary logistic regression model (Cox, 1958), the response variable is 
1y  or 0, which corresponds to the presence or absence of an event. The link 
function in this case is    1log)(logit)(g ; hence, the model can be written 
as      
)exp(1
)exp(
Xβ
Xβ

 . (4.1) 
     
Parameter estimation 
 Logistic regression models were fitted in MATLAB (The MathWorks, Inc 
1984-2010) using the ‘glmfit’ function. The function employs the iterative reweighted 
least squares (IRWLS) and produces the estimates for the regression coefficient ˆ j  of 
j-th predictors, standard error  ˆ jSE   and p-value.    
  
4.3.2 The response and predictors of the logistic regression  
 The records of all eye examination visits of 257 babies were examined (i) to 
confirm the end point of the eye examination, and (ii) to determine the binary status of 
ROP stage. For each baby, an ophthalmologist verified the most advanced ROP stage 
and classified the status as either presence (‘1’) or absence (‘0’) of severe ROP. These 
binary judgements were the response variable (y = 1 or 0) in the logistic regression 
models. 
  
There were 11 predictors considered in the analyses,  
 the four OS measures: cvOS, sdOS, meanOS, and dstOS, 
 weight at birth (weight), which  is recorded in grams,  
 age at birth (GA), which is measured in days; GA was not categorised by week 
(23 to 27 weeks GA) because of the small number of severe ROP babies in 
three of the GA categories (23, 26, and 27 weeks GA),  
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 gender with ‘1’ as male and ‘0’ as female, 
 number of days receiving ventilation during hospitalisation (daysVentilate),  
 number of days receiving supplemental oxygen during hospitalisation 
(daysO2),  
 dependency on supplemental oxygen at 36 weeks PMA (O2W36) with ‘1’ as 
presence of dependency and ‘0’ as absence of dependency,  
 weight-for-GA (wGA), which was formed from the information of weight 
combined with GA. It has been suggested that monitoring of babies classified 
by birth weight alone may introduce bias in identifying infants who are at risk 
of a poor outcome as there is no distinction of the size for age and maturity 
(Roberts and Lancaster, 1999). wGA was categorised according to the 
Australian national birth-weight-for-GA percentile charts (Roberts and 
Lancaster, 1999). To create the categories for the percentiles, the sparseness of 
the data in the large-for-GA (>75th percentile) and small-for-GA (<25th 
percentile) groupings was considered. Therefore, the data were divided into 
three percentile groups and were coded as follows: 1, >75th (reference group); 
2, 25th to 75th; and 3, <25th.  
 
The set of the 11 predictors consists of eight continuous predictors, two binary 
predictors, and one categorical predictor. To gain a better understanding of each 
predictor, their profile based on kernel densities and box plots were constructed 
separately for the severe ROP and no severe ROP groups. These series of plots are 
useful in discovering the structure of the data, in that potential distinct patterns 
between the two groups and outlying observations are highlighted.  
  
To complement the graphing of the data, the independent two-sample t-test, 
was applied to test for a difference in the group means between the severe and no 
severe ROP groups for the continuous predictors. Likewise, for the binary and 
categorical predictors, the chi-squared test was used to examine if there exists a 
difference in ROP status due to these predictors: gender, O2W36, or wGA.  
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4.3.3 Collinearity  
 Regression methods are sensitive to correlated predictors. When one or more 
predictors are linearly related with other predictors in the data set, this could 
potentially produce unreliable parameter estimates with inflated standard errors; thus, 
reducing the power of testing the affected coefficients (Belsley et al., 1980). To detect 
collinearity, one could examine the pairwise correlation coefficient, together with the 
95% confidence interval (CI). Alternatively, we could identify collinearity by 
computing the variance inflation factor (VIF) (Marquardt, 1970) computed from 
21 (1 )jR , 
2
jR  is the square of the multiple correlation of the j-th predictor regressed on 
the other predictors in the model.  
 
 To handle collinearity, the predictors were separated into groups as follows: 
 predictors with pairwise correlations of about 0.8 and above (ignoring the 
sign), and with extremely high VIF were grouped together, and 
 predictors not correlated with non-group members were grouped individually. 
 
In any given model, the combinations could consist of at most one predictor from 
each group of the strongly correlated predictors.   
 
4.3.4 Predictor selection 
 Predictor selection is a difficult but an important task, which requires one to 
consider carefully depending on the inferential goals and the nature of the data set. Of 
the various procedures for entering predictors into the model, the commonly used 
procedure is stepwise selection (Miller, 2002). For studies with a large number of 
predictors (say, more than 50), the stepwise selection provides a practical way of 
dropping predictors that do not contribute to the model. Its usage, however, has not 
been without criticism. It can only produce a single model with no guarantee of being 
a good one as it is capable of producing poor parameter estimates (Chatfield, 1995). 
The resulting model can be misleading as some authentic predictors may have been 
omitted, or a number of predictors with deleterious effects may have gained entry 
(Derksen and Keselman, 1992).  
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The alternative procedure that was used in this project was all-subsets 
regression, which produced single- and multi-predictor models for all possible 
combinations of predictors (Miller, 1990). There was different combination of 
predictors in each model; thus, the predictions for babies at risk of developing severe 
ROP differ as well. Additionally, an approach based on a weighted average of the 
models was employed to circumvent the need to base inference on only one or several 
models. Single- and multi-predictor models, and model averaging approaches were 
then used to analyse potential association between the predictors and severe ROP. The 
following sections provide the outlines for the three analyses.  
 
4.3.5 Single- and multi-predictor analyses  
We examined all models that were obtained from the all-subsets regression. 
The results for single-predictor models were discussed in terms of the odds ratio 
(OR), p-value, as well as fitted probabilities of severe ROP and no severe ROP for 
selected predictors. The unadjusted OR is estimated as 
 
 ˆOR exp X   (4.2) 
 
and the corresponding 95% confidence limits for the OR are 
  ˆ ˆexp 1.96X SE     , where X  interquartile range of predictor for 
continuous predictors, and 1X   for categorical predictors. Note that the ORs for 
continuous variables depict the odds of severe ROP for patients at the 75th percentile 
of the distribution of the variable versus patients at the 25th percentile.  
 
For the analysis of multi-predictor models, the models were ranked according 
to their respective AUC (refer to Section 4.5.2 and Section 4.6.3), and the number of 
occurrences of each predictor in the list of the first ten top models was recorded. The 
fitted probabilities of severe ROP and no severe ROP also were plotted to assess the 
prediction performance of several top models.  
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4.3.6 Model averaging analysis  
The degree of relationship between the predictors and severe ROP is likely to 
vary in the single- and multi-predictor models. Thus, a model averaging approach was 
undertaken to determine the degree of relationship between each predictor with severe 
ROP. This approach takes into account all models, hence all predictors, and weights 
the predictors accordingly. The analysis was based on three model-averaged 
measures: the p-values and ORs (with 95% CI) for each predictor that were computed 
by averaging over all models that contain the specific predictor, and fitted 
probabilities for severe ROP and no severe ROP groups that were computed by 
averaging over all models.  
 
Let J be the set of indices of models that contain predictor j. The model-
averaged p-value and model-averaged OR would have the form  
 
, ,( ),m j m j
m J
w f x

  (4.3) 
 
where f is a function of xmj for predictor j in model m, and 
 
,
AUC
AUC
m
m j
u
u J
w



 
(4.4) 
 
i.e. wm,j are the normalised AUCs over all u models that contain predictor j. By 
definition, ,0 < 1m jw  and , 1m j
m J
w

 for fixed j.  
 
Following from equation (4.3), each measure that is constructed in this form 
will be a weighted average of some function f of predictor j in model m. For model 
averaged p-value, , ,( )m j m jf x P , where Pm,j denotes the p-value of predictor j in 
model m and for model-averaged OR, , ,( )m j m jf x OR , where mjOR  denotes the OR 
of predictor j in model m, as obtained from equation (4.2). The latter is accompanied 
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with a model-averaged 95% CI, 
, , , ,,m j m j m j m j
m J m J
w L w U
 
 
 
 
  , where mjL  and mjU are, 
respectively, the lower and upper confidence limits for mjOR .  
 
 The model-averaged fitted probabilities are computed as ˆ ,m m
m M
w

 π where ˆ mπ  
is a vector of fitted probabilities of severe ROP for the observations in model m, and 
m
m
m M
AUC
w
AUC



are the normalised AUCs over all M models, with 0 < 1mw  and 
1m
m M
w

 .  
 
In the model-averaged analysis, the degree of relationship of each predictor 
with severe ROP was ranked according to its respective model-averaged p-value. 
Accordingly, the OR of the predictor was evaluated, and the model-averaged fitted 
probabilities were summarised in the form of boxplots. These results were then 
compared with those obtained from the single- and multi-predictor models, and the 
relations between these predictors and severe ROP were summarised. 
 
4.4 Diagnostics 
 Careful fitting of the statistical models during the model building is important 
to avoid losing clinically important predictors, especially after adjusting for other 
predictors. Before these models can be concluded as being adequate for the data, they 
need to be checked for an appropriate functional form for each (continuous) variable, 
and for any outlying observation in the data.  
 
Several diagnostic tools were used to accomplish the two aspects. For the first 
part, a direct way of checking was to plot the smoothed partial residuals from the 
logistic models and the Generalised Additive Models. For detecting outlying points, 
approximated jacknife residuals (Williams, 1987), Cook’s statistic (Cook and 
Weisberg, 1982), hat matrix (Belsley et al., 1980) and a diagnostic measure from the 
robust logistic regression (Cantoni and Ronchetti, 2001) were visually and jointly 
assessed.  
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It is important to identify outlying points as their presence not only affects the 
parameter estimates but also other statistics computed from the model. As a result, 
this causes the regression relationship to appear to look stronger than it is, or non-
existant leading one to abandon the model. Once the outlying points were detected, 
the sources of the errors were identified and the degree of their discrepancy on the 
data was assessed. This included analysing the data with and without the suspect 
observations.   
 
4.4.1 Linearity assumption for continuous predictors  
 At the predictor selection stage, it is quite common to assume that each 
predictor is linearly related to the log odds of the response. This assumption, however, 
may not always hold after the initial modeling of the predictors. The subject matter 
knowledge was taken into account to assess the appropriate scale of the predictors and 
to guide the transformation of the predictors. Increased variability in oxygenations 
(York et al., 2004), desaturation episodes (De Fiore et al., 2010), and duration of 
oxygen therapy (Gallo et al., 1993) have been reported to be associated with the 
development of ROP. On the other hand, GA and weight have been found to have the 
opposite effect on the risk of severe ROP (Darlow et al., 2005).    
 
Logistic regression partial residuals 
The first approach to assess the parametric scale for each continuous predictor 
was to use the partial residuals from the logistic model. A plot of the partial residuals 
against a predictor is helpful, in that the linearity of a predictor can be examined on 
the basis of other predictors. Along with the plot, a lowess smoother (Cleveland, 
1993) was applied on the residuals to create a clearer visual of the functional shape. 
The partial residual ijz  from a logistic regression model for the i-th observation of the 
j-th predictor, ijx , as given by Landwehr, et al. (1984) is 
 
ˆ ˆ ,
ˆ ˆ(1 )
i i
ij ij j
i i
y
z x


 

 

 (4.5) 
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where the first term corresponds to the variance-adjusted residual, jˆ  is the parameter 
estimate for the j-th predictor, iy  is the i-th response, and iˆ is the predicted 
probability of severe ROP for the i-th observation. 
 
Generalised additive logistic model 
As an alternative, the structure of a continuous predictor can be evaluated by 
fitting a generalised additive logistic model (GAM), which is defined as  
     
logit  0
1
( ) ,
p
j j
j
f x 

   (4.6) 
 
where 0  is the intercept parameter, )(jf  is a smooth nonparametric function of the 
j-th predictor, and p is the number of predictors.  
 
Additive models were enhanced by Hastie and Tibshirani (1990), the former 
author who developed the gam library in R. The library offers two types of smoother, 
cubic spline and lowess. The degree of smoothing depends on the smoothing 
parameter; higher penalties are imposed for more complex nonparametric fitted 
curves. gam uses the back-fitting algorithm, which is well-discussed in Hastie and 
Tibshirani (1990). The fitting process for a GAM involves two levels of iteration. The 
first iteration entails the GLM fitting using IRWLS procedure and the second iteration 
implements the back-fitting algorithm to estimate the jf s for the additive model 
(Faraway, 2006: Chapters 6 and 12). 
      
We experimented with both cubic spline and loess smoothers with several 
values of smoothing parameter on the eight continuous predictors. The differences in 
the results were very minimal between the two smoothers; for cubic spline, there was 
not much improvement when applying a smoothing parameter greater than three. 
Consequently, a cubic spline with a smoothing parameter equals to three was 
employed.  
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Piecewise linear regression model 
The fit of a GAM provides a smoothed estimate of the predictor effect which 
can then be plotted to check for nonlinearity. In the case when the linearity 
assumption is violated, it could indicate an appropriate transformation required for a 
predictor. For strong violations of the assumption, for instance a U-shaped 
relationship, an extra (or multiple) term can be flexibly added to the predictor. 
Polynomial and piecewise linear regressions (also known as linear splines) are among 
the common choices for the expansion. The latter (Smith, 1979) generally consists of 
at least two segments of linear fit with a continuous joint between the segments; this 
joint is also known as the knot. With two line segments and a knot, a single-predictor 
piecewise model for a logistic regression can be written as  
    
logit ),()()( 210 kxIkxx jjj    (4.7) 
 
where k is the position of the knot, and )(I  is the binary indicator variable of the j-th 
predictor, that is, 1)( AI  if A is true and 0 otherwise.  
 
4.4.2 Logistic regression diagnostics 
The discussions of outliers in regression normally involve detecting and 
handling several types of outliers; these include identification of outliers from the 
influential observations and large leverage values. Leverages are not necessarily 
influential points but have the potential to affect the fit.  A leverage ih  of the i-th 
observation can be extracted from the diagonal elements of the hat matrix H 
(Pregibon, 1981), 
 
21121 )( WXWXXXWH TT  , (4.8) 
 
where W is a n n  matrix of weights from the IRWLS procedure for fitting GLMs, 
and X  is the ( 1)n p  design matrix of predictors.  
 
For detection of the influential observations, we used the Cook’s distance 
(Pregibon, 1981), which measures the overall influence of each observation on the 
parameter estimates. The influence statistic is   
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
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C i
TT
i
i
WXX
, (4.9) 
 
where iβ-
ˆ  denotes the estimates of the parameters with the deletion of the i-th 
observation from the data.  
 
 The third diagnostic measure to check for the unusual points is a half-normal 
plot of approximated jacknife residuals. In the plot, the absolute residuals for n 
observations were sorted and compared with the quantiles of the half-normal 
distribution, 








12
1
n
in
, for i = 1,…, n. With all points in one tail, we did not 
anticipate a straight line trend as the residuals were not expected to be normally 
distributed. Instead, we looked for those points that deviate from the trend. The 
residuals developed by Williams (1987), with the deletion of i-th observation, 
represent the approximation to the jacknife residuals: 
 
2 2
, , ,(1 )L i i SD i i SP iz h z h z   , (4.10) 
 
where , ˆ ˆ ˆ( ) (1 )(1 )SP i i i i i iz y h       and  , ˆ (1 )SD i i i i iz sign y d h   . The 
numerator for the former is known as the Pearson residual, and for the latter the 
deviance residual. To define id , let 
yyyf  1)1()|(   denote the Bernoulli 
likelihood function for π evaluated at y, then ])ˆ|()|(ln[2 iiiii yfyyfd  .  
 
 There is, however, no exact threshold value as to what constitutes a large 
leverage and Cook’s statistic values. Several rule-of-thumbs have been suggested 
from the literature; for example, a leverage is suspected of being an outlier when 
nphi )1(2   (Hoaglin and Welsch, 1978). However, Belsley et al. (1980) warned 
that in general this cut-off detects too many high-leverage values. The same issue 
occurs for the Cook’s statistic. To be stringent with the cut-off, we fixed the threshold 
to np )2(2   for leverage and )22(8  pn for iC (Belio, 2005). 
   
61 
 
Detection for outliers in multiple regressions based on conventional 
procedures can frequently be a difficult task, especially if multiple extreme values 
exist in the data set or the number of predictors is large. Observations with high 
leverage may sometimes fail to stand out in the diagnostic plots, and so the regression 
analysis will produce poor results. In the view of this, the robust regression was 
considered and used in tandem with the conventional procedures.   
 
4.4.3 Robust logistic regression diagnostics 
 The application of the robust methods is not limited to estimation and 
hypotheses testing in regression. Because the estimators are developed so that they are 
resistant to the outliers, the procedure can also be used to screen for outlying points. 
There are three main approaches toward the robustness problem in regression: the 
Huber-type M-estimation (Huber, 1981) for detecting outliers in the y-direction; the 
Mallows-type bounded influence estimation (Mallows, 1973) for a moderate 
percentage of outliers in the x-direction, or high leverage points; and the high 
breakdown point estimation for a high percentage (at most 50%) of outliers.  
 
Several methods had been developed for the class of generalised linear 
models, for instance the Bianco and Yohai estimator (Bianco and Yohai, 1996; Croux 
and Haesbroeck, 2003), and the Cantoni and Ronchetti estimator (Cantoni and 
Ronchetti, 2001). The latter was used in this analysis. It is an M-estimator of 
Mallows-type, of which the effect of outlying values in the y-direction is controlled by 
placing a bound on the influence function, and in the x-direction by setting weights on 
the observations in the predictors. A suggested bounded function to ensure robustness 
in the y-space is 
( )
ˆ ˆ(1 )
t i
i i
z
 
 (see equation 4.11), whilst a choice of weights to down-
weight high leverage values is the diagonal elements of the hat matrix.  
 
The Cantoni and Ronchetti estimator is defined for a class of robust estimators 
in the general setup of generalised estimating equations. The j-th estimating equation 
can be written as 
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where  
, , ,
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(z) , ,
t
z z t
sign t z t

 
 

 (4.12) 
 
is the Huber function (Huber, 1981) with a tuning constant t, *ih is the i-th diagonal 
entry of 1( )T TX X X X , and 
*
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conditional expectation can be written explicitly as 
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.  
 
  
 The method described by equation (4.11) has been implemented in the 
robustbase library in R via the ‘glmrob’ function. It yields the estimates of the 
parameters along with their standard error and p-value.  The function also returns a set 
of weights with respect to their residual for each observation; these are denoted as the 
Mallows robust weights, 
ˆ ˆ
ˆ ˆ ˆ ˆ(1 ) (1 )
i i i i
t
i i i i
y y 

   
    
   
       
.  
 
4.4.4 Outliers detection 
Identification of multiple outlying points involves several stages. First, the 
sign of the parameter estimates in all models was examined whether it was similar to 
that in the single-predictor analysis and generally indicated in the literature. Models 
that contained parameters estimates with the opposite sign were listed. Next, the 
conventional and robust diagnostic measures for these models were computed and 
plotted concurrently to detect all candidate outliers. The occurrences of suspected 
observations that exceeded the suggested thresholds of the diagnostic measures were 
recorded. The listed models were then re-fitted with the exclusion of the suspected 
observations, and their impact on the sign and standard error of the parameter 
estimates was assessed. Identification of outliers was finalised using the results from 
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these stages.  To determine on how best to handle the outliers, we examined the effect 
of the outliers on the results obtained from the logistic regression and robust logistic 
regression performed on the full data set, and logistic regression with the outliers 
omitted. 
  
4.5  Assessment of models 
4.5.1 Fitting of Model  
In the previous section (Section 4.4.1), the preliminary assessment of the linearity in 
structure of the continuous predictors were described.  The partial residuals from the 
logistic regression models and GAM were plotted and the patterns were noted. Next, a 
test of adequacy of a linear relationship via a likelihood ratio (LR) test was performed 
to verify whether a nonlinear term in the form of cubic spline, piecewise or 
polynomial was worth considering for each predictor.  
 
 The LR test was used to evaluate the change in the deviance between two 
models: a model that was fitted with a linear term and another model that was fitted 
with a nonlinear term. A significant change in the deviance signifies that the model 
with the nonlinear term is significantly different from the linear model, and therefore, 
the nonlinear term is favourable for the predictor. If there are indications from the 
results that a nonlinear term could be needed for the predictors, simpler nonlinear 
parametric models such as linear piecewise or quadratic models are suggested as the 
alternatives to the cubic spline as they are more parsimonious and easier to interpret. 
Separate comparisons were then made between a linear model and a piecewise linear 
model, or between a linear model and a quadratic model. Using the results from the 
linear and nonlinear model fittings, the proposed functional form for each predictor 
was finalised. 
 
Throughout the comparisons between models to verify suitable functional 
forms of the predictors, the LR test was used in conjunction with the Akaike 
Information Criterion (AIC). When two models are compared, a model with a lower 
AIC value is preferred. However, there is often no one single best model when the 
difference in AICs between two models is assessed. Therefore, consideration must 
then be given to other models whose AIC values are close to the minimal AIC (Hilbe, 
2009).  The AIC is defined as 
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AIC = -2LL + 2q, (4.13) 
 
where LL is the model log-likelihood and q is the number of unknown parameters in 
the model. 
 
4.5.2 Measuring the performance of model 
The error rate, ROC curve and the associated AUC are popular measures to 
estimate the performance of binary classifiers such as the logistic regression model in 
the medical research. However, the AUC has been shown to exhibit several desirable 
properties over the error rate including decision threshold independent (Bradley, 
1997). The AUC summarises an ROC curve; its value reflects the overall performance 
of the model in discriminating between babies who will or will not develop severe 
ROP.  A large value of an AUC indicates better discriminative ability of a model. An 
assignment to a class by random chance has an AUC of 0.5 whilst a perfect 
classification corresponds to a maximum AUC value of 1.0, in which all subjects are 
classified correctly. 
  
A common approach to compute the AUC is to construct the ROC curve from 
the sensitivity (the proportion of correctly identified of diseased subjects) and 
specificity (the proportion of correctly identified of non-diseased subjects), as 
calculated from different threshold values, and then to estimate the area under it by 
numerical integration. An easier alternative that does not require explicitly 
constructing the ROC curve is to use the Wilcoxon statistic (Hanley and McNeil, 
1982) to estimate the AUC ( ), that is 
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where ,ˆ , 1,...,D i i v  and ,ˆ , 1,..., ( )ND l l n v   are the predicted probabilities for the 
diseased and non-diseased subjects, respectively, and 
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The estimate is more meaningful when accompanied with a CI. A convenient 
choice would be the approximate 95% CI given by  
 
)ˆvar(96.1ˆ   , (4.16) 
 
provided that the sample size is sufficiently large, and is not near the boundaries. An 
estimate of the variance of ˆ  is given analytically by the DeLong estimate (DeLong 
et al., 1988), which is computed as follows.   
 
For each diseased subject i, compute the quantities 
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Similarly, for each non-diseased subject j, compute the quantities 
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The variance for ˆ  is then estimated as  
 
1 1ˆvar( ) D NDV V
v n v
  

  (4.19) 
 
The all-subsets logistic models were re-fitted to the NZ-ROP data after 
diagnostics of model fits were undertaken. The fitted regression models were able to 
generate a fitted probability of severe ROP for each baby, and this was used to 
calculate the AUC for each model. The performance of the individual models were 
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then assessed by analysing the AUCs. Note that both the AUC and the fitted 
probabilities were computed via a cross-validation technique (Section 4.6.3).  
                              
4.6 Validation of model  
 It is important to examine if a developed model will yield a good predictive 
performance in other data sets. A good calibration of the model requires a validation 
on at least one independent data set. Nevertheless, if this is not feasible, one could 
withhold a percentage of the data from the model fitting process. An ideal procedure 
when the data set is large would be to divide the data into three subsamples: the 
training set for fitting the model, the test set for generating the predictive probability, 
and the validation set for validating the probability. However, when the amount of 
data is limited, sample-reuse validation schemes such as holdout validation and cross-
validation could be employed. These techniques use sampling without replacement, in 
which data are partitioned into two subsets: one serves as the training set and the other 
as the test set.  
 
4.6.1 Basic idea of cross-validation 
 The basic form of cross-validation is K-fold cross-validation. First, the data are 
partitioned into K equally (or almost equally) sized folds. One fold is used for testing 
and the remainder for training. To ensure equal chance of validation for each data 
point, the sets are rotated in K successive iterations such that within each iteration, a 
different fold of the data is held-out for testing and different K – 1 folds are used for 
training. Figure 4.1 demonstrates an example of K-fold cross-validation procedure 
with K = 3. The darker sections depict the subset of data that are used for training 
while the lighter sections represent the subset for testing. Occasionally, the subsets are 
stratified before the validation starts, and the cross-validation is repeated for several 
rounds, hence, yielding a repeat-stratified K-fold cross-validation scheme.  
 
 To compute an overall estimate of a performance metric such as AUC, two 
approaches that utilise the results of the folds during the cross-validation can be used. 
One is the pooling strategy, which involves collecting the model predictions from all 
folds and calculating the AUC on these combined outputs. Another is the averaging 
strategy, in which an AUC is computed separately for each fold and subsequently, 
these AUCs are averaged to produce an overall AUC. 
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       (a) 
 
 
             (b) 
Figure 4.1: Procedure of K-fold cross-validation for K = 3, which displays (a) 
partition of data and rotation of folds for each of the three successive iterations, and 
(b)  training and testing of data within each iteration. 
 
4.6.2 Assessment of several validation schemes 
 Several studies have been carried out to review (Refaeilzadeh et al., 2009) and 
assess various cross-validation and bootstrap procedures (Kim, 2009; Parker et al., 
2007; Kohavi, 1995). A brief summary of the comparison is presented in Table 4.1.  
 
 The studies compared a variety of simulation settings and real-world data with 
differing characteristics to evaluate the performance of most of the procedures (Table 
4.1). Many interesting results were demonstrated, including the 0.632+ bootstrap (a 
variant of the bootstrap) which displays superior performance for small sample case. 
However, it suffers from a bias problem for small and even more for large data, hence 
performing poorly as compared to a repeated cross-validation with ten folds. A repeat 
hold-out scheme faces the same fate as the 0.0632+ bootstrap, in that it also has a bias 
problem, particularly so for small data. Overall, both schemes show less stable 
performance for small and large sample cases. 
 
 
 
 
  
Model fitting, ˆ  
Train 
Model 
 
Test 
Model prediction, ˆ  
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Table 4.1: Evaluation of different validation methods 
Validation method Advantage Limitation 
Resubstitution 
validation 
All available data are used Over-fitting 
   
Holdout validation No overlap between 
training and test set 
Inefficient use of data; 
Results are highly affected 
by the choice of partition 
size for training and test 
sets 
   
K-fold cross-validation Available data are fully 
utilised 
High dependency on the 
choice of K; Higher bias 
for smaller K and data 
   
Leave-one-out cross-
validation 
Nearly unbiased 
performance 
estimation 
Very large variance and 
computationally expensive 
for large data  
   
Repeated K-fold cross-
validation 
Reduced variance  Computationally 
expensive 
   
Bootstrap Low variance; best for 
small data 
Very large bias   
  
The repeated-stratified 10-fold cross-validation was unanimously 
recommended for general use due to its most stable performance as compared to its 
contenders. Its attractive features such as stratification and repeated runs of the 
validation have been identified as being extremely useful for reducing both the bias 
and variability. The choice of K = 10 is often suggested as 90% of the data are used 
for model fitting, hence, allowing generalisability of the results for the case when all 
data are used. Additionally, the cross-validation based on ten folds has less biased 
estimation of model performance; the bias is more apparent with smaller K (Kohavi, 
1995). 
 
4.6.3 Validation for NZ-ROP data 
For the NZ-ROP data, we chose to implement a repeat-stratified 10-fold cross-
validation (RS10CV) based on the following grounds.  
 
1. It was not possible to get an external data set from the same population. The 
BOOST-NZ trial is part of an International Network, which consists of several 
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countries such as Australia, United Kingdom, Canada, Europe, and USA. The OS data 
from these trials were recorded from the Masimo oximeters, which employed 
different algorithms from that of the New Zealand study oximeters. 
 
2. It was not realistic to perform hold-out validation because of the small sample size 
( 41)v   in the severe ROP group. 
 
3. RS10CV appears to be the best method among its competitors. Results from the 
simulation studies (Kim, 2009; Parker et al., 2007; Kohavi, 1995) have shown that 
across the variants of internal validation (resubstitution, hold-out, leave-one-out, K-
fold, repeated-K-fold, and 0.632+ bootstrap), RS10CV has low estimation bias and 
excellent trade-off between bias and variance. It was, therefore recommended for 
various usages such as selection of models, estimation of AUC and error rate, and 
assessment of multiple classifiers. 
 
Cross-validation procedure for AUC and predicted probability 
To examine the performance of a model, and to verify that it could provide 
good prediction for new data sets, the AUC and its 95% CI were computed from 
100,000N   repeats of RS10CV as follows:  
  
1. Stratify the data according to their diseased status, yielding two groups of sizes v 
and (n − v) for the diseased and non-diseased groups, respectively. 
2. Randomly divide each of the groups into ten mutually exclusive folds of equal (or 
almost equal) size. 
3. Combine the diseased and non-diseased groups for each folds. 
4. Treat the first fold as the test set and the remaining nine folds as the training set. Fit 
the regression model to the training set, and obtain the regression estimates. 
5. Apply the regression estimates to the test data, and calculate the predicted 
probability for each observation in the test set. 
6. Rotate all folds and repeat step 4 to step 5 for all ten folds.  
7. Repeat step 2 to step 6 N times. For each repeat, store the predicted probability for 
each observation, that is, ,ˆ , for 1,..., and 1,...,B i i n B N   . 
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8. Estimate an overall predicted probability for each observation by averaging across 
all N repeats, that is, 
,
1
1
ˆ , 1,...,
N
i B i
B
i n
N
 

    (4.20) 
 
9. Calculate an AUC and its 95% CI using the estimated probabilities from step 8 in 
equations (4.14) to (4.19).  
 
4.7 Computational aspects 
 All analyses were conducted in MATLAB (v. 2010a) and R x64 2.12.0. 
Several packages that were used in R were gam, stats, faraway, splines, and 
robustbase. 
 
4.8  Summary  
The methodological background for the NZ-ROP analysis was addressed in 
this chapter. There were two stages of analysis involved: establishing a suitable time 
interval to summarise four OS statistics, and modelling of these measures and several 
additional ROP predictors aiming to investigate the relations between 11 predictors 
and severe ROP, and to identify the key risk predictors for the disease. 
 
The OS data were recorded at every 10 seconds within 24 hours after birth 
until 36 weeks PMA. To determine a suitable interval to compute the summary 
statistics for the OS data, an approach using an analysis of eight PMA weeks was 
used. It took into account the gestational age at birth of the oldest baby recruited for 
the NZ-ROP study. A time interval of 29 weeks PMA was finally chosen as it was 
able to detect the most distinct patterns that help to distinguish between babies with or 
without severe ROP.  
 
 Logistic regression models were developed to estimate the probability that a 
baby is at risk of developing severe ROP. The predictors for the models were weight 
at birth, GA, gender, weight-for-GA, duration of receiving ventilation, duration of 
receiving supplemental oxygen, and dependency on supplemental oxygen at 36 weeks 
PMA. Four new measures of pulse oximeter OS, whose relationship with ROP needed 
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to be determined, were also added to the list of predictors. The response variable was 
defined as the presence or absence of severe ROP.  
  
 Several predictors were identified to be strongly correlated, hence the 
predictors were separated into correlated and uncorrelated groups. Consequently, 
combinations of at most six predictors (from each group) were to be used in any one 
of the models. The models’ adequacy was examined using the conventional and 
robust diagnostic tools, and generalised additive modelling. All-subsets regression, 
which produced single- and multi-predictor models for all possible combinations of 
predictors, was performed to identify predictors that can best describe the 
relationships with severe ROP. The performance of these models was measured by 
their respective AUC, which was validated using a repeat-stratified 10-fold cross-
validation technique. Additionally, an approach based on the weighted average of the 
models was employed to determine the degree of relationship of the predictors with 
severe ROP. The analysis was based on three model-averaged measures: the p-values 
and ORs (with 95% CI) for each predictor, and fitted probabilities for severe ROP and 
no severe ROP babies, which were computed by averaging over all models.  
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CHAPTER 5 
RESULTS AND DISCUSSION FOR NZ-ROP 
 
5.1 Introduction  
Continuous advances in neonatal care have resulted in increased survival of 
babies at risk of developing ROP. It is a vision-threatening complication that could 
progress to visual impairment and blindness in preterm babies when treatment is not 
provided in time. Each year, it is estimated that over 200 extremely preterm babies in 
New Zealand are at high risk of developing severe ROP (Cust et al., 2003) and endure 
ongoing morbidity such as visual deficits (Darlow et al., 1997). 
  
Neonatal examination programmes are currently in practice in many countries 
to enable early diagnose of ROP among high-risk babies. Upon detection, the choices 
on specific treatments or decisions are based on an assessment of patient risk. Careful 
attention to pivotal factors that increase the risk of development of ROP might 
enlighten the role of interventions that could further lower the morbidity rate of this 
eye disease.  
 
A number of studies have been carried out to understand the underlying risk 
factors of ROP with the aim to prevent and control the disease. Among those that 
have been reported to be associated with an increased risk to develop ROP are low 
GA (Darlow et al., 2004), low birth weight (McColm and Fleck, 2001), use of oxygen 
therapy (Lala-Gitteau et al., 2007; Kinsey et al., 1956), and gender (Jacobson et al., 
2009). These factors are widely studied and more understood than that of oxygen 
fluctuations. Further, simultaneous analyses involving many key factors to unveil the 
most prominent ones are limited. Using data of preterm babies admitted to five 
neonatal NICUs in New Zealand, this study aims to provide a comprehensive analysis 
of relations between multiple clinical and postnatal factors and severe ROP. This 
chapter is focused on determining the usefulness of OS summary statistics for 
discriminating babies at risk of developing ROP, and the degree of relationship of 
these statistics and other factors with severity of ROP. Section 5.2 addresses the 
examination on identifying a suitable time interval for OS statistics. This is followed 
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by the details of the regression predictors according to ROP status in Section 5.3. The 
analysis from model fittings and diagnostics are shown in Section 5.4, while the 
results from using some common regression techniques and model averaging 
approach are presented in Section 5.5. The implications and limitations of the study 
are discussed in Section 5.6. All conclusions are summarised in the final section, 
Section 5.7. 
 
5.2 Time interval for computing OS summary statistics 
 As described in Chapter 3, four OS summary statistics were defined to be used 
for the regression analysis to investigate the relationship between measures of OS 
features and severe ROP. The OS data are time series data; hence, the time interval for 
computing the statistics must be determined. To facilitate the analysis, we looked for 
patterns that help distinguish babies with or without severe ROP in order to locate a 
pattern that indicates a good separation between the two groups at a particular time 
interval. 
 
5.2.1 Determining the time interval 
A simple analysis of eight weeks of data from 28 to 35 weeks PMA was 
performed to determine the best time interval for summarising the OS data. The 
following steps were performed for each of the severe and no severe ROP groups:  
 calculate a weekly value of meanOS from 28 to 35 weeks PMA for each baby; 
 calculate a group mean for each individual week; and    
 repeat the above steps for sdOS, cvOS, and dstOS. 
 
Figure 5.1 shows the group means of the four statistics with 95% CI for the 
eight-week time period. Looking closely across all statistics, it can be seen that there 
is good separation between the two groups of babies, as depicted by the non-
overlapping CIs of the mean values, for nearly all PMAs. To verify whether these 
differences are statistically significant, a two-sample t-test was applied to compare the 
group means of each statistic at each PMA. 
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Figure 5.1: Group means (with 95% CIs) of four OS statistics for 28 to 35 weeks 
PMA: first panel, cvOS; second panel, sdOS; third panel, meanOS; and fourth panel, 
dstOS   
 
 Table 5.1 presents the results from the t-test, which reveals that there are 
significant differences in the mean values of the statistics between the two groups of 
babies at nearly all weeks of PMA. This finding suggests that there are significant 
differences in the oxygenation profiles between the two groups of babies. To 
determine a particular time period of PMA(s) that would be appropriate for 
constructing the OS summary statistics, the eight-week OS data were scrutinised more 
closely. 
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Table 5.1: Group means of (a) cvOS, (b) sdOS, (c) meanOS, and (d) dstOS with 
respect to ROP status and PMA 
PMA 
(weeks) 
Mean of cvOS (95% CI) 
p-value 
No severe ROP Severe ROP 
28 0.054 (0.051,0.057) 0.067 (0.061,0.073) 3.0E-04 
29 0.058 (0.055,0.060) 0.068 (0.063,0.073) 1.2E-03 
30 0.059 (0.056,0.061) 0.065 (0.060,0.070) 3.1E-02 
31 0.057 (0.055,0.059) 0.065 (0.061,0.070) 5.2E-03 
32 0.054 (0.052,0.056) 0.063 (0.058,0.068) 3.0E-03 
33 0.052 (0.050,0.055) 0.063 (0.058,0.068) 8.6E-04 
34 0.051 (0.048,0.053) 0.057 (0.052,0.062) 5.0E-02 
35 0.048 (0.045,0.050) 0.058 (0.052,0.065) 1.4E-03 
      
 (a) 
 
PMA 
(weeks) 
Mean of sdOS (95% CI) 
p-value 
No severe ROP Severe ROP 
28 4.969 (4.743,5.196) 6.037 (5.531,6.542) 4.1E-04 
29 5.320 (5.078,5.503) 6.178 (5.737,6.619) 1.3E-03 
30 5.398 (5.207,5.589) 5.888 (5.480,6.297) 4.6E-02 
31 5.250 (5.049,5.452) 5.950 (5.555,6.345) 6.9E-03 
32 5.001 (4.803,5.199) 5.752 (5.357,6.146) 3.5E-03 
33 4.869 (4.656,5.083) 5.747 (5.296,6.198) 1.3E-03 
34 4.740 (4.512,4.968) 5.274 (4.812,5.736) 6.3E-02* 
35 4.469 (4.244,4.695) 5.362 (4.797,5.926) 2.1E-03 
      
 (b) 
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PMA 
(weeks) 
Mean of meanOS (95% CI) 
p-value 
No severe ROP Severe ROP 
28 92.87 (92.48,93.26) 90.93 (90.15,91.72) 1.6E-04 
29 92.51 (92.14,92.87) 90.66 (89.89,91.43) 1.3E-04 
30 92.62 (92.26,92.98) 91.12 (90.38,91.85) 1.3E-03 
31 93.03 (92.63,93.42) 91.30 (90.60,92.00) 6.6E-04 
32 93.50 (93.10,93.90) 91.89 (91.06,92.72) 2.0E-03 
33 93.91 (93.49,94.32) 91.82 (90.89,92.74) 1.0E-04 
34 94.39 (93.98,94.81) 92.93 (91.96,93.91) 6.5E-03 
35 94.79 (94.38,95.20) 92.95 (91.94,93.96) 5.0E-04 
      
(c) 
 
PMA 
(weeks) 
Mean of dstOS (95% CI) 
p-value 
No severe ROP Severe ROP 
28 0.043 (0.037,0.048) 0.071 (0.057,0.085) 3.4E-04 
29 0.049 (0.042,0.055) 0.078 (0.065,0.092) 5.0E-04 
30 0.048 (0.042,0.054) 0.065 (0.052,0.079) 2.3E-02 
31 0.046 (0.040,0.052) 0.063 (0.052,0.075) 2.3E-02 
32 0.039 (0.034,0.045) 0.056 (0.044,0.067) 2.3E-02 
33 0.037 (0.031,0.042) 0.060 (0.046,0.074) 1.7E-03 
34 0.033 (0.028,0.039) 0.045 (0.034,0.055) 9.9E-02* 
35 0.028 (0.023,0.033) 0.048 (0.034,0.061) 2.2E-03 
      
 (d) 
p-values are from t-test for comparing differences in the mean values of OS statistics 
between severe ROP and no severe ROP babies. *p-values > 0.05. 
 
Figure 5.1 illustrates that the group means of cvOS, sdOS, and dstOS exhibit 
similar patterns over time:  (i) an increasing trend followed by a decreasing trend with 
a maximum occurring at 29 weeks PMA, and (ii) higher mean values for severe ROP 
babies. The statistic meanOS displays patterns that are opposite to these. Taken 
together, these indicate that OS has highest variability and lowest level at 29 weeks 
PMA, thus, making it a candidate time interval for summarising the OS data. A 
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further observation from Table 5.1 is that the largest differences (indicated by 
P<0.0005) occur at 28 weeks PMA for cvOS, sdOS, and dstOS; and at 28, 29, and 33 
weeks PMA for meanOS. These suggest that 28 weeks PMA should also be 
considered for summarising the OS data.  
 
Subsequently, in addition to 28 and 29 weeks PMA considered separately, a 
combined data set from both weeks was also assessed. These results are shown in 
Table 5.2. Comparing them with the earlier results for 28 and 29 weeks PMA in Table 
5.1, we see that the p-values for the combined data remain significant for all four 
statistics, and are consistently smaller than those for 29 weeks PMA. Three pairwise t-
tests were then conducted for babies with ROP for the three periods: between 28 and 
29 weeks PMA, 28 weeks PMA and the combined data, and 29 weeks PMA and the 
combined data. Likewise, these tests were also performed for babies without ROP. 
Table 5.3 presents the p-values from the six tests. The results indicate no significant 
difference in the means of OS statistics between the pairwise time periods (the 
smallest p-value, P>0.05). Therefore, any of these three time periods could be used to 
obtain the OS summary statistics for the regression analysis for investigating the 
influence of risk factors for severe ROP.   
 
Table 5.2: Group means of cvOS, sdOS, meanOS, and dstOS, with respect to ROP 
status, based on a combined data set of 28 and 29 weeks PMA 
OS statistic 
Mean (95% CI) 
p-value 
No severe ROP Severe ROP 
cvOS 0.057 (0.055,0.059) 0.068 (0.063,0.073) 5.3E-04 
sdOS 5.242 (5.035,5.448) 6.146 (5.704,6.587) 8.4E-04 
meanOS 92.65 (92.28,93.10) 90.80 (90.03,91.57) 1.1E-04 
dstOS 0.046 (0.040,0.052) 0.074 (0.061,0.088) 1.9E-04 
      
p-values are from t-test for comparing differences in the mean values of OS statistics 
between severe ROP and no severe ROP babies; the differences between the two 
groups are significant. 
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Table 5.3: P-values from t-test for comparing differences in means of OS statistics 
between pairwise time periods in severe ROP and no severe ROP babies 
OS 
statistic 
No severe ROP  Severe ROP 
T1 vs. T2 T1 vs. T3 T2 vs. T3  T1 vs. T2 T1 vs. T3 T2 vs. T3 
cvOS 0.0637 0.1245 0.7296  0.6599 0.7478 0.9005 
sdOS 0.0531 0.1018 0.7431  0.6801 0.7510 0.9198 
meanOS 0.2268 0.4342 0.6589  0.6264 0.8057 0.8073 
dstOS 0.2158 0.4897 0.5613  0.4798 0.7331 0.6981 
        
Time periods are indicated as T1: 28 weeks PMA; T2: 29 weeks PMA; and T3: 
combined 28 and 29 weeks PMA. 
 
Hence, a separate all-subsets regression was conducted involving OS statistics 
derived from each time period. The results from the three regression analyses were 
quite similar, in that, the predictor variables that were significantly associated with the 
ROP status were the same – albeit a slight difference in the regression coefficients. 
However, the AUC of the models were slightly higher and the p-values of the 
regression coefficients were much smaller (by at most 86%) for 29 weeks PMA. 
Hence, only the results based on 29 weeks PMA will be presented in this chapter in 
Section 5.5. 
 
5.2.2 Discussion 
Recent studies have shown that mature babies tend to have increased and more 
stable OS levels (Hofstetter et al., 2007), whilst babies with complications of 
prematurity such as chronic lung disease are more likely to exhibit lower OS levels, 
leading to greater frequency of desaturation episodes (McEvoy at al., 1993). Using 
continuous OS monitoring by oximeters, we observed higher OS variability (cvOS, 
sdOS, and dstOS), and lower levels (meanOS) in babies with stage 3 ROP and above, 
or requiring laser therapy, which are in accordance with the findings from the 
previous studies. 
  
Previous findings that increased oxygen fluctuations occur in the earlier weeks 
of life rather than later (York et al., 2004; Cunningham et al., 1995; Saito et al., 1993) 
are quite compatible with our observations at 28 and 29 weeks PMA for babies with 
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severe ROP. In those studies, which used intermittent sampling of oxygenation, the 
CV of arterial oxygen (York et al., 2004; Saito et al., 1993) and SD of oxygen tension 
(Cunningham et al., 1995) were significantly elevated in babies with threshold ROP 
(York et al., 2004) or with stage 3 or higher ROP (Cunningham et al., 1995; Saito et 
al., 1993) within the first two weeks after birth.  
 
In an early study of ROP (Pierce at al., 1996), it was suggested that irregular 
hypoxic events in oxygenation may induce abnormal retinal development in the later 
phase of ROP.  This was then supported by Di Fiore et al. (2010), who reported that 
babies who went on to develop severe ROP requiring laser therapy had higher 
hypoxic events, with an increasing trend during the first four to five weeks of life. 
Their data were recorded at 2-second sampling rate, and a desaturation or hypoxic 
event was defined as a fall in OS below 80% for duration between 10 seconds and 3 
minutes. The babies were born at 24 to 27 weeks GA. In our study, we used a 10-
second sampling rate, and defined dstOS as the percentage of OS readings below 
80%. The babies had almost similar ages as those in the Di Fiore et al. (2010) study. 
Our data show higher dstOS in babies with severe ROP than in the other group of 
babies with an increasing trend observed during 28 to 29 weeks PMA (refer Table 
5.1), which agree well with Di Fiore et al.’s (2010) results.  
 
There have been numerous threads of evidence pointing out the importance of 
time course, starting from 30 weeks PMA, in relation to the progress of ROP. One 
study (Good et al., 2005) observed that the vision threatening disease started to 
develop from about 32 to approximately 41.5 weeks PMA. Another (Coats et al., 
2000) found that progression to severe ROP occurred at a median of 35 weeks PMA 
in preterm babies born less than 25 weeks GA and of birth weight up to 1250 gram. 
The progress of ROP from phase one to phase two (as described in Section 4.2) has 
been suggested to be associated with oxygen-regulated growth factors, VEGF and 
IGF-1 (Smith, 2005; Chen and Smith, 2007). Hellstrom and colleagues (2003) 
measured the mean of IGF-1 prospectively at a weekly interval; the growth factor was 
most deficient at 30-33 weeks PMA among severe ROP babies compared to less 
severe or no ROP babies. They concluded that low IGF-1 levels after preterm birth 
appeared to inhibit retinal vascular development. Smith (2005) further showed that 
when the cessation of blood vessel development persisted until 30-32 weeks PMA, 
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hypoxia that precipitates the second phase of retinal detachments and loss of vision 
will occur.  This second destructive phase can be avoided if some preventive 
measures are taken during the chain of events in the first phase.  
 
These studies reiterated that the timing of changes in the course of ROP 
development is important. They showed that some of the factors contributing to the 
first phase of ROP were observed from 30 weeks PMA in a premature child.  In our 
data, we noted that there were marked differences in the OS statistics between babies 
with and without severe ROP, with higher variability and lower levels of OS in severe 
ROP babies in the earlier weeks of PMA, particularly 28 and 29 weeks. It may 
therefore be possible to examine and hence detect the retinal disorder as early as 28 
weeks PMA.  
  
5.3 The response and predictors for logistic regression  
The study population included 257 preterm babies from 23-27 weeks GA. 
They were admitted to five hospitals: Christchurch Women’s Hospital, National 
Women’s Hospital, Middlemore Hospital, Wellington Hospital, and Dunedin 
Hospital, between September 2006 and December 2009. This cohort represented 
85.4% of the 301 BOOST-NZ babies that survived until 36 weeks PMA. The 257 
babies were divided into two groups based on their individual highest stage of ROP. 
41 babies were categorised into the severe ROP group (‘1’), comprising stage 3 and 
above or requiring laser surgery. The remaining 216 were placed into the no severe 
ROP group (‘0’), comprising babies with no ROP (115, 44.7%), ROP stage 1 (60, 
23.3%), and ROP stage 2 (41, 15.9%), all of whom did not require laser surgery. 
 
The percentage of severe ROP in extremely premature babies in New Zealand 
for the 40-month period was 13.6% (41/301), which was comparable with 15.0% of 
the Australian (Gunn et al., 2012) and 16.0% of the American (SUPPORT Group, 
2010) studies. Severe ROP was also seen in 14.8% in a German (Schwarz et al., 2011) 
study. These figures have been summarised in Chapter 2, Table 2.1. When comparing 
the incidence of severe ROP in New Zealand over a 12-year period, it was noted that 
the incidence based on BOOST-NZ data was higher (P=0.0079) than the rate 6.9% 
(20/288) seen in the 1998-1999 study (Cust et al., 2003). Overall, premature babies 
survival improved slightly, from 79% in 1998-1999 to 89% in 2006-2009 (P=0.0004). 
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With relatively small sample size in both studies, the observed increased (from 42% 
to 65%) survival of 23 weeks GA babies was not significant (P=0.2021). However, 
there was a particular rise (from 68% to 84%) in survival of 24-25 weeks GA babies 
(P=0.0014). 
 
Recent reports have indicated that over the past two decades, incidences of 
certain prematurity problems including respiratory and ROP illness have been rising 
in developed countries (Slidsborg et al., 2008). Such complications, however, are in 
accordance with the improved survival rate of very premature babies due to 
improvement in fetal monitoring technology and neonatal intensive care (Horbar et 
al., 2012). Our results support these trends, showing more premature babies survived 
from 1998 to 2009.  
 
5.3.1 Characteristics of severe ROP and no severe ROP babies 
Table 5.4 summarises seven postnatal variables, and four OS statistics 
according to the ROP status; these variables are the predictors for the regression 
models. The entries for weight and GA in Table 5.4 show that babies in the severe 
ROP group tend to be smaller (P=3.2E-08) and younger (P=1.8E-07). This is also 
observed in the composite variable wGA, where the percentage of severe ROP babies 
is higher in the <25th percentile category (34% vs. 16%, P=0.012). Additionally, they 
have significantly higher duration of ventilation (mean 28 days vs. 9 days, P=2.2E-11; 
median 23 vs. 4 days, P=6.5E-07) and supplemental oxygen (mean 102 days vs. 52 
days, P=1.7E-09; median 100 vs. 43, P=2.3E-06). Since the severe ROP babies 
require extended intensive care due to late recovery from respiratory problems, this 
might perhaps explain for their dependency on oxygen at 36 weeks PMA (P=4.3E-
05). Prematurity, weight, and prolonged exposure to oxygen therapy have been 
consistently identified as the risk factors for ROP (Wilkstrand et al., 2011; Di Fiore et 
al., 2010).  
 
Overall, there are more male babies in the study (139, 54%), but there is no 
significant difference between the severe ROP and no severe ROP babies (P=0.688). 
As discussed previously in Section 5.2, the mean values (at 29 weeks PMA) between 
the two groups differ for cvOS, sdOS, dstOS, and meanOS. 
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Table 5.4: Summary of severe ROP and no severe ROP babies 
Variable 
Severe ROP 
(n = 41)a 
No severe ROP 
(n = 216)a 
p-valueb 
cvOS 0.068 (0.017) 0.058 (0.019) 1.2E-03 
sdOS (%) 6.18 (1.44) 5.32 (1.64) 1.9E-03 
meanOS (%) 90.7 (2.53) 92.5 (2.82) 1.3E-04 
dstOS  0.078 (0.044) 0.049 (0.049) 5.0E-04 
 [0.079 (0.048, 0.110)] [0.035 (0.013, 0.072)] 5.2E-05 
weight (g)  730 (157) 917 (199) 3.2E-08 
GA (weeks) 25.3 (1.2) 26.3 (1.1) 1.8E-07 
daysVentilate (days) 28 (24) 
[23 (4, 41)] 
9 (13) 
[4 (1, 11)] 
2.2E-11 
6.5E-07 
daysO2 (days) 102 (65) 
[100 (45, 143)] 
52 (43) 
[43 (17, 79)] 
1.7E-09 
2.3E-06 
O2W36   26 (63%) 65 (30%) 4.3E-05 
wGA (percentile)   0.012 
>75thc 8 (20%) 76 (35%)  
25th to 75th 19 (46%) 106 (49%)  
<25th 14 (34%) 34 (16%)  
gender    21 (51%) 118 (55%) 0.688 
    
aEntries in table are mean(SD) and [median(interquartile range)] for continuous data;  
and frequency count (%) for categorical data. 
bp-values are from t-test for difference in means, Mann-Whitney test for difference in  
medians, and chi-squared test for difference in frequency counts. 
cReference group for wGA 
  
The characteristics of the continuous variables were further explored by 
examining their densities, using the kernel density estimators and box plots. Figure 
5.2(a) illustrates the density of each variable according to ROP status. The red line 
represents the density for the severe ROP group, and the blue line for the no severe 
ROP group. The density for dstOS, daysVentilate and daysO2 is notably skewed, 
which lend support for using the Mann-Whitney test, median, and interquartile 
summaries in Table 5.4 above. 
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There is a higher probability mass in regions corresponding to greater 
variability in severe ROP babies at 29 weeks PMA (refer Figure 5.2(a) for cvOS, 
sdOS and dstOS), which is consistent with increased variability of OS in severe ROP 
cases observed in a number of studies (Di Fiore et al., 2010; York et al., 2004; 
Cunningham et al., 1995; Saito et al., 1993). Additionally, it was observed that babies 
who developed severe ROP also had lower OS levels as can be seen from the mode 
for severe ROP, which is to the left of the mode for no severe ROP (refer from Figure 
5.2(a) for meanOS). The OS level is still being actively studied to determine its 
influence on the progression of ROP. Previous trials (Anderson et al., 2004; Sun et al., 
2002; Tin et al., 2001) focused on assessing the effects of lower (85-89%) and higher 
ranges (91-95%) of OS on the occurrence of ROP (refer Section 2.3.1). A policy of 
lower OS less than 93% had been suggested to control severe cases (Chow et al., 
2003). However, a recent trial (Support Study Group, 2010) has reported a higher rate 
of death in the lower OS group; therefore, expressing concern for the increasing 
support of lower range of OS. Note that these trials have not considered the issue of 
whether optimum OS would differ according to PMA.  
 
The pairwise box plots in Figure 5.2(b) depict that there are potentially 
outlying points occurring in all variables except GA. Upon closer inspection, most of 
these potential outliers correspond to the same babies. The impacts of these 
observations will be further investigated and discussed in Section 5.4.2.  
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(a)  
 
(b) 
Figure 5.2: Kernel density plots (a), and box plots (b) for continuous variables of NZ-
ROP according to ROP status  
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5.3.2 Collinearity among the predictors 
   The variables were checked before regression models were fitted in order to 
detect whether collinearity exists among them. Figure 5.3 displays scatterplots for 
each pair of continuous variables with binary ROP status encoded in red and blue 
colours. In addition, estimate of the Pearson correlation (95% CI) for each pair of 
variables are shown in Table 5.5. From both Figure 5.3 and Table 5.5, we 
immediately observe that all OS statistics (cvOS, sdOS, meanOS, and dstOS) exhibit 
strong correlation with absolute value greater than about 0.8, and that the correlation 
for daysVentilate and daysO2 is also quite strong being close to 0.8. 
 
 
Figure 5.3: Scatterplots for each pair of predictors in NZ-ROP with binary ROP status 
encoded in red and blue (red dots indicate severe ROP cases and blue dots indicate no 
severe ROP cases)  
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Table 5.5: Estimates of Pearson correlation (with 95% CI) for each pair of predictors 
 
Variable  sdOS meanOS dstOS GA weight days Ventilate daysO2 
cvOS 0.997 -0.788 0.881 -0.469 -0.430 0.385 0.501 
  (0.997, 0.998) (-0.830, -0.736) (0.850, 0.906) (-0.560, -0.368) (-0.525, -0.325) (0.275, 0.484) (0.403, 0.587) 
         
sdOS  -0.746 0.849 -0.465 -0.415 0.361 0.476 
   (-0.796, -0.686) (0.811, 0.880) (-0.556, -0.363) (-0.512, -0.309) (0.250, 0.463) (0.376, 0.566) 
         
meanOS   -0.850 0.411 0.475 -0.485 -0.617 
    (-0.881, -0.812) (0.304, 0.508) (0.374, 0.564) (-0.573, -0.386) (-0.687, -0.535) 
         
dstOS    -0.432 -0.442 0.463 0.543 
     (-0.526, -0.327) (-0.535, -0.338) (0.361, 0.554) (0.450, 0.624) 
         
GA     0.623 -0.438 -0.457 
      (0.542, 0.692) (-0.532, -0.334) (-0.549, -0.355) 
         
weight      -0.512 -0.590 
       (-0.597, -0.415) (-0.664, -0.504) 
         
days 
Ventilate 
      0.738 
      (0.677, 0.789) 
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Table 5.6: VIF for eight continuous variables 
Variable VIF  
weight 5.8 
GA 2.9 
gender 1.1 
wGA 3.1 
daysVentilate 2.4 
daysO2 4.0 
O2W36 2.0 
cvOS 5851 
sdOS 4616 
meanOS 27 
dstOS 39 
 
Collinearity was also checked using VIF (Table 5.6). An inspection for each 
variable shows that the VIFs for cvOS, sdOS, meanOS, and dstOS, ranging from 27 to 
5851, were high compared to the rule-of-thumb threshold of 10 suggested by 
Marquardt (1970). These outcomes were consistent with the earlier results from the 
estimates of the correlation.  
 
Further examinations revealed that (i) there were problems with the sign of the 
parameter estimates i.e. whenever a regression model contained at least two of the OS 
statistics, (ii) only one parameter estimate was significant for models containing both 
daysVentilate and daysO2, and (iii) only one parameter estimate was significant for 
models containing both weight and wGA. All of these variables are of great interest to 
the clinicians for identifying patients who will require treatment for severe ROP.  
 
These results indicate that substantial correlation existed between certain 
groups of variables: the four OS statistics, two oxygen therapy variables, weight and 
size for GA. All-subsets regression was employed, in which each regression model 
was fitted with a combination of at most six predictors, with at most one variable from 
each group of the strongly correlated variables as follows.  
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 GA 
 gender 
 O2W36 
 one of cvOS, sdOS, meanOS, or dstOS 
 one of daysVentilate or daysO2  
 one of weight or wGA.  
 
This restriction on the occurrence of predictors in each model was not far from the 
rule-of-thumb suggested by Harrell et al. (1984) that not more than about 10v  
predictors should be considered in a model. Here, v is the smaller of the sample sizes 
for the two groups of babies, which in our case is 41 babies for the severe ROP group. 
The resulting total number of possible models is 359.  
 
5.4 Logistic regression model fitting and diagnostics  
 Results from diagnostics of model fits are presented in two parts. Firstly, 
verification of linear structure of continuous predictors is presented in Section 5.4.1. 
For predictors that appear to have nonlinear structure, fitting based on nonlinear 
models were considered. Secondly, the outcomes from detecting potential outlying 
observations are explained in Section 5.4.2.  
 
5.4.1 Examination of structure of continuous predictors 
 The linearity in the structure of the continuous predictors was first checked 
using the partial residuals from the logistic regression, and was again examined using 
generalised logistic additive models (GAMs). Figure 5.4 shows the partial residual 
plots for the eight continuous variables. As it was difficult to discern a pattern in the 
plots of the residuals, a lowess curve was fitted through the points of each plot. The 
smooth for the eight predictors are relatively flat. Additionally, note that the residuals 
that occur mostly above the lowess smooth belong to the severe ROP group. A more 
careful look at the residuals indicates that there appear to be several strongly 
influential observations. Most of them are from severe ROP babies, which correspond 
to the same observations that were identified by the box plots in Section 5.3.1. The 
effects of the outliers are revisited in Section 5.4.2. 
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Figure 5.4: Partial residual plots of eight continuous predictors. The circles denote the 
residuals and the solid line depicts the smoothed residuals using a lowess smoother. 
 
 Additionally, GAM was used to check the linearity assumption for the 
predictors. Recall that the nonlinear term that we are using in GAM is based on cubic 
spline (refer Section 4.4.1). To check the structure of each predictor, several models 
based on the combinations of at least two predictors were fitted, and the GAM fit for 
each predictor was plotted separately; the structure for individual predictors was 
found to be quite similar among the models. Consequently, only results from models 
with two predictors are presented in this section.  
  
Each two-predictor model contains a predictor and GA, which is well-known 
as an important risk factor for severe ROP. An examination to determine the 
appropriate fit for GA was then carried out. A GAM consisting of a nonlinear term for 
GA and a linear term for weight was fitted; weight was chosen as it is another 
important risk factor for severe ROP. Through the GAM fitting for GA (Figure 5.5), it 
is noted that the curve has an approximately monotonically decreasing pattern as GA 
increases. It is noted that the curve decreases steeply in two periods of GA: from 23 
weeks GA (160 days) to about 24 weeks GA (170 days), and from 26 weeks to 27 
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weeks GA. To determine whether a linear structure is adequate for GA, a linear model 
(consisting of a linear term for GA and weight) and GAM were compared. The first 
two entries (denoted by Model 1) in Table 5.7 present the results of the fittings. A 
smaller AIC value for the linear model and a large p-value from the LR test 
(P=0.3577) lend a support on using a linear term for GA. Recall that the null 
hypothesis for the test states that simpler model holds.  
 
Using this result, the structure for the remaining seven predictors was 
examined by fitting a GAM that contained each predictor fitted as a nonlinear term 
together with GA fitted as a linear term. The resulting curves of the predictors with 
the structures chosen by the GAM fits are displayed in Figure 5.5. For most of the 
predictors, there are wider ranges at the extremes of the standard-error curves, which 
are due to fewer data points at the extreme regions. The smooth appears to be linear 
for weight, daysVentilate, and daysO2. Risk appears to be decreasing monotonically 
as weight increases, with babies of weights less than 750 g facing higher risk of 
severe ROP. In contrast, daysVentilate and daysOS produce the opposite effect on this 
retinal disorder. The data show that the risk escalated rapidly after the babies were 
exposed to more than 20 days of ventilation, and 50 days of supplemental oxygen. 
The trends for the four OS statistics, however, warrant for a closer inspection. It can 
be seen that a straight line could fit between the pointwise standard error curves for 
cvOS and sdOS. On the other hand, the GAM fits of meanOS and dstOS seem to 
exhibit some form of nonlinear characteristics. To ascertain whether these patterns are 
the appropriate structure for the seven predictors, a further evaluation was undertaken 
by comparing a linear model (consisting of linear terms for GA and the predictor) 
against the GAM. 
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Figure 5.5: Plots of GAM fit for eight continuous predictors, with pointwise standard 
errors and partial residuals included. The black solid line represents the fitted cubic 
spline )(s , the dotted lines represent the upper and lower pointwise twice-standard-
error curves, and the dots represent the residuals. The rug plots at the bottom of each 
graph show the occurrences of the data values. 
 
The results from fitting linear model and GAM for each of the seven 
predictors together with GA (denoted by Model 2 to Model 8) are summarised in 
Table 5.7. Notice that the AIC for the linear model is no larger than the one for the 
GAM for weight, sdOS, daysVentilate, daysO2, and cvOS, which suggests that a 
linear term would suffice for these five predictors. An examination of the p-values of 
the LR test, which yielded large values (P>0.05) re-affirm these results. Opposite 
results, however, were obtained for dstOS and meanOS. The AIC based on GAM is 
smaller, with significant p-value from the LR test (P=0.0209) for dstOS, and 
marginally significant (P=0.0677) for meanOS. These results indicate that a nonlinear 
term could be needed for the two predictors. From the shape of the GAM curves in 
Figure 5.5, it appears that linear piecewise or quadratic models could provide 
alternatives to the cubic spline. These simpler nonlinear parametric models are more 
parsimonious and easier to interpret. 
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Table 5.7: Comparison between models with linear term, and 
GAM with nonlinear term for continuous predictors 
 Model
b AIC p-valuea 
1. weight+GA 194.5 0.3577 
 weight+s(GA) 196.4  
2. weight+GA 194.5 0.3590 
 s(weight)+GA 196.5  
3. cvOS+GA 204.8 0.1367 
 s(cvOS)+GA 204.8  
4. sdOS+GA 205.1 0.2272 
 s(sdOS)+GA 206.1  
5. meanOS+ GA 201.5 0.0689 
 s(meanOS)+ GA 200.1  
6. dstOS+ GA 204.3 0.0209 
 s(dstOS)+ GA 200.6  
7. daysVentilate+GA 190.1 0.5981 
 s(daysVentilate)+GA 193.0  
8. daysO2+GA 191.4 0.1798 
 s(daysO2)+GA 191.9  
ap-values are from the LR test for comparing a model with linear terms (first 
row) against a model with a nonlinear additive term (second row). 
b )(s denotes a cubic spline.   
 
Based on these analyses, it is concluded that six of the predictors would 
adequately be modelled as linear. The remaining two predictors, namely meanOS and 
dstOS required further investigation, which will be discussed next.  
 
 The fitted cubic spline for meanOS shows an interesting pattern of a steady 
increasing risk as the level of OS increases up to about 89% followed by a sharp 
decrease. Accordingly, the curve could be partitioned into two regions with a knot at 
89% when fitted with a piecewise linear function. MeanOS was then examined 
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separately, using a piecewise linear model with a knot at k denoted as pw ),( k , and a 
quadratic model denoted as poly )( . To determine which model will be better for 
meanOS, a linear model (consisting of linear terms for meanOS and GA) and a 
piecewise linear model were compared using the LR test and AIC. Likewise, a 
separate comparison between a linear model and a quadratic model was performed. 
The results for these models (denoted by Model 1 and Model 2) are displayed in Table 
5.8. No significant difference is found, either between a linear model and a two-
segment piecewise linear model (P=0.0987), or between a linear model and a 
quadratic model (P=0.5614). These results are reflected in the models’ AICs, which 
are very close together. The GAM fit that corresponds to meanOS also has a hint of a 
peak at 89% and a trough at 93%. Therefore, a three-segment piecewise linear model 
with knots at 89% and 93% was fitted (not shown in Table 5.8). This, however, 
yielded a similar outcome as obtained from the two-segment piecewise linear model. 
Therefore, we concluded that a linear model would suffice for meanOS.  
 
 Next, we investigated the nonlinear feature in dstOS. From Figure 5.5, it can 
be seen that there was a gradual increase in risk of severe ROP with increasing dstOS, 
and thereafter, a steady decrease as dstOS passes a threshold at about 0.15%. The 
decreasing trend in the upper range of dstOS is interesting as this suggests that the risk 
of developing severe ROP weakens gradually after dstOS increases to a certain level. 
We considered two nonlinear parametric models for dstOS: a piecewise linear model 
with a knot at 0.15% (thus having a positive slope in the left hand segment and a 
negative slope in the right hand segment), and a quadratic model. In both models, 
dstOS was fitted together with GA fitted as a linear term. Evaluation was made to 
determine which one of these models was most appropriate for dstOS. The results, 
denoted by Model 3 and Model 4, are represented in Table 5.8. The AIC for the two-
segment piecewise linear model is much lower than that of the linear model; this is 
further supported by the small p-value (P=0.0028). An improved result, however, is 
not achieved from the quadratic model, which yields a higher AIC and a larger p-
value (P=0.0110) as compared to the piecewise linear model; thus, justifying the 
preference for using a two-segment piecewise linear model for dstOS in the ROP 
analysis.  
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Table 5.8: Comparison between models with a linear term, and models 
with a nonlinear parametric term for meanOS and dstOS 
 Model
b AIC p-valuea 
1. meanOS+GA 201.5 0.0987 
 pw (meanOS, 89)+GA  200.7  
2. meanOS+GA 201.5 0.5614 
 poly (meanOS)+GA  203.1  
3. dstOS+GA 204.3 0.0028 
 pw(dstOS, 0.15)+GA  197.4  
4. dstOS+GA 204.3 0.0110 
 poly(dstOS)+GA  199.8  
ap-values are from the LR test for comparing a model with linear terms (first 
row) against a model with a nonlinear parametric term for meanOS or dstOS 
(second row).  
bpoly )( denotes a polynomial fit and pw ),( k denotes a piecewise linear 
regression fit with a knot at k.   
 
There appears to be a conflicting phenomenon on the contribution of dstOS to 
the risk, in which there is a decreasing trend as dstOS passes a threshold. This pattern 
seems to contradict with the clinicians’ intuition that ROP risk should increase with 
increasing desaturation episodes of preterm babies (Di Fiore et al., 2010). Fetuses are 
regularly treated with prenatal steroids. These steroids have been suggested to provide 
a protective effect against the risk of ROP (Jagielska et al., 2008; Console et al., 
1997). In this study, the medical history of the babies was examined; the clinical 
records of the 13 babies in the right-hand segment of dstOS showed that they had all 
received steroids during their prenatal period to promote fetal lung development. 
Hence, this provides the plausible explanation for the phenomenon of the negative 
slope of the right-hand segment. 
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5.4.2 Detection of outlying observations   
 The analyses that had been performed so far, had not taken into account the 
presence of outlying points. However, earlier on, we have noted the existence of 
several suspicious observations from the box plots (Figure 5.2(b) in Section 5.3.1) and 
partial residual plots (Figure 5.4 in Section 5.4.1). These observations could be 
candidate outliers, which are normally detected by identifying overly influential 
points and high leverage values.  
 
 In this section, results from the analysis of detecting outlying points are 
presented. The analysis was performed using a combination of conventional 
diagnostic measures and a robust measure (refer to Section 4.4.4). Identification of 
multiple outlying points involves a three-step approach. In the first exploratory step, 
all-subsets regression was fitted to the full data, and the sign of the parameter 
estimates in all models was examined. Results showed that “incorrect” sign in some 
of the estimates occurred in 21 models, each containing three or four predictors. Here, 
“incorrect” was defined as having the opposite sign to that indicated in the single-
predictor analysis and generally indicated in the literature. In the second step, the 
conventional and robust diagnostic measures for these 21 models (with full data set) 
were fitted and plotted to detect all candidate outliers. The occurrences of suspected 
data points that exceeded the suggested thresholds of the diagnostic measures were 
recorded. In the third step, these observations were further examined by assessing 
their impact on the sign and the standard error of the parameter estimates. The list of 
outliers was then finalised using results from both steps two and three.    
 
To identify data points that are candidate outliers, four diagnostic measures 
were used: approximated jackknife residual, Cook’s distance statistic, leverage from 
hat matrix, and Mallows robust weight, which is used in order to identify observations 
assigned with small weights.  Recall in Section 4.4.2 that none of these diagnostic 
measures is reliable enough on its own to detect all outliers. This is illustrated in the 
following example (refer Figure 5.6 and Table 5.9) based on a model, with dstOS, 
weight, and daysVentilate as predictors. The jackknife residual plot shows that 
observations 130 and 157 are quite isolated from the main data. These observations, 
along with observations 204 and 207, also receive small Mallows weights, with values 
between 0.1 and 0.35. This indicates that the four observations are potentially 
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influential for both modelling and inference. Notice that two of them (observations 
130, 207) attain the maximum values of the Cook statistic. In particular, there is a 
leverage point (observation 8), which is assigned with a high weight of one by the 
Mallows weight. Results from these plots suggest that there appear to be five 
candidate outliers, namely, observations 8, 130, 157, 204, and 207. 
 
Figure 5.6: Diagnostic plots for model dstOS+weight+daysVentilate. Jackknife 
residuals (top left); Cook’s distance against leverage (top right); Marlows weight 
against leverage (bottom left); and Marlows weight against Cook’s distance (bottom 
right). The dotted lines denote the thresholds, )22(8  pn  for Cook’s distance and 
np )2(2   for leverage. The numbers beside the circles correspond to the observation 
numbers. 
Table 5.9: Identification of candidate outliers from diagnostic 
measures for model dstOS+weight+daysVentilate 
Diagnostic measure Candidate outliers 
Jackknife residuals  130, 157 
Cook’s distance 130, 207 
Leverage 8 
Mallows weight 130, 157, 204 
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 A list of five potential outliers emerging from the 21 models in step two is 
produced in Table 5.10. Observations 130, 157, and 204 have the highest frequency 
among other observations, occurring in 20 of the 21 models (95%). Observations 8 
and 207 are another two candidate outliers, which occur in 19 (90%) and 12 (57%) of 
the 21 models, respectively. This result provides evidence of aberrant observations 
that deserve further investigation. 
 
Table 5.10: Candidate outliers and their occurrences in 21 
models, as identified by four diagnostic measures 
Candidate outlier Occurrences in models (%) 
130 20 (95) 
157 20 (95) 
204 20 (95) 
8 19 (90) 
207 12 (57) 
 
  
 It is known that atypical observations can have a large impact on the 
maximum likelihood estimates, leading to biased estimators and wrong interpretations 
of the fitted models (Rousseeuw and Leroy, 1987). In the next step, the effect of these 
candidate outliers on the sign and standard error of the parameter estimates was 
assessed. Using the list of potential outliers from step 2, the 21 models were re-fitted 
after removing the five observations. Some changes were observed in the models’ 
estimates and standard errors, which resulted in appropriate signs for the estimates in 
all models. Taken together the results from steps two and three, observations 157, 
130, 204, 8 and 207 were flagged as outliers. 
 
The following analysis was carried out to determine on how best to handle the 
five observations. Three approaches were used: logistic regression on the full data set 
(denoted as MLE), robust logistic regression on the full data set (denoted as Robust), 
and logistic regression with the five outliers omitted (denoted as MLE2). The robust 
estimation of the parameters is via the Mallows estimator, as defined by equation 
(4.11) in Section 4.4.3, with tuning constant t = 1.2 and weight 
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function ( ) 1i iw X h  . The various results yielded by these approaches are 
demonstrated in the following cases. 
 
Case I 
 The results in Table 5.11 summarise a case of an incorrect sign of a parameter 
estimate for predictor meanOS, produced by MLE as shown in the first column. 
Nevertheless, the sign changes when the robust method is used or when the outliers 
are removed. The estimates from both MLE and robust methods are quite different, in 
that the estimated standard errors of the non-robust method are smaller, and the 
parameter estimates are somewhat larger than their robust counterparts. For the 
remaining three predictors, it can be seen that the parameter estimates of MLE2 are 
relatively close to the MLE estimates.  
 
Table 5.11: Comparison of parameter estimates between logistic and robust logistic 
estimation for a model, meanOS+weight+daysVentilate+O2W36 
 MLEa   Robusta  MLE2b 
Predictor 
Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
Constant -0.625 7.859  14.605 11.063  8.507 8.739 
meanOS 0.013 0.088  -0.149 0.123  -0.081 0.097 
weight -0.004 0.001  -0.004 0.002  -0.004 0.001 
daysVentilate 0.030 0.012  0.012 0.017  0.034 0.014 
O2W36 0.496 0.451  0.230 0.593  0.287 0.486 
      
Model is estimated with afull data or with bexclusion of observations 130, 157, 8, 204, 
and 207.  
 
Case II 
A second case is illustrated based on a model, with sdOS, GA, daysO2, and 
wGA as predictors. Table 5.12 shows a surprising finding when the robust method 
estimates a negative sign for sdOS. A close inspection at Mallows robust weight 
showed that observation 204 was not assigned with a low weight. A positive sign is 
obtained only when observation 204 is removed from the analysis. The re-fitted 
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MLE2 model, which excludes the observation, takes into account the atypical nature 
of the observation in the estimation procedure.  
 
Table 5.12: Comparison of parameter estimates between logistic and robust logistic 
estimation for a model, sdOS+GA+daysO2+wGA 
 MLEa  Robusta  MLE2b 
Predictor 
Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
Constant 12.720 5.384  13.128 6.062  13.069 5.393 
sdOS 0.004 0.146  -0.027 0.167  0.045 0.151 
GA -0.087 0.028  -0.089 0.031  -0.090 0.028 
daysO2 0.011 0.004  0.013 0.005  0.010 0.004 
wGA (pct):         
   25th to 75th  0.366 0.491  0.099 0.554  0.391 0.491 
        <25th 1.040 0.575  0.962 0.625  1.037 0.576 
   
      
Model is estimated with afull data or with bexclusion of observation 204. 
 
Case III     
A further example based on cvOS, weight, and gender as predictors (given in 
Table 5.13) shows the effect of observations 130, 157, 8, 204, and 207. These 
observations seem to increase the MLE estimate of gender. The negative sign for 
gender, which is correct for NZ-ROP data, is attained only when the five observations 
are removed from the data. 
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Table 5.13: Comparison of parameter estimates between MLE and robust estimation for 
a model, cvOS+weight+gender 
 MLEa  Robusta  MLE2b 
Predictor 
Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
 Parameter 
estimate 
SE 
Constant 1.535 1.329  0.946 1.409  1.181 1.408 
cvOS 13.468 11.411  18.496 12.414  28.290 12.750 
weight -0.005 0.001  -0.005 0.001  -0.005 0.001 
gender 0.040 0.371  0.121 0.395  -0.0208 0.396 
   
      
Model is estimated with afull data or with bexclusion of observations 130, 157, 8, 204, 
and 207. 
  
With these results, the all-subsets logistic models were re-fitted to the NZ-
ROP data. The model fittings excluded the previously identified five outlying 
observations. Diagnostic checking (as in Section 5.4.1) was again undertaken; the 
parametric forms of the predictors are almost similar to those obtained in the earlier 
analysis. Figure 5.7 depicts the GAM fits for the OS statistics. Overall, there is an 
increasing trend of risk that corresponds to cvOS and sdOS, and decreasing trend for 
meanOS, whilst the nonlinear form for dstOS appears to be clearer. The OS statistics 
for variability have a downward trend for larger values; this trend, however, is more 
prominent in dstOS. Additionally, there was little evidence of any distinct outlying 
observations in the reduced data set. The performance of these models was then 
assessed and the results are presented in the next section.  
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Figure 5.7: Plots of GAM fit (excluded observations 157, 130, 204, 8, and 207) for 
four statistics of OS (cvOS, sdOS, meanOS, and dstOS), with pointwise standard 
errors and partial residuals included. The black solid line represents the fitted cubic 
spline )(s , the dotted lines represent the upper and lower pointwise twice-standard-
error curves, and the dots represent the residuals. The rug plots at the bottom of each 
graph show the occurrences of the data values. 
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5.5 Comparative performance of models 
 The logistic regression models were fitted using all-subsets regression, which 
performed predictor selection by fitting separate logistic regressions on the 
combinations of at most six predictors. In total, 359 models were fitted, which 
included the single-predictor and multi-predictor regression models. The predictors 
were seven clinical and postnatal factors and four OS statistics, whilst the response 
variable was severe ROP or no severe ROP. Predictors that were most influential in 
discriminating babies at risk of developing severe ROP were assessed and identified. 
These are discussed in the following sections.  
 
5.5.1 Single-predictor models 
The parameter estimates  ˆ  for single-predictor logistic regression models are 
reported for each of the eleven predictors in Table 5.14, accompanied by their 
respective SEs, p-values, and ORs (depicted in Figure 5.8). With the exception for 
gender (P=0.595), all predictors were significant for severe ROP (P<0.05), with 
meanOS, weight and GA showing protective associations. Strong relation (P<1.0E-6) 
with severe ROP was demonstrated by the following predictors: weight, GA, 
daysVentilate, daysO2, and dstOS. The first three variables are well known risk 
factors for severe ROP. Within the wGA category, babies born with lower weight for 
GA had a higher risk of ROP (OR = 4.15, 95% CI = (1.52, 11.31)). There were 
relatively few babies (Table 5.15) in this category (47 out of 252 or 18.7%), but their 
severe ROP rate was high (13 out of 47 or 27.7%).  
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Table 5.14: Single-predictor logistic regression models of NZ-ROP 
Predictor ˆ (95% CI) SE p-valuec 
Unadjusted ORe 
 (95% C1) 
cvOS 43.00 (21.63, 64.37) 10.90 8.0E-5 3.406 (1.853, 6.261) 
sdOS (%) 0.485 (0.236, 0.734) 0.127 1.3E-4 3.288 (1.784, 6.057) 
meanOS (%) -0.338 (-0.489, -0.187) 0.077 9.9E-6 0.286 (0.163, 0.500) 
dstOS (%)a     1.6E-7d  
< 0.15% 25.38 (15.76, 35.00) 4.909 2.3E-7 4.380 (2.502, 7.668) 
≥ 0.15% -128.7 (-232.1, -25.27) 52.77 0.015 0.031 (0.002, 0.505) 
weight (g) -0.007 (-0.009, -0.005) 0.001 8.7E-8 0.129 (0.070, 0.240) 
GA (days) -0.131 (-0.180, -0.082) 0.025 1.1E-7 0.194 (0.105, 0.358) 
daysVentilate (days) 0.064 (0.040, 0.088) 0.012 2.5E-8 2.884 (1.957, 4.252) 
daysO2 (days)  0.020 (0.012, 0.028) 0.004 1.2E-7 4.446 (2.499, 7.911) 
O2W36  1.506 (0.775, 2.237) 0.373 5.5E-5 4.509 (2.170, 9.366) 
wGA (percentile)     0.017d  
 > 75thb      
25th to 75th 0.631 (-0.290, 1.552) 0.470 0.180 1.879 (0.748, 4.721) 
< 25th 1.423 (0.419, 2.427) 0.512 0.005 4.150 (1.521, 11.31) 
gender -0.187 (-0.877, 0.503) 0.352 0.595 0.829 (0.416, 1.653) 
a dstOS is fitted with a piecewise linear function with a knot at 0.15%. 
b Reference group   
c p-value is from the Wald’s test.  
d p-value is from the LR test.  
e The unadjusted ORs for continuous variables depict the odds of severe ROP for patients at the 75th percentile of the distribution of the variable versus   
patients at the 25th percentile. 
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Figure 5.8: Unadjusted ORs (with 95% CIs) of severe ROP based on 252 babies in 
NZ-ROP for all predictors. For continuous variables, the value depicted reflects the 
odds of severe ROP for babies at the 75th percentile of the distribution of the variable 
versus patients at the 25th percentile. 
 
Table 5.15: Predictor weight-for-GA and severe ROP 
 Severe ROP  
no./ total (%) 
wGA (percentile)   
> 75tha 7/83 (8.4%) 
25th to 75th 18/122 (14.8%) 
< 25th 13/47 (27.7%) 
  
a Reference group    
 
The ˆ  for meanOS is negative, which suggests that severe ROP cases are less 
likely with higher OS levels at 29 weeks of PMA. For OS statistics for variability 
(cvOS, sdOS and the lower range of dstOS), their ˆ s are all positive; thus indicating 
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that higher variability implies a higher probability of severe ROP. dstOS is the most 
dominant predictor (P=2.3E-7) among the four OS statistics, with the risk of severe 
ROP increased with increasing dstOS up to 0.15% (OR = 4.380, 95% CI = (2.502, 
7.668)). Figure 5.9 shows the box plots of fitted probabilities of severe ROP and no 
severe ROP calculated from the model containing dstOS; it can be seen that the two 
groups of babies are well-separated. These results lend support to the clinicians’ 
suspicion that OS fluctuations could be an early indicator of ROP. 
 
Figure 5.9: Box plots of fitted probabilities of severe ROP and no severe ROP for a 
single-predictor model, dstOS. The 25th, 50th, and 75th quartiles are 0.1361, 0.246, and 
0.370 for severe ROP, and 0.047, 0.079, and 0.171 for no severe ROP, respectively. 
 
5.5.2 Multi-predictor models 
The all-subsets regression comprised of 359 models. Potential interaction was 
assessed among selective predictors such as between OS statistics and gender, and 
O2W36. However, no appreciable interaction effect was detected.  Table 5.16 shows 
15 models listed according to their AUCs; the first ten were the top models, whilst the 
remaining five contained several combinations of OS statistics and risk factors that 
clinicians felt were important for ROP. The predictors that were highly related to 
106 
 
severe ROP in the single-predictor analysis remained important here. After adjustment 
with other key clinical factors, strong relationships with severe ROP were shown by 
dstOS, GA, weight, and daysVentilate; dstOS appears in all the top ten models and 
each of the other three appears in eight of these models. Other variables such as 
gender, O2W36, wGA, and daysO2 appear less often (four times for gender, three 
times for O2W36, and only once for wGA and daysO2). dstOS was the most 
important predictor among the four OS statistics, as indicated by its presence in the 
top models.  
 
Table 5.16: Selected multi-predictor regression models of NZ-ROP 
Ranka Modelsc AUC (95% CI) 
1b dstOS, weight, daysVentilate 0.853 (0.792, 0.914) 
2 dstOS, GA, weight, daysVentilate 0.853 (0.792, 0.914) 
3 dstOS, weight, gender, daysVentilate 0.852 (0.792, 0.912) 
4b dstOS, GA, weight, O2W36 0.851 (0.787, 0.915) 
5 dstOS, GA, weight, daysO2 0.851 (0.790, 0.912) 
6 dstOS, GA, weight, daysVentilate, O2W36 0.851 (0.788, 0.914) 
7 dstOS, GA, weight, gender, daysVentilate  0.849 (0.790, 0.909) 
8 dstOS, GA, gender, daysVentilate, wGA 0.848 (0.786, 0.911) 
9 
dstOS, GA, weight, gender, daysVentilate, 
O2W36  
0.848 (0.785, 0.911) 
10b dstOS, GA, daysVentilate 0.847 (0.788, 0.905) 
    
37b dstOS, GA, wGA  0.835 (0.771, 0.899) 
63b meanOS, GA, weight  0.829 (0.766, 0.893) 
107b cvOS, weight, O2W36  0.822 (0.753, 0.891) 
115b sdOS, weight, O2W36  0.821 (0.753, 0.889) 
176b meanOS, GA, wGA 0.815 (0.744, 0.886) 
    
a Actual rank from 359 models. 
b p-value of each predictor is less than 0.05. 
c dstOS is fitted with a piecewise linear function with a knot at 0.15%. 
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In Table 5.16, there are several models containing predictors with p-values 
less than 0.05 and AUCs well above 0.8. Note that the performance of individual 
models depends on the combination of predictors in each model. The box plots of the 
probabilities of severe ROP and no severe ROP predicted using the top model with 
dstOS, weight, and daysVentilate as predictors are shown in Figure 5.10.  
 
Figure 5.10: Box plots of fitted probabilities of severe ROP and no severe ROP for a 
multi-predictor model, dstOS+weight+daysVentilate. The 25th, 50th, and 75th quartiles 
are 0.174, 0.384, and 0.622 for severe ROP, and 0.016, 0.039, and 0.138 for no severe 
ROP, respectively. 
 
With 11 predictors being investigated, we aim to pare down the variables to a 
smaller number that impacts the outcome the most, and hence, useful for 
discriminating between babies with good or poor outcome. One possible way is to 
consider a number of potential models, which differ in terms of combination of 
predictors and predictions for babies at risk of developing severe ROP, as seen from 
Table 5.16, Figure 5.9, and Figure 5.10. Alternatively, rather than to base inference on 
only one or several models, a weighted average of the models could be employed to 
circumvent the need for predictor or model selection. Using this approach, all models, 
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hence all predictors were taken into account and weighted accordingly. The results for 
NZ-ROP using a model averaging strategy are illustrated in the next section.  
 
5.5.3 Model averaging approach 
To determine predictors that have a strong relationship with severe ROP, a 
model averaging approach (refer Section 4.3.4) was adopted, in which model-
averaged p-values were calculated. Additionally, the OR (with 95% CI) for each 
predictor, and fitted probabilities for the risk of severe ROP were also computed by 
averaging over all models. Together with the analyses of the single- and multi-
predictor models, the results are discussed in Section 5.6.  
 
Model-averaged p-values and ORs  
 With the model-averaged p-value, the relative dominance of the predictors 
with respect to their relationship with severe ROP can be quantified. Table 5.17 
presents the strength of each predictor, as ranked according to their corresponding p-
values. Highly influential variables in this group of predictors, with model-averaged 
p-values less than 0.01, were lower range of dstOS (< 0.15%), weight, GA, and 
daysVentilate. Other variables such as the upper range of dstOS (≥ 0.15%) and 
daysO2 were marginally associated with the risk of severe ROP. From Table 5.17, it 
can be seen that (i) dstOS was the strongest predictor among the four OS statistics, (ii) 
weight and GA were more important individually than when combined as wGA, and 
(iii) daysVentilate was the dominant predictor among the three oxygen therapy 
variables, i.e. daysO2 and O2W36. Overall, these predictors represent a subset of risk 
factors that could be clinically useful in identifying babies potentially at risk of severe 
ROP.  
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Table 5.17: Model-averaged p-values and ORs of severe ROP based on 
252 babies in NZ-ROP 
Predictor p-value
a 
ORa (95% CI) 
dstOS (< 0.15%)b 0.0073 2.800 (1.455, 5.399) 
weight 0.0075 0.261 (0.102, 0.685) 
GA 0.0088 0.318 (0.157, 0.646) 
daysVentilate 0.0093 2.045 (1.330, 3.146) 
dstOS (≥ 0.15%)b 0.0423 0.020 (0.001, 0.883) 
daysO2 0.0816 2.527 (1.244, 5.170) 
wGA (< 25th percentile) 0.1154 3.305 (1.011,10.85) 
meanOS 0.1371 0.563 (0.287, 1.107) 
cvOS 0.1428 1.932 (0.941, 3.975) 
sdOS 0.1457 1.926 (0.933, 3.986) 
O2W36 0.2447 2.097 (0.849, 5.230) 
wGA (25th to 75th percentile) 0.2568 1.847 (0.657, 5.198) 
gender 0.3472 0.670 (0.298, 1.507) 
   
        a p-values and ORs are obtained from model averaging. 
        b dstOS is fitted with a piecewise linear function with a knot at 0.15%. 
 
Table 5.17 also provides the model-averaged ORs for severe ROP for each 
predictor; the results are depicted in Figure 5.11. The OR for dstOS (< 0.15%), of 
which the predominant relation with severe ROP has been noted earlier (Table 5.16), 
was quite pronounced. Even after adjustment for all other clinical predictors, preterm 
babies at the upper quartile of the dstOS (< 0.15%) distribution were nearly three 
times more likely to develop severe ROP than babies at the lower quartile, (OR = 
2.800, 95% CI = (1.455, 5.399)). The presence for high ROP risk, however, was not 
apparent in the other three OS statistics, or in O2W36 and gender. 
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Figure 5.11: Model-averaged ORs (with 95% CIs) of severe ROP based on 252 babies 
in NZ-ROP for all predictors. For continuous variables, the value depicted reflects the 
odds of severe ROP for babies at the 75th percentile of the distribution of the variable 
versus patients at the 25th percentile. 
 
Model-averaged fitted probabilities 
 A summary of the model-averaged fitted probabilities is presented in Figure 
5.12. The upper quartile of the estimated probabilities for the severe ROP group was 
0.426, whilst the lower quartile for the no severe ROP group was 0.035. Overall, a 
good separation exists between the two groups (Kolmorov-Smirnov two-sample test, 
P=2.9E-8). This suggests that the model averaging approach performs well in 
discriminating between babies who will or will not develop severe ROP.  
111 
 
 
Figure 5.12: Box plots of fitted model-averaged probabilities of severe ROP and no 
severe ROP. The 25th, 50th, and 75th quartiles are 0.147, 0.275, and 0.426 for severe 
ROP, and 0.035, 0.069, and 0.176 for no severe ROP, respectively. 
 
5.6  Discussion 
The influence of clinical determinants of severe ROP in extremely preterm 
babies is multifaceted, involving many factors. In this study based on a cohort of 
babies less than 28 weeks GA, we attempted to provide an analysis of relationships 
between eleven postnatal predictors including OS statistics, and severe ROP.  
 
The best subset of predictors 
Single-, multi-predictor, and model averaging analyses were performed to 
identify predictors that can best describe the relationships with severe ROP. Some of 
the results from the three analyses were identical, whilst others differed in terms of the 
strength of association between predictors and outcome. We observed that these 
predictors could be categorised into three cases. 
 
 Case I: dstOS, weight, GA, and daysVentilate emerged as the most highly 
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significant predictors in the single-predictor and model averaging analyses. 
Additionally, they appeared no less than eight times in the top ten models in 
the multi-predictor analysis.  
 Case II: cvOS, sdOS, meanOS, wGA, and O2W36 were significantly 
associated to severe ROP in the single-predictor analysis. However, the 
individual effects of these variables were negated when adjusted for other 
variables. Gender was not significant in the single-predictor and model 
averaging analyses. 
 Case III: Besides daysVentilate, daysO2 was another highly associated oxygen 
therapy variable in the single-predictor analysis. However, unlike 
daysVentilate, the strong effect of daysO2 did not persist in the multi-predictor 
analysis and was only marginally associated (P=0.082) with the adverse 
outcome of ROP in the model averaging.  
 
Taking the results produced by these three analyses together, it appeared that 
dstOS, weight, GA, and daysVentilate were dominant risk factors for severe ROP. 
Therefore, these factors emerged as the best subset of predictors among the eleven 
initially considered. Note that this combination of four predictors appeared as the 
second top model in the multi-predictor analysis.  
 
As we scrutinised closely the results from all three analyses, it can be seen that 
the results from the single- and multi-predictor analyses tended to be more liberal, 
whilst the model averaging approach was somewhat more conservative. We illustrate 
this in the following examples. 
 
 In the single-predictor analysis, nearly all predictors were significantly 
associated with the outcome, with very small p-values. In contrast, many of 
them did not remain significant in the model averaging analysis.  
 The fitted probabilities obtained from the top model (Figure 5.10) in the multi-
predictor analysis and those from the model averaging analysis (Figure 5.12) 
were broadly similar, in that, discrimination between the two groups of babies 
with severe ROP and no severe ROP was very distinct. However, the former 
had more fitted probabilities that were closer to 1 for the severe ROP group. 
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We believe that the subtle differences in the three approaches indicate two extreme 
limits of performance; hence, the actual relationships could be somewhere between 
these two limits.   
 
Oxygen fluctuations 
 Early studies on newborn rats exposed to oxygen-induced retinopathy showed 
that repeated hypoxic episodes (McColm et al., 2004; Coleman et al., 2008), 
alternating hypoxia and hyperoxia, small increments (Werdich et al., 2004), or wider 
range of oxygen fluctuations (Penn et al., 1995) caused severe retinal 
neovascularisation. In studies involving preterm babies, increased fluctuations of 
oxygen in the early weeks of life were reported as a critical factor for development of 
severe or threshold ROP (Saito et al., 1993; Cunningham et al., 1995; York et al., 
2004). Except from York et al., (2004), information on the magnitude of the risk due 
to OS fluctuations is very limited as it has not been investigated in-depth and 
extensively. In our study of preterm babies at 29 weeks PMA, we examined the 
relation of variability and level of OS (using four OS statistics) on the development of 
severe ROP, and found that desaturation was the most significant OS predictor 
(model-averaged P=0.007) for severe ROP. This finding is in accord with De Fiore et 
al. (2010), who studied the association of severe ROP with multiple factors including 
desaturation episodes (P<0.001). Importantly, after adjustment with other clinical 
predictors, we noted that the relationship of desaturation with severe ROP risk was the 
strongest among all OS statistics (model-averaged OR = 2.800, 95% CI = (1.455, 
5.399)). cvOS was another statistic that we had considered for OS variability; its 
contribution to the risk of developing severe ROP (model-averaged OR = 1.93, 95% 
CI = (0.94, 3.98)) was broadly similar to the study by York et al. (2004), which 
reported increased risk of severe ROP (OR = 1.69, 95% CI = (0.95, 2.99)) for preterm 
babies based on a 10% increment of CV of PaO2 after receiving 30 days of oxygen 
therapy.  
 
There have been previous studies that had investigated the impact of different 
OS levels on the morbidity of preterm babies including ROP. For instance, four 
studies (Tin et al., 2001; Anderson et al., 2004; Sun et al., 2002; Chow et al., 2003) 
have suggested that a OS target range of about 80-95% may reduce retinal surgery by 
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61-100%. Recent studies, however, showed that lower saturation targets reduce the 
incidence of severe ROP but may also increase risk of death (SUPPORT Group,  
2010; Vaucher et al., 2012; Schmidt et al., 2013); BOOST II Group, 2013). The 
HOPE ROP study (McGregor et al., 2002) examined the progression rate to threshold 
(severe) ROP in two groups of preterm babies, one with median OS greater than 94%, 
and the other less than 94%, in room air when ROP was first diagnosed. They found 
that fewer babies progressed to threshold ROP in the higher OS group compared to 
the lower OS group (32% vs 46%, P<0.004). Our data showed that with lower 
meanOS, there is a higher risk of severe ROP (model-averaged OR = 0.563, 95% CI = 
(0.287, 1.107)), which appeared to be consistent with the neonatal physiology at 29 
weeks PMA as advised by a pediatrician. The basis for this phenomenon is not fully 
known but may be attributed to persistent hypoxia that occurs at the end of phase one 
ROP. This induces an overproduction of the VEGF growth factor and eventually leads 
to the second phase of retinal detachments (Smith, 2005).   
 
Demographics 
 Lower GA and birth weight are the strongest and most consistently identified 
risk factors for ROP (McColm and Fleck, 2001; Good et al., 2005). We observed 
similar findings, wherein the risk increased for babies born earlier or with lighter 
weight. In the US, initial eye examinations have been recommended for babies born at 
less than 30 weeks GA, or with birth weight less than 1500 g, or between 1500 g to 
2000 g in the case of high risk babies (American Association for Pediatric 
Ophthalmology, 2006). Our observations re-emphasised the importance of monitoring 
these babies with timely eye examinations and consistently scheduled ophthalmologic 
follow-ups. 
  
Recent evidence has shown that the incidence of ROP cases has risen in the 
group of extremely premature babies in several developed countries, and that the 
increase was more notable in lower birth weight babies (Slidsborg et al., 2008). As 
GA and weight reflect different aspects of fetal wellbeing, i.e. maturity and growth, 
some studies on ROP started to use relative weight for GA (wGA). However, the 
adverse effects of low wGA on ROP among preterm babies are difficult to determine 
from published findings because these varied from one study to another. Some studies 
report that being born low wGA increases the risk of severe ROP (Qiu et al., 2012; 
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Slidsborg et al., 2008; Darlow et al., 2005), whilst others found no association 
between wGA and severe ROP (Austeng et al., 2010; Filho et al., 2009; Allegaert et 
al., 2009), which is in accordance to what we have obtained in our study. These 
conflicting results may be due to different ways of defining the low wGA group, such 
as (i) restriction on percentiles for GA (e.g. birth weight < 10th percentiles for GA or 
birth weight < 4th percentiles for GA); (ii) use of growth chart that differ according to 
countries (Australia, Canada, and Sweden); and (iii) use of single-centre versus 
multiple-centre data.  
 
 It has been suggested that the relationships between GA, weight and morbidity 
are less clear partly due to using cohorts of babies based on weight alone. In contrast, 
low wGA babies are shown to have higher rates of morbidity in cohorts selected on 
the basis of GA and weight (Qiu et al., 2012; Regev et al., 2003). This might explain 
why wGA is sometimes preferred over weight when assessing the impact of growth 
restriction on the development of ROP. Our data, however, showed that when weight 
and GA are considered individually, their relationship with the severity of ROP is 
stronger than when they are combined as wGA. 
 
Gender has been increasingly recognised as a critical determinant in babies 
with ROP. Darlow et al. (2005) and Jacobson et al. (2009) have identified male 
gender to be significantly associated with an increased risk of ROP. In this study, it 
was not an important risk factor before and after adjustment for other factors. This 
was also observed in other comparable studies of ROP that involved a larger number 
of babies (Austeng et al., 2010; Gunn et al., 2012). More generally, whilst female 
babies were noted to have a survival advantage, male babies were found to be more 
susceptible to complications of prematurity and mortality (Synnes et al., 1994). The 
basis of the better outcomes for female babies is unclear, but may relate to the 
development of organ maturation during fetal growth (Ingemarsson, 2003). 
 
Oxygen therapy 
It has long been evident that ROP was observed more often among babies 
treated with extended duration of oxygen therapy during the perinatal period (Kinsey 
et al., 1956; Lala-Gitteau et al., 2007). This was further supported by Di Fiore et al. 
(2010), Cunningham et al. (1995), and our study, which found that babies who 
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developed severe ROP had received longer duration of ventilation and supplemental 
oxygen as compared to the no severe ROP group; these findings are summarised in 
Table 5.18.  
 
    Table 5.18: Findings on duration of oxygen therapy and ROP status 
Oxygen 
therapy 
Study Severe 
ROPa 
No severe 
ROPa 
p-valueb 
Ventilation Di Fiore et al., 2010 
Cunningham et al., 1995 
NZ-ROP 
40 (18) 
50 (34) 
28 (24) 
14 (15) 
29 (23) 
9 (13) 
< 0.001 
< 0.01 
2.2E-11 
Supplemental 
oxygen 
Di Fiore et al., 2010 
Cunningham et al., 1995 
NZ-ROP 
51(12) 
104(42) 
102(65) 
34 (20) 
70 (69) 
52 (43) 
< 0.001 
< 0.001 
1.7E-09 
a Mean (SD) 
b p-values are from t-test for difference in means. 
 
The impact of greater periods of assisted ventilation and supplemental oxygen 
on the health of young newborns is of great concern especially in extremely preterm 
babies as they are often given oxygen therapy due to their under-developed cardio-
respiratory system. It is therefore relevant to ascertain which of the factors related to 
oxygen therapy has greater association with ROP. Our analysis of three factors - 
duration of ventilation, duration of supplemental oxygen, and use of supplemental 
oxygen until 36 weeks of PMA - disclosed that the first is the strongest predictor for 
severe ROP, rather than the other two. Recall that the risk of severe ROP increases 
with longer duration of ventilation (Table 5.15).  
 
 Apart from ROP, there have been numerous other reports on ventilation-
related complications such as bronchopulmonary dysplasia, cancer, and cerebral 
palsy. Bronchopulmonary dysplasia that is in a form of inflammation of the lungs and 
airways is quite common in preterm neonates who are ventilated and exposed to 
oxygen (Askie et al., 2003). An increased risk of childhood leukemia has been 
reported for babies who were resuscitated with 100% oxygen at birth; the odds ratio 
was 2.6 when a facemask and bag were used, and increased to 3.5 for manual 
ventilation lasting 3 minutes or more (Naumburg et al., 2002). In a another study of 
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newborn babies exposed to prolonged sessions of oxygen therapy, the odds ratio of 
cerebral palsy was almost 3.0 in mechanically ventilated very low birth weight babies 
(Collins et al., 2001). 
 
Limitations of study 
 There are several possible limitations to this study. First, the wGA categories 
were defined based on the Australian national growth charts (Roberts and Lancaster, 
1999). The charts were chosen due to the absence of locally derived charts and close 
similarity in the demography and environmental factors of New Zealand and 
Australia. However, Indigenous babies (28230, 4%) were not included in the 
Australian charts as their correct GAs were difficult to be obtained (Roberts and 
Lancaster, 1999). This issue could cause a small number of babies in this study to be 
inappropriately classified for certain wGA categories. Second, inter and within centres 
variability in certain aspects of care and clinical monitoring of patients is inherent in 
this study. As trial protocols had been implemented in BOOST-NZ to ensure 
homogeneity among care providers when providing treatments to patients, the 
resulting variability is believed to be minimal and does not influence the conclusions 
of the study. The third and final limitation, the ROP incidence in this study pertains 
only to babies of birth weight < 1500g and < 28 weeks of GA. Previous studies have 
reported on severe ROP cases among low birth weight babies that were older than 
those in this analysis (Regev et al., 2003). There are possibilities that these older 
babies were inadvertently not screened for ROP screening, which could lead to under-
estimation of ROP incidence for low birth weight babies.  
  
Despite these limitations, this study was based on a comprehensive database 
collected prospectively and consistently throughout the study period. It clearly 
documents some important risk factors of severe ROP for extremely preterm babies 
born in several hospitals in New Zealand.  
 
5.7  Summary 
The OS data from an eight-week period (28 to 35 weeks PMA) were analysed 
to determine a suitable time period for computing OS statistics to be used in the 
logistic regression. We observed that (i) there were significant differences in the 
means of the OS statistics between the two groups of babies at nearly all weeks of 
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PMA, with the largest difference occurring at 28 or 29 weeks PMA; (ii) cvOS, sdOS, 
and dstOS were significantly higher in babies who develop severe ROP while 
meanOS was significantly lower, and (iii) the maximum value for variability and 
minimum value for level were attained at 29 weeks PMA. Taking into account the 
results from the 28 and 29 weeks PMA, and combined data, all findings for OS 
statistics of the NZ-ROP study were reported based on 29 weeks PMA. 
 
Single-, multi-predictor, and model averaging analyses were performed to 
investigate the relationships between levels, variability of OS, and severe ROP; the 
relationships between multiple risk factors and severe ROP; and the respective degree 
of importance of these factors with the disease. We identified that there is a 
relationship between dstOS and severe ROP, and we confirmed weight, GA, and 
daysVentilate as significant risk factors for severe ROP. Of these variables, we found 
that (i) dstOS was the strongest predictor among the four OS statistics, (ii) weight and 
GA were more important individually than when combined as wGA, and (iii) 
daysVentilate was the most prominent predictor among the three oxygen therapy 
variables. Our analysis also identified four factors that formed a set of the most 
dominant factors of severe ROP in preterm babies: desaturation of OS levels, baby’s 
age and weight at birth, and duration of exposure to oxygen therapy (ventilation 
support).   
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CHAPTER 6 
NZ –LP STUDY: INVESTIGATION OF SOME 
STATISTICAL SUMMARIES OF OS DATA 
 
6.1 Instability in neonatal oxygenation 
Preterm infants display physiological instabilities such as low OS level and 
variation of heart rate and respiratory patterns.(Baird, 2004) These instabilities arise 
from a combination of immature organ development, neonatal illnesses (Hofstetter  et 
al, 2007), clinical interventions (Murdoch and Darlow, 1984), and environmental 
factors (temperature, light and noise). This makes it difficult to distinguish 
instabilities that are merely due to prematurity from those partly caused by neonatal 
illnesses that affect cardiorespiratory functions. Determining the cause, so as to 
provide appropriate clinical care that avoids unnecessary and potentially harmful 
interventions often presents a challenge.  
 
Various measures and techniques have been developed to detect instabilities in 
heart rate and respiratory (Seely et al., 2014). Fetal heart rate variability has been 
quantified to monitor fetal wellbeing in high-risk pregnancies and labour (Yum and 
Kim, 2003). Validated measures of prediction of neonatal illness have been developed 
based on heart rate characteristics (Malik et al., 1996; Griffin et al., 2007). Indices or 
scores have been calculated from respiratory support data to describe the severity of 
pulmonary status and respiratory failure in ventilated preterm babies (Madan et al., 
2005; Subhedar et al., 2000).  
 
However, a similar level of understanding has not been reached for OS. It is 
known that an inappropriate amount is detrimental for premature infants, with both 
hypoxaemia and hyperoxaemia capable of tissue injury in preterm babies (Silverman, 
2004). But what the appropriate amount is and what features of OS are useful are still 
unclear (Cole et al, 2003). There is a considerable uncertainty regarding the OS 
threshold below which additional inspired oxygen should be given to babies (Cole et 
al, 2003).  
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 In the absence of gold standard for code of practice for oxygen monitoring, 
many clinicians use clinical experience and limited information defined for term 
babies as surrogate values for preterm babies (Silvestri et al., 2002; Balfour-Lynn et 
al., 2009). Such information was often presented in the form of saturation level, i.e. 
mean, median, and median baseline (Hoppenbrouwers et al., 1992; Hunt et al., 1999), 
and the data were gathered under various settings using conventional devices. Hence, 
there were some variations in the definitions suggested for normal oxygenation for 
full term babies.  
 
 A convenient source of OS measurements is pulse oximeter, which is routinely 
used in many modern NICUs. A set of oximeter OS data from preterm babies 
admitted to an NICU was obtained. The data consisted of OS measurements recorded 
for ten babies at 34 weeks, nine babies at 35 weeks and 31 babies at 36 weeks PMA. 
All babies were healthy but two were considered to be mildly unstable and require 
greater attention. Due to the small sample size, a modest investigation was carried out 
at 36 weeks PMA to explore whether some common statistical summaries of the OS 
recordings are useful in the clinical care of late preterm babies. Three statistical 
measures: the mean, SD and CV, which is the ratio of the SD to the mean, were 
investigated. The potential usefulness of each measure was assessed by its ability to 
distinguish the two unstable babies from the others using box plots and a hierarchical 
clustering technique. 
   
6.2 Studies on oxygenation in healthy preterm babies 
One of the knowledge gaps still remains involving oxygenation in healthy 
preterm babies is the lack of a standard reference range of OS (Silvestri et al., 2002; 
Balfour-Lynn et al., 2009). These ranges, also referred to as reference ranges, 
reference intervals and normal values, are an important tool in medical area. They 
serve as a guideline to clinicians and medical practioners in interpreting results 
obtained from the patients. In clinical term, a normal range consists of a range of 
values that typically represent the proportion of healthy individuals that take their 
values of a variable. Thus, values lying outside the range may suggest the presence of 
an illness or a disorder. 
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A clear definition of what constitutes normal oxygenation for preterm infants 
has been difficult to obtain. This could be partly due to the absence of clarity on how 
often and/or how long a baby could be allowed on low concentration of oxygen level, 
lack of both longitudinal data and knowledge on the dynamics of the preterm infants, 
and limited study on suitable measures that can adequately summarise the instabilities 
in OS. Previous studies on OS in term and preterm babies had used readings from the 
conventional oximeter, umbilical artery catheters and oxymonitor electrodes. These 
studies had focused on the saturation level, and the most common measure used was 
the median baseline. To compute this measure, the means of individual babies were 
first calculated using “clean” segments of data, and then the median of these means 
was obtained. A segment is classified as “clean” when the duration is at least ten 
seconds and at least 15 seconds away from any respiratory pause; the respiratory rate, 
amplitude and waveform are regular; and there is no occurrence of movement artefact 
(Hunt, et al., 1999). 
 
6.2.1 Full term babies studies 
Previous studies that contributed important information on the oxygenation in 
early life for healthy term babies have been extensive (Poets, 1998; Hunt, et al., 1999; 
Bakr and Habib, 2005; Samuel, et al., 2013; Rhein et a., 2012; Terrill et al., 2014). 
The studies involved between 34 and 4274 babies born more than 36 weeks GA. The 
investigators evaluated the impact of GA, activity state (sleeping, quiet, fussy, 
crying), altitude of hospitals, and type of monitoring device on OS at the time of 
measurement. They reported that the OS values increase to a small degree with 
increasing postnatal age, fussy/ crying newborns have lower OS values compared to 
quiet and sleeping newborns, babies born at high altitude have significantly lower OS 
values than those born at sea level, and the difference of OS values were about 2% 
between several oximeters that employ different algorithms. The OS values of the 
newborns were computed as mean, median or median baseline for several specific 
duration such as a 24- to 72-hour period from admission to discharge (O’Brien et al., 
2000; Samuel et al., 2013), and the two to six months after birth (Terrill et al., 2014; 
Hunt et al., 1999; Poets et al., 1998; Stebbens et al., 1991; Poets et al., 1991). Median 
baseline of OS greater than 95% has been suggested as “normal” for healthy babies 
(Hunt et al., 1999; Balfour-Lynn et al., 2009), which indicates that the acceptable 
range of oxygenation in term healthy babies is relatively narrow.   
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6.2.2 Preterm babies studies 
According to Rhein, et al. (2012) and our own findings, published data relating 
to oxygenation pattern and typical values in preterm babies have been limited. It was 
also noted that the number of babies in those studies was small, ranging from 28 to 55 
babies (27 – 36 weeks GA). These babies were monitored under various conditions 
and settings: there were babies with periodic breathing (Razi et al., 2002) and lung 
complications (Poets, et al., 1992; Hofstetter et al., 2007), babies monitored within a 
laboratory setting (Hoppenbrouwers, et al., 1992), babies studied within their first 
week (Richard et al., 1993; Ng, et al., 1998) or first month of life (Harigopal et al., 
2011; Rhein et al., 2012), and babies followed-up at 37 and 43 weeks PMA (Poets et 
al., 1992) and at three-monthly intervals in the first year of life (Beresford et al., 2005; 
Mok et al., 1988). These studies mostly used mean, median, median baseline, 5th and 
95th percentiles (Rhein et al., 2012; Harigopal et al., 2011; Beresford et al., 2005; Ng 
et al., 1998) to investigate the oxygen values in healthy preterm babies. The median 
(or median baseline) of the OS levels for preterm babies in these studies were from 
95% to 100%. 
 
 Late-preterm babies have received less attention than extremely preterm ones 
as they tend to be considered similar to term babies. However, there have been 
growing concerns that late-preterm babies are at an increased risk of morbidity, 
mortality and hospital readmission compared to term babies (Escobar et al., 2006; 
Engle et al., 2007). Guidelines for the evaluation and management of these babies 
have been recommended (Balfour-Lynn et al., 2009; Raju et al., 2006), addressing 
clinical care, knowledge gaps and pre-discharge of the babies. Two of the knowledge 
gaps that have been identified are the level of physiological maturity and tools to 
identify medical complications in late preterm babies. In the pre-discharge criteria 
(American Academy of Pediatrics, 2004), it was recommended that the “vital signs of 
the babies need to be within reference ranges and stable for the 12 hours preceding 
discharge, including a respiratory rate of less than 60 breaths per minute, a heart rate 
of 100 to160 beats per minute, and axillary temperature of 36.5 to 37.4°C (97.7–
99.3°F) measured in an open crib with appropriate clothing”. Note that OS levels have 
not been included in the criteria, reflecting the lack of information on this 
physiological variable. As preterm infants are often prone to life threatening events, 
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more oxygen studies are needed to aid clinicians in making health assessments or 
treatment decisions. 
 
6.3 NZ-LP study 
The typical measures to summarise OS values from the previous studies were 
based on the saturation level (mean, median percentiles, median of the means and 
median baseline). However, some clinicians also believe that the information about 
the health state of preterm babies is contained in the variability of physiological 
signals. Variability in oxygen has been suggested to be closely associated with ROP 
(Cole, 2010; Di Fiore et al., 2012). Studies have found that variability in oxygen in the 
first two weeks of life is a significant predictor of severe ROP (Cunningham, et al., 
1995), and it can increase the severity of retinopathy in newborn rats (Penn, 1995). 
For very-low-birth-weight premature babies, increased in fluctuation of oxygen may 
impose a higher risk of developing threshold ROP (Saito, et al., 1993; York, et al., 
2004). These studies show that variability derived from the OS measurements could 
provide some insight on the health conditions of babies.  
 
We therefore aimed to explore the possible usefulness of several OS statistics 
in the clinical care of preterm babies. This investigation, New Zealand Late Preterm 
Babies (NZ-LP) study, was prompted by the availability of a set of oximeter OS data 
of late preterm babies obtained from an NICU in Christchurch, New Zealand. Since 
OS level has been of considerable interest (Poets, 1998; Hunt et al., 1999; 
Hoppenbrouwers et al., 1992; Beresford et al., 2005; Rhein et al., 2012; Terrill et al., 
2014), one of the statistics investigated is the mean. Another feature of OS that has 
received some attention is variability; hence, the second statistic chosen is the SD. 
The third is the CV, which is the ratio of the SD to the mean; thus, providing a 
composite measure of variability relative to the mean level. 
 
6.3.1 Patients 
This study was an observational study that required no intervention. It was 
approved by the Upper South B Regional Ethics Committee in New Zealand. Babies 
were eligible for the study if they had been admitted to the neonatal intensive care unit 
at Christchurch Women’s Hospital between November 2004 and January 2006 with 
gestation less than 36 weeks, had never received mechanical ventilation or had 
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required continuous positive airways pressure (CPAP) for less than twelve hours. 
Babies were also excluded if they had required treatment with opiates or sedative 
drugs, were born after maternal drug use in pregnancy, had known congenital 
malformations involving the cardio-respiratory system, or had conditions requiring 
major surgery. At the time of entry to the study, babies had to be well, not requiring 
supplemental oxygen with OS consistently >92% and not have been treated with 
methylxanthine therapy in the previous seven days. The study depended on the 
availability of a Masimo Radical pulse oximeter (Masimo Corporation, Irvine, CA, 
United States) and research nurse time; hence not all eligible babies were approached 
for consent.  
 
After parental consent was obtained, an enrolled baby was connected to the 
pulse oximeter. A sensor was secured to the baby's finger or foot in a position that 
provided the most optimal signal. Data acquisition commenced once a good 
waveform was attained after the baby had been breathing spontaneously for at least 6 
hours. OS was recorded once every two seconds for a continuous duration of at least 6 
hours. Eventually, data were collected for two groups of babies: (1) Group P, 
comprising 10 babies, had OS measurements recorded once a week from 34 weeks 
PMA until discharge, there were 9 babies still in the study at 35 weeks, 6 at 36 weeks 
and 1 at 37 weeks.; and (2) Group N, consisting of 25 babies with recordings made 
only at 36 weeks PMA. For an investigation that was exclusively carried out for 36 
weeks PMA, the subset of Group P’s data taken at 36 weeks PMA was combined with 
the Group N’s data to form a data set of 31 babies altogether).  
 
Although all babies had to be clinically well to be eligible for study, two 
babies were identified as being clinically mildly unstable. Baby P17 was unstable at 
34 - 36 weeks PMA. The day following enrolment at 34 weeks PMA, she had several 
episodes of apnea requiring stimulation and was placed on low-flow nasal oxygen, 
which was continued for 3 days. There was no evidence of sepsis or other problems. 
At 35 weeks PMA, her OS readings were less than 90%for 24% of the time, some of 
these episodes were associated with feeds. She was again placed on low-flow nasal 
oxygen, which was continued for 48 hours. At 36 weeks PMA, she had brief 
desaturations with feeds and the low-flow nasal oxygen was recommenced for a 
further 3 days. Baby N21 was unstable at 36 weeks PMA when saturations less than 
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90% were recorded for almost 30% of the monitoring period. Clinical review revealed 
no problems bar a soft systolic murmur and an echo-cardiogram was undertaken, 
which was normal but showed a small patent foramen ovale. The saturations were 
consistently 93% or greater over the next few days. 
 
6.3.2 Pre-processing of OS data 
 The Masimo Radical has maximum sensitivity with OS values between 70-
100%. Readings below 70% were less reliable as they could occur from movement or 
detachment of the sensor (Giuliano and Higgins, 2005). However, as a new generation 
oximeter the Masimo Radical reduced errors from these causes. Suspect readings that 
occurred from unclear causes were retained by introducing a weighting function to 
down-weight them. This weighted each measurement between 70-100% by 1, while 
measurements between 0-69% were linearly weighted between 0 and 1. All 
subsequent analyses were based on the weighted measurements. These down-
weighted measurements constituted a very small part (about 0.3% were readings of 1-
69% and 1.2% were readings of 0%) of the total measurements that were recorded. 
The formulation for the weighting function is described in the next passage. 
 
Each measurement is assigned to a (normalised) weight according to three 
categories: the zeros, less reliable measurements (1-69%) and all measurements of 70-
100%. For the first category, the weight for each measurement is assigned as zero. For 
the remaining two categories, assignment of weight involved three stages:  
 
1. Sort all measurements 1-100% in ascending order, )()1()()1( ,...,,,..., nmm xxxx   such 
that measurements i = 1,..., m are the less reliable data and measurements i = m+1,..., 
n are the measurements of 70-100%.  
 
2. Assign weight to each of the sorted measurements. The less reliable data in some 
way reflect the unreliable level of the readings from the oximeter. Hence, the weight 
for the less reliable data is assigned as 
mixw ii ,...,1,)()(   (6.1) 
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while the weight for each measurement of 70-100% is assigned as 
nmiw i ,...,1,100)(  . (6.2) 
 
3. Redistribute the weight for all measurements in categories two and three so as to 
ensure that the weight of the measurements is proportionate within its own category. 
With normalisation of the weights, the weights of the zeros are redistributed to the 
non-zero measurements. The normalised weight for the less reliable data is given as 
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and for measurements of 70-100% is  
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 The weighted measurements of OS for each baby were summarised for each 
available PMA using three statistical measures: the mean for measuring saturation 
level, SD for measuring saturation variability and CV (= SD/ mean) as a composite 
measure of variability relative to the mean level. The weighted mean and weighted 
SD, respectively, are given by 
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Using equations (4.25) and (4.26), the weighted CV was computed as 
* *s x . (6.7) 
 
These statistics were then assessed whether they could be useful in distinguishing two 
clinically mildly unstable babies from a group of healthy babies.  
 
6.4 Methodology 
In this section, the approaches to identify unstable babies through the use of 
the three measures are outlined. First, a qualitative graphical assessment was made 
using the kernel density technique and box plots. The distribution of saturations at 
each PMA for stable and unstable babies were plotted and assessed. Subsequently, a 
quantitative appraisal was performed by using each measure in turn to group the 
babies into clusters, such that babies within a cluster looked more “similar” with 
respect to the measure than babies from different clusters. This was done using the 
hierarchical clustering (Sneath, 1973) technique together with a distance measure for 
determining the degree of similarity. The extent to which this is achieved was 
measured by an index of clustering performance. All computations were performed 
using MATLAB (v. 2010a) package. 
 
6.4.1 Graphical assessment 
Kernel density 
 Consider a random sample nxx ,...,1  for density f.  The kernel density estimator 
for f is defined as  
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where K(x) is the kernel function and h is the bandwidth that controls the degree of 
smoothing applied to the data. The following conditions are required for the bandwith 
and kernel function: 0h  , 0)( xK  and  1)( dxxK  (Wand and Jones, 1995).  
 
The computational task of the kernel density estimate requires the 
specification for the bandwidth, kernel function and adjustment at the boundaries of 
the distribution. The direct plug-in method (Wand and Jones, 1995) was employed to 
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obtain a suitable bandwith for the NZ-LP oxygen data. It has been reported as one of 
the most successful approaches among all bandwidth selection methods, both 
empirically and theoretically (Jones et al., 1996). The choice of kernel function has 
little impact on the performance of the kernel density estimator as the efficiency is 
close to unity for many distributions. The widely used Gaussian kernel function of 
zero mean and unit variance was chosen due to its simplicity. For the boundaries of 
the distribution, these were adjusted using the transformation method (Marron and 
Ruppert, 1994; Ruppert and Cline, 1994).  
 
Box plots  
The weighted CV, SD and mean were computed (using any available data sets 
of 34 weeks until 37 weeks PMA) for each baby, and the distributions of these 
measures were then assessed using box plots. In a box plot, the lower and upper edges 
of the box denote the locations of the first and third quartiles, respectively. The line 
within the box denotes the location of the median. The difference between the third 
and first quartiles, which corresponds to the length of the box, is the interquartile 
range (IQR). The lower tail of the box plot extends from the lower edge to the 
smallest point that is within 1.5 times the IQR below the lower edge. Likewise, the 
upper tail extends from the upper edge of the box to the largest point that is within 1.5 
times the IQR above the upper edge. The common convention of labeling points that 
were more than 1.5 times the IQR beyond the first or third quartile as outliers was 
adopted. The actual number of times the IQR that an outlier fell beyond the first or 
third quartile was used to indicate the extreme level of that outlier, and will be 
referred to as the extremeness index. 
 
6.4.2 Clustering analysis 
At 36 weeks PMA, in which the sample size is larger (31 babies), a more 
detailed analysis for the usefulness of mean, SD and CV statistics was conducted 
using a hierarchical clustering (Sneath, 1973) method. The squared Euclidean distance 
was employed as the distance measure, where all values computed from this measure 
serve as inputs to the clustering algorithm. Clustering performance was measured 
using the Calinski-Harabasz (CH) index (Calinski and Harabasz, 1974), which has 
been in the ranking of top three indices among 30 indices that evaluate clustering 
results (Milligan and Cooper, 1985; Arbelaitz et al., 2013).   
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Hierarchical clustering 
Hierarchical clustering is a method of grouping unlabelled objects into 
homogeneous groups such that the within-group similarity is maximised and the 
between-group similarity is minimised. Clustering of objects was performed through 
the use of pairwise distances of all observations via the agglomerative algorithm 
(Ward, 1963), the procedure is described below. 
 
1. Compute ( 1) 2n n  pairwise distances between n observations using the squared 
Euclidean distance. This is given as 
 
2
, 1,..., 1 and 1,...,E i kd x x i n k i n      . (6.9) 
 
2. Consider each observation as being apart and in its own cluster. Therefore, there are 
n clusters.  
3. Compute between-cluster dissimilarity, i.e. compute the maximum distance 
between any two clusters. Here, all pairwise distances of observations between two 
clusters are considered. 
4. Find the smallest between-cluster dissimilarity and merge the two clusters, there are 
now n-1 clusters.   
5. Repeat step 3 to step 4 until only one cluster is left.  
 
Dendogram 
The dendograms are used to illustrate the results from the hierarchical 
clustering using the mean, SD and CV. A dendrogram provides the overall insight of 
the cluster structure, i.e. informing the amalgation process of clusters at each step. It 
shows possible clusters of objects labelled on the horizontal axis, with distances 
between clusters represented by the lengths of the vertical lines. For data set that 
consisted of 30 or fewer observations, each leaf in the dendrogram corresponds to one 
observation, whereas some leaves correspond to more than one observation for data 
set that consisted of more than 30 observations. This is due to the lower branches 
being collapsed to make the complete tree looking less crowded.  
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Measuring the clustering performance 
The CH index was employed to assess the quality of the clustering outcomes. 
It quantifies the degree of separation among groups of data points, specifically, it 
measures the dispersion of the data points in a cluster and between clusters, 
respectively. A higher value of the index indicates that there is a better separation 
between clusters and greater homogeneity within each cluster, hence a stronger 
clustering result overall. The index is defined as 
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 (6.10) 
 
where n is the number of data points, c is the number of clusters, W is the within-
cluster sum of squares, and B is the  between-cluster sum of squares.  
 
6.5 Results  
Due to the small sample sizes at 34 and 35 weeks PMA, a limited longitudinal 
analysis was performed for 34 to 36 weeks PMA utilising box plots as well as 
summary statistics. Table 6.1 shows the basic demographic data of babies included in 
the study and Table 6.2 provides key summary statistics (mean, median, SD, and IQR) 
for all of the OS measurements taken at 34 to 36 weeks PMA of groups P and N. A 
pattern of increasing saturation level over time can be observed from the mean. There 
is also a pattern of decreasing variability with increasing PMA emerging from the SD. 
These trends are consistent with improving cardiorespiratory function as the babies 
matured. In these healthy babies, the improvement appears to be discernible at weekly 
intervals.     
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  Table 6.1: Summary of GA, birth weight and gender of the babies included in study  
 
GA in weeks 
mean (range) 
Birth weight in g 
mean (range) 
Gender  
Male: female 
Group P (n = 10) 31.5 (29-33) 1775 (1310 - 2630) 0:10 
Group N (n = 25) 34.2 (33-35) 2240 (1415 - 2810) 12:13 
Group P and N  
(pooled from 31 babies at 
36 weeks PMA) 
32.9 (29-35) 2008 (1310 - 2810) 12:19 
 
Table 6.2: Summary of OS (%) data in healthy preterm babies at 34 to 36 weeks 
PMA 
 
34 weeks 
(n = 10) 
35 weeks 
(n = 9) 
36 weeks 
(n = 31) 
Mean (SD) 95.4 (5.1) 96.6 (4.3) 96.9 (3.6) 
Median (IQR*) 97 (94 - 98) 98 (96 - 99) 98 (96 - 99) 
5th, 95th percentiles 81, 100 83, 100 90, 100 
                *IQR expressed as lower quartile to upper quartile 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
 
Figure 6.1 shows the distributions of OS for two babies – P02 and P17. OS 
was recorded from 34 weeks until 36 weeks PMA for P02 and until 37 weeks PMA 
for P17. P02 was clinically stable during this period but P17 was mildly unstable from 
34 to 36 weeks and became stable only at 37 weeks. In both cases, the general trend of 
increasing OS over time is visible. More importantly, whilst P02 had consistently high 
OS at all three PMAs, the OS for P17 was persistently low at 34, 35 and 36 weeks and 
improved markedly only at 37 weeks. As can be seen from the plots, the densities for 
P17 became wider and the concentration gradually shifted toward higher percentages 
with increasing PMAs. 
 
 
 
Figure 6.1: Kernel densities of OS for two babies, P02 (up) and P17 (down) 
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Table 6.3: CV, SD and mean of OS for individual babies at 34, 35 and 36 weeks PMA 
34 weeks  35 weeks 
Case no. CV SD mean  Case no. CV SD mean 
P02 0.036 3.5 98.0  P02 0.029 2.9 98.5 
P03 0.024 2.3 97.3  P03 0.021 2.0 98.2 
P06 0.053 5.1 96.0  P06 0.038 3.6 96.8 
P10 0.014 1.4 97.9  P10 0.020 2.0 96.4 
P11 0.014 1.4 97.2  P11 0.016 1.6 97.9 
P14 0.052 4.8 92.3  P14 0.025 2.4 95.0 
P17 0.062 5.8 92.4  P17 0.087 8.1 92.4 
P18 0.020 1.9 97.7  P18 0.018 1.8 98.4 
P19 0.091 8.1 89.0  P19 0.044 4.2 96.7 
P20 0.027 2.5 95.3      
         
36 weeks 
Case no. CV SD mean  Case no. CV SD mean 
P02 0.014 1.4 99.2  N24 0.022 2.1 98.2 
P03 0.023 2.3 98.2  N26 0.033 3.1 96.0 
P06 0.045 4.3 97.2  N28 0.027 2.5 94.2 
P10 0.014 1.4 97.7  N36 0.044 4.2 96.5 
P11 0.014 1.4 97.4  N37 0.037 3.6 95.8 
P17 0.079 7.4 93.1  N52 0.024 2.3 97.6 
N01 0.030 2.9 96.9  N56 0.010 1.0 97.2 
N02 0.032 3.2 97.1  N57 0.020 2.0 96.8 
N04 0.021 2.1 98.9  N58 0.020 1.9 96.4 
N05 0.020 1.9 99.0  N66 0.016 1.5 97.4 
N06 0.022 2.2 98.2  N76 0.015 1.5 98.6 
N13 0.038 3.6 97.1  N77 0.017 1.6 97.4 
N16 0.033 3.1 95.8  N79 0.018 1.7 97.4 
N17 0.032 3.1 96.4  N81 0.024 2.4 97.5 
N19 0.024 2.3 98.2  N82 0.016 1.5 96.9 
N21 0.082 7.3 88.9      
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6.5.1 Box plot 
The mean, SD and CV of OS for individual babies at each PMA are given in 
Table 6.3. The empirical distributions of these three statistics are illustrated using box 
plots in Figure 6.2. Each box plot represents the empirical distribution of a statistic 
(i.e. mean, SD or CV) across individual babies at a given PMA. Once again, a trend of 
increasing level and decreasing variability over time can be seen (medians of the 
means are 96.6%, 96.8% and 97.2%, medians of the SDs are 3.0%, 2.4% and 2.0%, 
medians of the CVs are 0.032, 0.025 and 0.023 at the three PMAs). Due to the small 
sample sizes of 10 and 9, respectively, for 34 and 35 weeks PMA, neither the medians 
(tested using the Wilcoxon rank-sum test) nor the distributions (tested using the two-
sample Kolmogorov-Smirnov test) of any of the statistics were statistically different at 
the 10% level of significance between pairs of PMAs (i.e. 34 versus 35 weeks, 34 
versus 36 weeks and 35 versus 36 weeks). Note that this does not rule out differences 
actually exist but it is more likely that the tests were lacked of power due to the small 
sample sizes.  
 
 
Figure 6.2: Box plots for mean (left), SD (middle) and CV (right) at 34, 35 and 36 
weeks PMA 
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Figure 6.3: Box plots for the mean (left), SD (middle) and CV (right) at 36 weeks 
PMA 
 
We now analyse the box plots for babies at 36 weeks PMA, where data from 
31 babies are pooled and represented. Recall that points that are more than 1.5 times 
the IQR beyond the edges of the box are regarded as outliers. Thus, the box plot for 
each statistical measure represents the empirical distribution of that measure across 
the 31 babies. The line within the box plot for the mean denotes the location of the 
median of the means and is situated at 97.2%; likewise, the median of the SDs is at 
2.0% and the median of the CVs is at 0.023. Each box plot flags babies P17 and N21 
as outliers. None of the other babies is flagged as an outlier. The values of the 
extremeness index for babies P17 and N21 respectively are: 2.02 and 4.56 with the 
mean, 2.92 and 2.85 with the SD, and 2.98 and 3.18 with the CV. Recall that both 
babies were clinically assessed to be mildly unstable at 36 weeks PMA. 
 
6.5.2 Clustering 
Hierarchical clustering was performed by using each statistic to group babies 
at 36 weeks PMA into clusters. Clustering was performed on each of the three 
statistics (mean, SD, CV) in turn. The results from hierarchical clustering using the 
mean, SD and CV in turn are illustrated by dendograms in Figure 6.4. To avoid 
cluttering the figure, babies P17 and N21 have been labelled explicitly but all of the 
other stable babies have simply been labelled as SB. Results of clustering outcomes 
and number of clusters depend on the decision of which horizontal lines is cut. The 
best choice is the one that maximises within-group similarity while minimising 
Post-menstrual age Post-menstrual age Post-menstrual age 
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between-group similarity at the same time. In the figure, the best choice in each 
dendogram is denoted by a common colour for objects belonging to the same group. 
This is illustrated in the first dendogram for clustering with the mean. The best 
outcome is shown as two groups, with N21 by itself in one group but with P17 
together with all of the stable babies in the other group (coloured red). Clustering of 
the means was able to isolate N21 but P17 ended up in the stable group. Using the 
SDs or the CVs, P17 and N21 were placed in one group and the rest in another group. 
To determine whether clustering using CVs and SDs had any advantage over means, 
the CH index was computed. Successful clustering of the stable and unstable babies 
into two groups is achieved using the CV (CH = 72.8) and SD (CH = 63.3) but not 
with the mean. Even though the clustering outcomes for CV and SD are the same – 
P17 and N21 in one group and all other stable babies in another group – the higher 
CH index for CV indicates that its clusters are better separated and more 
homogeneous within. Thus, the combination of saturation variability and saturation 
level in the form of the CV appears to be more effective for detecting instability than 
either variability or level taken separately. 
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Figure 6.4: Dendograms for hierarchical clustering with the mean (top), SD (middle) 
and CV (bottom) 
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6.6 Discussion 
 In this study, we observed a trend of increasing saturation level and decreasing 
variability with advancing PMA, which is consistent with improving maturity and 
stability over time. At 34, 35 and 36 weeks respectively, medians of the means were 
96.6%, 96.8% and 97.2%; medians of the SDs were 3.0%, 2.4% and 2.0%; and 
medians of the CVs were 0.032, 0.025 and 0.023. With each of the three statistical 
measures at 36 weeks PMA, the box plot flagged the two unstable babies as outliers 
and none of the other babies. Successful clustering of the stable and two unstable 
babies into two groups was achieved using the CV (CH = 72.8) and SD (CH = 63.3) 
but not with the mean.  
  
 Limited information is available on OS values in preterm babies being 
monitored longitudinally, with some reports that mean of OS tends to become more 
stable with increasing PMA (Hofstetter et al., 2007; Beresford et al., 2005; Mok et al., 
1988) Our study observed that for healthy late preterm babies, the increase in OS level 
and decrease in variability are discernible at weekly intervals, which accord to those 
prior studies. The observed changes in OS are consistent with physiological maturity 
over time and may also be associated with postnatal chemoreceptor activity (Rigatto 
et al., 1975).  
  
The group of babies in previous studies differed from our own cohort, in that, 
they had examined babies at different age ranges and pooled data from different ages. 
Our pooled data from 31 babies for 36 weeks PMA, however, are still broadly similar 
in terms of OS level. For example, for babies pooled from 29 to 36 weeks GA 
(Harigopal et al., 2011; Beresford et al., 2005) and from 30 to 34 weeks GA (Ng et al., 
1998), and studied between 2 - 14 days after birth, the medians of the means for OS 
were between 95% and 97%. From the box plot for the mean in Figure 6.3, the 
median of the means of the 31 babies at 36 weeks PMA is 97.2%. Other studies had 
included preterm babies with respiratory disorders (Hofstetter et al., 2007; DiPietro et 
al., 1994), babies monitored within a laboratory setting (Hoppenbrouwers et al., 
1992), babies studied at 37 and 43 weeks PMA (Poets et al., 1992) and babies 
followed-up at three-month intervals over the first 12 months post-delivery period 
(Beresford et al., 2005). Median or median baseline OS levels ranging from 96.25% to 
100% were obtained in these studies. The mean of our pooled data is 96.9% and the 
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median is 98%, these summary statistics are consistent with the literature. Studies 
involving full-term newborns found the median or median baseline of OS to be 98.3% 
(Samuel et al., 2013) in a 24-hour to 72-hour duration from admission to discharge, 
about 98% in the first month of age (Poets, 1998) and between 98% and 100% in the 
2 to 6 months after birth (Terrill et al., 2014; Hunt et al., 1999; Poets, 1998). 
 
 Most previous studies on OS in preterm babies concentrated on saturation 
level (mean, median, median of the means or median baseline (DiPietro et al., 1994; 
Levesque et al., 2000; Poets, 1998; Hunt et al., 1999; Hoppenbrouwers et al., 1992; 
Poets et al., 1992; Beresford et al., 2005; Ng et al., 1998) for monitoring of babies in 
an NICU. Alternative measures such as SD and CV, however, were under-utilised to 
serve as measures of variability and stability. In our study, we investigated the 
usefulness of mean, SD, and CV statistics for distinguishing unstable preterm babies. 
Our findings suggest that variability in OS gives better result than saturation level, in 
that, the two clinically unstable babies were successfully identified by SD and CV 
whereas mean was able to detect only one baby. The relatively low extremeness index 
of 2.02 for P17 exacerbated by the large value of 4.56 for N21 helps explain the 
unsuccessful clustering with the mean; P17 looks more like it belongs in a group with 
the stable babies than with N21 in an unstable group. With the SD or CV, the values 
of the extremeness index for P17 and N21 are close together and relatively large 
(around 3); thus, aiding their clustering into a group apart from the other babies. The 
larger value of the CH index for the CV suggests that the resulting clusters are more 
pronounced than for the SD. This appears to be consistent with the larger values of the 
extremeness index for both P17 and N21 obtained from the CV box plot as compared 
to those from the SD. It therefore seems plausible that variability might be more 
effective than mean level for detecting instability in OS in preterm babies, and that the 
combination of variability and level through the CV might be even better.  
 
Our results here add to the few known studies (DiPietro et al., 1994; DiFiore at 
al., 2012), suggesting that variability may reflect perinatal health conditions even 
though a baby may appear to be well. The box plots in Figure 6.3 show that the use of 
mean level or variability (SD) separately can lead to conflicting views about which of 
the two unstable babies is at greater risk. The mean appears to suggest that N21 is 
much more unstable than P17 while the SD seems to show that P17 is slightly more 
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unstable than N21. One way to resolve this is to use an appropriate composite 
measure combining mean level and variability, such as the CV.  
 
The use of the CV for quantifying OS in preterm babies is uncommon but not 
new. It has been used by studies that assessed the effect of oxygen fluctuation on ROP 
(Saito et al., 1993; York et al., 2004). The investigators found that the CV of OS was 
higher for babies with threshold ROP (York et al., 2004) or with stage 3 or higher 
ROP (Saito et al., 1993) within the first two weeks after birth. They concluded that 
increased fluctuation of arterial oxygen tension might increase the risk of developing 
threshold ROP in very-low-birth-weight premature babies. In another study 
examining the impact of echocardiography on the cardio-respiratory stability of 
preterm babies, Groves and colleagues (Groves et al., 2005) reported that the CV of 
blood pressure, heart rate and OS, albeit not clinically significant, were statistically 
higher during the echocardiography period than during the rest period. 
 
A limitation of this study that hampered stronger results was the small sample 
size of the data sets that included only two unstable babies. Nevertheless, the current 
results do help to draw attention to the use of both mean level and viability in the 
continuing quest to better understand OS in preterm babies. Further investigation is 
needed to develop tools that utilise these summary statistics for constructing the 
reference range of OS in preterm infants; this can be done in the context of studies 
with large number of patients. 
 
6.7 Summary 
The NZ-LP study was conducted to explore whether some statistical measures 
of OS recordings are useful for saturation monitoring of late preterm babies. This 
investigation involved ten babies at 34 weeks, nine babies at 35 weeks and 31 babies 
at 36 weeks PMA. All babies were healthy but two (identified as babies P17 and N21) 
were considered to be clinically unstable and required greater attention. OS readings 
were recorded continuously for at least 6 hours for each baby using a pulse oximeter. 
Each baby’s recordings were summarised using three statistical measures, the mean 
for measuring saturation level, SD for measuring saturation variability and CV as a 
composite measure of variability relative to the mean level.  
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At 36 weeks PMA, in which the data set is larger, an extremeness index of box 
plots and a clustering performance index (CH index) of the hierarchical clustering 
were computed to assess the potential usefulness of each measure, i.e. by its ability to 
distinguish the two unstable babies from the others. The extremeness index measures 
the extreme level of an outlier that fell beyond the IQR while the CH index evaluates 
the quality of the clusters produced by the clustering method. A higher value of CH 
index indicates that there is a distinct separation between groups of babies, hence a 
better result overall. 
 
With each of the statistics, both babies were flagged as outliers and none of the 
other babies. Nonetheless, the value of extremeness index with the mean was 
relatively low for baby P17, in comparison to the large value for baby N21. In 
contrast, the values of the extremeness index for the two babies, respectively, are 
relatively large and close together with the SD or CV. Thus, these helped in 
explaining the successful clustering of the babies into two groups (stable and 
unstable) using the CV and SD, with larger value of CH index was attained for the 
CV. This indicates that the grouping of the babies was markedly pronounced for the 
CV than that for the SD. These results were also supported by the larger values of 
extremeness index for CV. Taking the results together, this study show that the 
measures of SD and CV are believed to be more effective in detecting instability in 
OS in preterm babies than by using mean, but CV as the ratio of SD and mean could 
be even better than either SD or mean alone. 
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CHAPTER 7 
CONCLUDING REMARKS  
 
7.1 Overview and summary  
In this thesis, the potential value of some summary statistics for OS features in 
pulse oximeter, particularly mean level and variation in OS readings, for saturation 
monitoring in preterm babies was investigated through two studies, NZ-ROP and NZ-
LP. In the first study, four statistics were considered: mean (meanOS) for measuring 
saturation level, standard deviation (sdOS) for measuring saturation variability, 
coefficient of variation (cvOS) as a composite measure of variability relative to the 
mean level, and desaturation (dstOS) as another variability measure. With the 
exception of dstOS, similar OS statistics were used in the second study. A measure 
based on desaturation events was proposed for NZ-ROP study because generally, very 
young preterm babies experience a relatively higher percentage of OS readings below 
80% compared to healthy term and late preterm babies (Rhein et al., 2012; McEvoy et 
al., 1993). The usefulness of each statistic was assessed by its ability to identify babies 
with unstable health conditions for NZ-LP while for NZ-ROP, statistics that could 
best describe the relationship between OS and severe ROP.   
  
The first objective of NZ-ROP is to determine any plausible relationships 
between saturation level, three measures of variability of OS, and severe ROP. This 
was achieved through the fitting of logistic regression models, with the OS statistics 
as the predictors and the presence or absence of ROP as the response variable. Prior to 
the models fitting, some exploratory analysis was carried out and it was found that the 
four statistics were highly correlated. Since many clinicians believe that both 
variability and level of OS are important in describing the development of ROP, these 
predictors were separated into correlated and uncorrelated groups; thereby, each of the 
OS statistics could be assessed separately. Through single-, multi-predictor, and 
model averaging analyses, it was found that dstOS was strongly related to severe 
ROP. Importantly, after making adjustment for other predictors, dstOS was identified 
as having the greatest association with the risk of severe ROP among all OS statistics. 
These results shed additional information to the current knowledge that desaturation 
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episodes in extremely preterm babies could provide better insight on the adverse 
outcome of severe ROP than other OS statistics. 
 
ROP is a potentially blinding disease that is related to multiple risk factors, 
including fluctuations in oxygenation, immaturity, growth and exposure to oxygen 
therapy (Cole, 2010; McColm & Fleck, 2001). Guided by the current evidence in the 
literature, this research also explored the respective degree of relationships of eleven 
predictors that are related to the four risk factors, with severe ROP. From the analysis, 
dstOS, GA, birth weight, and daysVentilate emerged as four of the most important 
predictors on the list. Subsequently, a separate analysis was conducted to identify 
predictor that has the strongest relationship with severe ROP for each group of the 
risk factors, and the following results were obtained. First, dstOS was found as the 
most significant OS predictor among the OS statistics, as noted previously. Second, 
the extent of immaturity and growth’s influence on severe ROP was investigated by 
considering GA, birth weight and a composite variable birthweight-for-GA. Notably, 
weight and GA have stronger relationships with severity of ROP than when combined 
as birthweight-for-GA. Third, among three predictors of oxygen therapy, duration of 
ventilation support is the strongest predictor for severe ROP rather than duration of 
supplemental oxygen and use of supplemental oxygen until 36 weeks PMA. Taking 
these results together, the combination of desaturation of OS levels, baby’s age and 
weight at birth, and duration of ventilation support was identified as a set of most 
dominant predictors for severe ROP. A multi-variable model consisted of these 
predictors yielded the lowest AIC among all models, and an AUC of 0.853 (95% 
CI=(0.792, 0.914)). These suggest that factors related to OS fluctuations, degree of 
immaturity, growth, and exposure to oxygen therapy are of great important in 
discriminating babies potentially at risk of developing severe ROP.  
 
In NZ-LP, three OS statistics (mean, SD and CV) were investigated for their 
benefit in the clinical care of late preterm babies through the use of graphical and 
clustering approaches. OS readings of each baby were summarised using each 
statistic. Based on these statistics for 31 babies at 36 weeks PMA, an extremeness 
index that measures the extreme level of a particular outlying point, and a hierarchical 
clustering technique with a clustering performance index were employed to assess the 
ability of each measure to distinguish two clinically mildly unstable babies from a 
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group of healthy babies. The results from the two methods consistently showed that 
the two groups of babies were prominently separated with the SDs or CVs but not 
with the means. With SD and CV, both unstable babies were so very well distinct 
from the other babies that they were clustered in a same group and all stable babies in 
another group; the separation, however, was more prominent with the use of CV. 
Measures of variability such as SD and CV are believed to be more effective than 
mean for detecting late preterm babies with unstable health conditions, but the 
combination of variability and level through the CV could be even better.  
 
7.2 Data management and adjustments 
The contributions mentioned above would not be possible unless a sound data 
management and processing have been carried out through the implementation of 
several novel algorithms and procedures on OS data. Many recent studies on OS-
related information had used the new generation oximeters, including the Masimo 
Radical that is noted for its superior performance. However, the maximum sensitivity 
of OS values for the Masimo oximeter is highly sensitive with OS values between 70-
100% (Giuliano & Higgins, 2005). To account for acquisition of calibration errors, 
many studies on oxygen-related information studies had excluded artefactual 
readings, which were marked as 0% by the signal quality indicator, and erroneous 
data. For NZ-LP data, it was found that all readings between 0-69% that were 
suspected to be erroneous constituted only 1.5% from the total data. These less 
reliable readings were down-weighted linearly through the use of a weighting function 
to ensure that they will be given a lesser weight. The weighted readings were then 
incorporated into the NZ-LP analysis.  
 
In managing and processing the NZ-ROP data, substantial efforts have been 
carried out to compile the NZ-ROP data sets that were obtained from the BOOST-NZ 
trial. The data consisted of the OS data (recorded from 24-hour until 36 weeks PMA 
or early discharge), clinical data and information on eye examinations for screening of 
ROP. Reports from 932 eyes examinations for 257 baby were compiled and the 
disease status was diagnosed by an ophthalmologist as severe ROP (stage three and 
above or requiring laser surgery) or no severe ROP. An algorithm was developed to 
remove erroneous observations and to assemble all data. Complete information was 
finally collected from 257 babies for the study.  
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The OS readings of Masimo oximeters used in the double-blind BOOST-NZ 
trial were influenced by trial-imposed offsets and oximeter artefact. The offsets 
occurred due to the oximeters that were specially programmed to study two groups of 
babies, of whom each was randomly assigned to one of two types of masked 
oximeter. There was a concern for the offsets and artefact as their presence would 
affect the choice of methods in the analyses. A procedure was outlined to identify the 
oximeter’s type, and two algorithms involving linear and quadratic interpolations 
were developed and implemented on the New Zealand data to remove the effects of 
the offsets and artefact features. The algorithms were then validated using offsets and 
non-offset data sets of a UK preterm baby; the latter were considered as the reference 
data set for the analysis of the algorithms. The result was satisfactory: the oximeters 
for all babies were correctly identified, and the adjusted OS data were found to be 
very close to the non-offset data; hence suggesting that the features had been 
successfully adjusted to reflect the actual OS readings.  
 
7.3 Further work 
Managing neonatal oxygenation poses a great challenge to the healthcare 
providers since there are many issues on this complex topic that still require further 
understanding and questions that still need answers. Several critical areas have been 
identified for further research and these include the development of tools for 
measuring oxygen-related complications for newborns at various GAs, and 
investigating relations between varying oxygen levels over time, ROP, body systems 
and organs (Higgins et al., 2007). 
 
7.3.1 Curve-fitting methods 
In NZ-ROP study, the linear and quadratic interpolations were implemented 
for adjusting the offsets and oximeter artefact (described in Chapter 3), and loess and 
cubic spline smoothers (Hastie and Tibshirani, 1990) were applied for determining the 
preliminary functional form of continuous predictors in the logistic regression models 
(as outlined in Chapter 4). Other variants of spline functions (De Boor, 2001; Wahba, 
1990) and including those within the Bayesian framework (Yue et al., 2014) could 
also be explored as regression splines and smoothing splines for the application of OS 
data.  
146 
 
 
Another curve-fitting method to be considered for the application of OS data is 
barycentric rational interpolation (Floater and Hormann, 2007). It is a variant of 
polynomial interpolation, with a set of weights and local polynomials specified for the 
barycentric function. The ‘roughness’ of the fitted curve depends on the value chosen 
for the polynomial order. Recently, Baker and Jackson (Baker and Jackson, 2014) 
demonstrated the application of this method to golf players data. More complicated 
approaches are available based on the Fourier series regression fitting for interpolating 
time series data (Brooks et al., 2012).  
  
7.3.2 Measures of OS dynamics  
This research had focused on time-domain measures for identifying useful 
measures of OS features for neonatal oxygenation monitoring. It was found that 
variability of OS was strongly related to severe ROP diagnosis. The variation in OS, 
however, may be contributed by linear and nonlinear signals, of which the latter may 
signify an impending or presence of a particular disease. To quantify this dynamical 
aspect of OS variability, sophisticated measures of nonlinear dynamical analyses such 
as power spectral (Scargle, 1982) and entropy measures (Richman and Moorman, 
2000) will be required. These measures have been applied to quantify fetal heart rate 
features for predicting fetal distress (Cao et al., 2004), and to characterise patterns of 
hypoxemia events in preterm babies with and without severe ROP (Di Fiore at al., 
2012).  
 
7.3.3 Investigation on the behaviour of OS 
The use of simple longitudinal analysis on eight-week OS data in this study 
(Chapter 5, Section 5.2) provided some early indication on the oxygenation patterns 
among babies with and without severe ROP. This approach, however, could be 
refined using nonlinear analyses, for instance fractal analysis, across the two groups 
of babies to uncover any patterns of subtle or temporal changes in oxygenation 
behavior of OS with advancing PMAs; thereby could confer some information on the 
long-range behavior between healthy and disease states (Shang et al., 2007). Analyses 
on the nonlinear behaviors in the OS time series data may provide a further direction 
on the studies of preterm babies.   
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7.3.4 Range of measure values 
Since measures of variability of OS have been found useful, it would be 
helpful to clinicians if reference ranges of values are defined for each measure to 
monitor potential unstable babies and those at higher risk of severe ROP. Ranges (or 
control charts) developed for each advancing PMA would facilitate diagnosis and 
treatment decisions, thereby establishing the link with the state of health.  
 
7.3.5 Time-dependent predictors 
A statistical measure for desaturation episodes, which was included in the list 
of predictors for the logistic regression models developed in Chapter 5, was found to 
be strongly related to the development of ROP at 29 weeks PMA. However, given 
that the OS data were recorded continuously from 24 hours after birth until 36 weeks 
PMA, it may be possible to further exploit models with correlation structure involving 
longitudinal designs and time-varying OS measures. Development of such models 
could shed further light on the disease status over time in relation to OS fluctuations 
and other determinants. Using these models, it is also likely to investigate other 
neonatal complications associated with the use of oxygen on preterm babies, 
including chronic lung disease and potential damage to the postnatal growth of babies 
(Askie et al., 2003; Tin et al., 2001).  
 
7.4 Concluding remarks 
NZ-ROP is among the early studies that have investigated summary statistics 
of oximeter OS data, including desaturation episodes (Di Fiore et al., 2010; Di Fiore 
et al., 2012), as predictors for severe ROP. An investigation on the possible 
association between OS fluctuations at 29 weeks PMA and severe ROP revealed 
dstOS as the most significant OS statistic compared to cvOS, sdOS, and meanOS on 
severe ROP risk. The result therefore contributes to the ROP studies that desaturation 
episodes of OS along with variability of transcutaneous oxygen (Cunningham et al., 
1995; York et al., 2004), are related to the risk of developing severe ROP. The present 
study demonstrated that greater occurrences of desaturation episodes exposed preterm 
babies to an increased risk of severe ROP. Particularly, babies with higher 
desaturation episodes were nearly three times more likely to develop severe ROP than 
babies with fewer episodes. Hence, these results advocate for care practices that could 
reduce fluctuations in oxygenation such as utilising automatic oxygen controllers 
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(Claure et al., 2009) or minimising frequent manual adjustments of supplemental 
oxygen. 
 
It is noteworthy that the analyses of the NZ-ROP data conferred more 
information than other studies on the risk factors of ROP, in that, those studies have 
not investigated the relative contribution of each factor to the development of severe 
ROP. In this study for a cohort of babies of <29 weeks GA, the most significant 
predictor for each group of risk factors: exposure therapy, oxygenation fluctuations, 
immaturity and growth, was investigated. Longer periods of ventilation support, 
higher desaturation episodes of OS, and low GA and birth weight were found as the 
most important factors related to the development of severe ROP. These findings 
extend the results of Durand and colleagues (1992) who reported that very young 
babies with low birth weight, greater number of desaturation events and assisted 
ventilation, exhibit the early signs of chronic lung disease. Outcomes from NZ-ROP 
may have direct clinical implications in predicting potential babies at high risk for 
severe ROP.   
 
Multiple clinical and oxygen-related predictors were considered in NZ-ROP to 
establish important predictors of severe ROP. The circumstances by which each one 
contributes to the findings of NZ-ROP are particularly relevant towards identifying 
and managing factors that exacerbate the development of severe ROP. Therefore, all 
available clinical predictors were considered in the model fitting stage. Because each 
model contained information of certain predictors, it was vital that all models are 
included in the analyses of predictors for ROP. The model averaging approach, which 
takes into account all models, i.e. all predictors, was able to fulfill this objective; thus, 
successfully enumerating all information needed.  
 
 The analysis of determining time interval for summarising OS data of NZ-
ROP contributed in some way to the understanding of the links between onset of ROP 
and first examination after birth. The present study highlighted the pattern of OS 
during the early perinatal life of preterm babies, where it was found that a distinct 
separation on the variability and level of OS between babies with or without severe 
ROP could be observed as early as 28 weeks PMA. Whereas onset of ROP has been 
reported (Hellstrom et al., 2003; Smith, 2005) to occur from 30 weeks PMA; our 
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results here suggested the possibility of examining and hence detecting the retinal 
disorder as early as 28 weeks PMA in a premature child. Early identification of 
preterm babies at future risk of developing advanced stages of ROP would enable 
them to receive individual perinatal care; thus reducing the chance of disease 
progression and childhood blindness. 
 
An increased rate of severe ROP to 13.6% from 6.9% in premature New 
Zealand babies was seen over the past 10 years (1998-2009). The observed increase, 
which is similar to those found in several developed countries, could be partly 
accounted for by the increasing survival rate of babies born at lower GA in recent 
years. This adds weight to the current trends of ROP that there is an increasing 
population of premature babies at greatest risk of visual impairment outcome; such an 
increment is likely to result in more babies being screened or treated with surgery. It 
is therefore important that clinical information on caring for these vulnerable patients 
is managed efficiently through the process of analysing, linking and delivering the 
information to either physical or “virtual” medical decision site. The analysis on the 
relationships between saturation level and variability of OS, other clinical and 
postnatal factors, and the risk of severe ROP exemplifies the start of this process. 
 
Previous studies on OS in convalescing preterm babies have mostly reported 
the information in the form of saturation level such as mean, median and media 
baseline of OS. The observational NZ-LP study, however, found that the saturation 
variability, as measured by SD, could be more effective than saturation level for 
detecting instability in OS in late preterm babies; in that, variability may reflect 
perinatal unstable health conditions even though a baby may appear to be well; and 
that the combination of variability and level through the CV could be even better.  
 
In brief, the findings from the analyses demonstrated that identification and 
summarisation of useful OS features quantitatively hold great promise for improving 
clinical monitoring and diagnosis of high-risk preterm babies. Although different 
cohorts of babies were examined in the two studies, i.e. extremely preterm babies in 
the NZ-ROP and late-preterm babies in the NZ-LP, the results found based on the two 
studies can be combined and become more informative for the clinicians in providing 
preterm babies with appropriate health assessments and timely interventions.  
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Appendix A 
 
MATLAB programs 
 
A.1 Algorithm for cleaning and assembling NZ-ROP data 
This appendix gives the implementations of seven steps for preparing NZ-ROP data, 
which consist of OS, ROP status, clinical and postnatal data of 257 babies from 5 
centres in New Zealand. These include files conversion (Excel, text and MATLAB), 
cleaning and aggregation of data. 
 
Step 1: Creation of a folder for each baby and re-format of text files 
% 5***_02mthyy_02mthyy.txt -> 5***_2-mm-yyyy_2-mm-yyyy.txt 
% 5***_02mthyy_12mthyy.txt -> 5***_2-mm-yyyy_12-mm-yyyy.txt 
  
% 5***_12mthyy_02mthyy.txt -> 5***_12-mm-yyyy_2-mm-yyyy.txt 
% 5***_12mthyy_12mthyy.txt -> 5***_12-mm-yyyy_12-mm-yyyy.txt 
 
function [numfolder,numfiles] = createfolder(dirfiles,dirtarget) 
  
files = dir(dirfiles); 
numfiles = length(files);  
%cd(dirsource) 
cd(dirfiles) 
% for i = 1:numfiles 
for i = 3:numfiles 
     
    T = files(i).name;   
    M = T(1:4);   
    if isdir(strcat(dirtarget,M)) == 0 
        mkdir(dirtarget,M) 
    end 
    if strcmp(M,T(1:4)) == 1 
       copyfile(files(i).name,strcat(dirtarget,M)) 
            
    end 
end 
  
Folder = dir(strcat(dirtarget,'5*')); 
numfolder = length(Folder); 
 
function [numfolder,numfiles] = renamemth(dirfolder,dirsource,dirtarget) 
  
Folder = dir(dirfolder); 
numfolder = length(Folder); 
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numfiles = zeros(1,numfolder); 
listmth = {'Jan','Feb','Mar','Apr','May','Jun','Jul','Aug','Sep','Oct','Nov','Dec'}; 
listmt = {'01','02','03','04','05','06','07','08','09','10','11','12'}; 
  
for j = 1:numfolder 
    cd(strcat(dirsource,Folder(j).name)) 
    files = dir('*.txt');   
    numfiles(j) = length(files);  
    mkdir(dirtarget,Folder(j).name); 
     
    for i = 1:numfiles(j) 
        T = files(i).name;   
         
        B = strcmp(listmth,T(8:10)); b = strcmp(listmth,T(16:18));  
        C = listmt(find(B == 1)); c = listmt(find(b == 1)); 
        D = strcmp('0',T(6)); d = strcmp('0',T(14)); 
        if (find(B==1)) ~= 0 
            if D && d 
                T = (strcat(T(1:5),T(7),'-',C,'-20',T(11:13),T(15),'-',c,'-20',T(19:20),'.txt')); 
            elseif D && ~d 
                T = (strcat(T(1:5),T(7),'-',C,'-20',T(11:15),'-',c,'-20',T(19:20),'.txt')); 
            elseif ~D && d 
                T = (strcat(T(1:7),'-',C,'-20',T(11:13),T(15),'-',c,'-20',T(19:20),'.txt')); 
            elseif ~D && ~d 
                T = (strcat(T(1:7),'-',C,'-20',T(11:15),'-',c,'-20',T(19:20),'.txt')); 
            else  
                T = (strcat(T(1:5),'.unknown')); 
            end 
        end 
        movefile(files(i).name,strcat(dirtarget,Folder(j).name,'\',char(T))) 
   end 
     
end 
 
 
Step 2: Files conversion from text to MATLAB format for OS data 
function [numfolder,numfiles] = convertdata(dirfolder,dirsource,dirtarget,centre) 
  
%[numfolder,numfiles] = renamefile1(dirfolder2,dirtarget1,dirsource); 
Folder = dir(dirfolder); 
numfolder = length(Folder); 
numfiles = zeros(1,numfolder); 
  
for j = 1:numfolder 
    cd(strcat(dirsource,Folder(j).name)) 
    files = dir('*.txt');  
    numfiles(j) = length(files);  
    coxy = zeros(1,1); cflag = cell(1); cdate = cell(1); ctime = cell(1); campm = cell(1); 
     
    for i = 1:numfiles(j) 
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        T = files(i).name; % str contains filename.txt    
        fid = fopen(T,'r+');                             
         
        C = textscan(fid, '%s %n %s','delimiter',','); 
        RawOxy = C{2};  
        Flag = C{3}; 
        DateTimeAmpm = C{1}; 
        [Date,TimeAmpm] = strtok(DateTimeAmpm); 
        [Time,Ampm] = strtok(TimeAmpm); 
        fclose(fid);  
         
        coxy = [coxy;RawOxy]; cflag = [cflag;Flag]; cdate = [cdate;Date]; ctime = 
[ctime;Time]; campm = [campm;Ampm]; 
    end 
     
    n = length(coxy); 
    rawoxy = coxy(2:n); flag = cflag(2:n); date = cdate(2:n); time = ctime(2:n); ampm 
= campm(2:n); 
    M = strcat(centre,'B',Folder(j).name); 
    cd(dirtarget) 
    save(M,'date','time','ampm','rawoxy','flag')  
    clear coxy cflag cdate ctime campm C datetimeampm timeampm ans    
     
end 
 
Step 3: Re-format of filenames for each baby in MATLAB directory 
function [numfolder,numfiles] = renamefile(dirfolder,dirsource,dirtarget) 
  
Folder = dir(dirfolder); 
numfolder = length(Folder); 
numfiles = zeros(1,numfolder); 
  
for j = 1:numfolder 
    cd(strcat(dirsource,Folder(j).name)) 
    files = dir('*.txt');   
    numfiles(j) = length(files);  
    mkdir(dirtarget,Folder(j).name)     
    for i = 1:numfiles(j) 
        T = files(i).name;   
        A = strcmp('-',T(7)); B = strcmp('-',T(8)); C = strcmp('-',T(17)); D = strcmp('-
',T(18)); E = strcmp('-',T(19)); 
         
        if sum([A,C]) == 2 || sum([A,D]) == 2 || sum([B,D]) == 2 || sum([B,E]) == 2         
            if A && C 
                %T = (strcat(T(1:15),T(21:24),'-',T(18:19),'-',T(16),'.txt')); 
                T = (strcat(T(1:15),T(21:24),'-',T(18:19),'-','0',T(16),'.txt')); 
            elseif A && D 
                T = (strcat(T(1:15),T(22:25),'-',T(19:20),'-',T(16:17),'.txt')); 
            elseif B && D 
                %T = (strcat(T(1:16),T(22:25),'-',T(19:20),'-',T(17),'.txt')); 
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                T = (strcat(T(1:16),T(22:25),'-',T(19:20),'-','0',T(17),'.txt')); 
            elseif B && E 
                T = (strcat(T(1:16),T(23:26),'-',T(20:21),'-',T(17:18),'.txt')); 
            else  
                T = (strcat(T(1:5),'unknowntxt')); 
            end 
        end 
        movefile(files(i).name,strcat(dirtarget,Folder(j).name,'\',char(T))) 
    end 
     
end 
 
 
Step 4: Data cleaning for NZ-ROP data 
function Ix = cleandata(rawoxy,flag,date,GAweeks,GAdays,DOB) 
  
Ix = find(rawoxy >= 50); % Discard data below 50 
X50 = rawoxy(Ix); flag = flag(Ix); date = date(Ix);  
sig = {'normal'}; 
goodflag = strncmp(sig,flag,6); 
Igoodflag = find(goodflag == 1); 
X50 = X50(Igoodflag);  date = date(Igoodflag); 
date = char(date); 
GA = 36 - GAweeks + 1; 
meanGA = zeros(1,GA); 
for i = 1:GA  
    d = 6 - GAdays; 
     
    if (DOB(2) == '/') 
        Ia = find(date(:,2) == '/'); a = str2num(date(Ia));  
        Ib = find(date(:,3) == '/'); b = str2num(date(Ib,1:2)); 
        startdate = str2num(DOB(1)); 
        enddate = startdate + d; 
        Ic = find([a;b] <= enddate);      
                 
    else % DOB(3) == '/' 
        startdate = str2num(DOB(1:2)); 
        enddate = startdate + d; 
        if enddate >= 29 
        e = DOB(4:5); % Detect the month of birth  
        ee = strcat(DOB(4),num2str(str2num(DOB(5)) + 1));  % Detect the month of 
enddate    
        Ia = find(date(:,4) == DOB(4) & date(:,5) == DOB(5));  
             
             if enddate >= 32 
                if (e == '01') | (e == '03') | (e == '05') | (e == '07') | (e == '08') | (e == '10') | (e 
== '12') 
                    enddate = enddate - 31; 
                end 
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             elseif enddate >= 31    
                if (e == '04') | (e == '06') | (e == '09') | (e == '11') 
                    enddate = enddate - 30; 
                end 
             
             elseif ((enddate >= 30) & (e == '02')) & (DOB(7:10) == '2008') 
                    enddate = enddate - 29;   
                 
             elseif ((enddate >= 29) & (e == '02'))  
                if (DOB(7:10) == '2006') | (DOB(7:10) == '2007') | (DOB(7:10) == '2009') 
                    enddate = enddate - 28; 
                end 
             % else % Those == 28,...,31 in Feb, 30-day mth and 31-day month  
             %Ib = find((date(:,4) == DOB(4)) & (date(:,5)==DOB(5)); b = 
str2num(date(Ib,1:2)); 
             %Ic = find(b <= enddate); 
             end 
             Ib = find(date(:,3)== ee(1) & date(:,4) == ee(2)) & str2num(date(:,1)) <= 
enddate); 
             Ic = [Ia;Ib]; 
              
        else    
             Ib = find(date(:,3) == '/'); b = str2num(date(Ib,1:2)); 
             Ic = find(b <= enddate); %%% CHECK 
        end    
    end 
    oxy = X50(Ic); 
    rfadj = NZraw4(oxy); % correction for dips and offsets 
     
end 
 
Step 5: Compilation of postnatal, clinical and oxygen data  
% Convert DOB dates-format to numbers-format 
% a) import ID (4 digits babies identifier) and DOB3(dates-clock format) 
% from Excel to MATLAB 
% b)DOB2 = datestr(datenum(DOB3,'dd/mm/yyyy'),1); output=dd-mmm-yyyy 
% c) DOB = datenum(DOB,'dd-mmm-yyyy') 
% d) create .mat that consists vectors of short-term outcomes (each row 
% corresponds to each baby's information 
 
function numfiles = appendData(dirfolder,dirsource) 
  
Folder = dir(dirfolder); 
numfiles = length(Folder); 
  
for k = 1:numfiles 
    cd(dirsource) 
    f = dir('C*.mat');  
    T = f(k).name; 
    load(T,'date') 
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    date2 = date; 
    date = datestr(datenum(date, 'dd/mm/yyyy'), 1); date = datenum(date); 
    load('STO_add_babies','ID','Baby','GAdays','WeightBirth','Gender',... 
    'HighestROP','DaysVentilate','DaysO2','O2atW36','DOB2','DOB') 
    t = T(1:8);     
    post = strmatch(t, Baby, 'exact'); 
    DOB2 = DOB2(post,:); 
    DOB = DOB(post);  
    ID = ID(post); 
    HighestROP = HighestROP(post); 
    GAdays = GAdays(post); 
    Gender = Gender(post); 
    WeightBirth = WeightBirth(post); 
    DaysVentilate = DaysVentilate(post); 
    DaysO2 = DaysO2(post); 
    O2atW36 = O2atW36(post); 
    save(t,'date','date2','GAdays','DOB','DOB2','ID','HighestROP','Gender',... 
    'WeightBirth','DaysVentilate','DaysO2','O2atW36','-append') 
end 
 
Step 6: Computation of summary statistics of oxygen data (CV, Mean, SD)  
% date = datestr(datenum(date, 'dd/mm/yyyy'), 1); date = datenum(date); 
% Date and DOB have been converted to numbers using appendData.m 
% X50 and date50 = final data with (i) values >= 50 and (ii) good signals ('normal') 
% Extract cv and mean for the combined weeks  
% treatB = high (1) or low (0) readings of oxygen saturation  
  
function [cvB,meanB,F] = boostOS(dirsource,dirfolder,nweek) 
  
Folder = dir(dirfolder); 
numfiles = length(Folder); 
  
cvB = zeros(numfiles,nweek+2); meanB = zeros(numfiles,nweek+2); F = 
zeros(numfiles,1); 
for k = 1:numfiles 
     
    cd(dirsource) 
    f = dir('C*.mat');  
    T = f(k).name; F(k) = str2num(T(5:8)); 
    %load(T,'rawoxy','flag','date','DOB','HL') 
    load(T,'date50','X50','DOB','HL') 
    %Ix = find(rawoxy >= 50); % Discard data below 50 
    %X50 = rawoxy(Ix); flag = flag(Ix); date = date(Ix);  
    %sig = {'normal'}; 
    %goodflag = strncmp(sig,flag,6); 
    %Igoodflag = find(goodflag == 1); 
    %X50 = X50(Igoodflag);  date50 = date(Igoodflag); % Maintain good data 
('normal' signal flag) 
    %xdate = unique(date50); n = length(xdate); 
    %GA = 36 - GAweeks + 1; 
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    meanGA = zeros(1,nweek); sdGA = zeros(1,nweek); cvGA = zeros(1,nweek); 
    startGA = zeros(1,nweek); endGA = zeros(1,nweek); 
    startGA(1) = DOB + 1; endGA(1) = DOB + 7; 
    startW12 = startGA(1); endW12 = DOB + 14; % W12 = combined data of the first 
and second week after birth 
    startM = startGA(1); endM = DOB + 28; % M = combined data of the first until the 
fourth week after birth 
  
    for i = 2:nweek 
        startGA(i) = startGA(i-1) + 7; endGA(i) = endGA(i-1) + 7; 
    end 
    xIpol = 97; 
    for i = 1:nweek 
        Ioxy = find(date50 >= startGA(i) & date50 <= endGA(i));  
        oxy = X50(Ioxy); 
        Mem = sum(ismember(xIpol,oxy)); 
        E = isempty(oxy); 
        if ((E == 1) || (Mem == 0)) % empty vector for that week 
            meanGA(i) = NaN; sdGA(i) = NaN; cvGA(i) = NaN; % missing oxy data for 
that week 
        else 
            [sumf,sumfadjx,sumfadjx2] = NZraw4(oxy,HL); % correction for dips and 
offsets 
            meanGA(i) = sumfadjx/sumf; sdGA(i) = sqrt((sumfadjx2 - 
meanGA(i)*sumfadjx)/(sumf - 1)); 
            cvGA(i) = sdGA(i)/meanGA(i); 
        end 
    end 
    IW12 = find(date50 >= startW12 & date50 <= endW12); IM = find(date50 >= 
startM & date50 <= endM); 
    W12 = X50(IW12); M = X50(IM); 
    Mem = sum(ismember(xIpol,W12)); 
    E = isempty(W12);  
    if ((E == 1) || (Mem == 0)) 
        meanW12 = NaN; cvW12 = NaN; 
    else 
        [sumf,sumfadjx,sumfadjx2] = NZraw4(W12,HL); % correction for dips and 
offsets 
        meanW12 = sumfadjx/sumf; sdW12 = sqrt((sumfadjx2 - 
meanW12*sumfadjx)/(sumf - 1)); 
        cvW12 = sdW12/meanW12; 
    end 
    Mem = sum(ismember(xIpol,M)); 
    E = isempty(M); 
    if ((E == 1) || (Mem == 0)) 
        meanM = NaN; cvM = NaN; 
    else 
        [sumf,sumfadjx,sumfadjx2] = NZraw4(M,HL); % correction for dips and offsets 
        meanM = sumfadjx/sumf; sdM = sqrt((sumfadjx2 - meanM*sumfadjx)/(sumf - 
1)); 
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        cvM = sdM/meanM; 
    end 
  
    cvB(k,:) = [cvGA,cvW12,cvM]; CVx = cvB(k,:);  
    meanB(k,:) = [meanGA,meanW12,meanM]; MEANx = meanB(k,:); 
    save(T,'CVx','MEANx','-append') 
end 
  
 
Step 7: Computation of desaturation episodes (OS<=80% per week)  
function [dstB,nB,F] = BOOSTdesat(dirsource,dirfolder,nweek) 
  
Folder = dir(dirfolder); 
numfiles = length(Folder); 
  
dstB = zeros(numfiles,nweek+1); nB = dstB; F = zeros(numfiles,1); 
for k = 1:numfiles 
     
    cd(dirsource) 
    f = dir('C*.mat');  
    T = f(k).name;  
    F(k) = str2num(T(5:8)); 
    load(T,'date50','X50','DOB') % Use good data ('normal' signal flag) 
     
    dstGA = zeros(1,nweek); ndst = dstGA; 
    startGA = zeros(1,nweek); endGA = zeros(1,nweek); 
    startGA(1) = DOB + 1; endGA(1) = DOB + 7; 
    startW14 = startGA(1); endW14 = DOB + 28; % M = combined data of the first 
until the fourth week after birth 
  
    for i = 2:nweek 
        startGA(i) = startGA(i-1) + 7; endGA(i) = endGA(i-1) + 7; 
    end 
     
    for i = 1:nweek 
        Ioxy = find(date50 >= startGA(i) & date50 <= endGA(i));  
        oxy = X50(Ioxy); nGA = length(oxy); 
        Idst = find(oxy <= 80);  
        dst = oxy(Idst);          
        E = isempty(oxy); 
        if (E == 1)  
            dstGA(i) = NaN;  % oxy data are missing for that week 
        else 
            ndst(i) = length(dst); 
            dstGA(i) = ndst(i)/nGA; 
        end 
    end 
    IW14 = find(date50 >= startW14 & date50 <= endW14);  
    W14 = X50(IW14); nW14 = length(W14); 
    Idst = find(W14 <= 80);  
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    dst = W14(Idst); nd = length(dst); 
    E = isempty(W14);  
    if (E == 1)  
        dstW14 = NaN; 
    else 
        dstW14 = nd/nW14; 
    end 
    nB(k,:) = [ndst,nd]; 
    dstB(k,:) = [dstGA,dstW14]; DST = dstB(k,:);  
         
    save(T,'DST','-append') 
     
end 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
160 
 
A.2 Algorithms for adjusting the offsets and artefact of 
Masimo oximeters 
This appendix gives the implementations of procedure for identifying types of 
oximeters (high or low saturation), and algorithms to remove the effects of the offsets 
and artefact from the OS data. 
 
function [sumfreq,sumfadjx,sumfadjx2,freqadj,rfadj,rf] = NZraw4(rawoxy,highlow) 
     
tabfreq = tabulate(rawoxy); ox = tabfreq(:,1); 
sumfreq = sum(tabfreq(:,2));  
rf = tabfreq(:,3);                      % All freqs (in %) 
%maxrf = find(tabfreq(:,3)==max(tabfreq(:,3))); 
%H = [rf(85) rf(86) rf(87)]; 
%L = [rf(93) rf(94) rf(95)]; 
  
%if std(H) < std(L) 
%    highlow = 1; 
%else 
%    highlow = 0; 
%end 
  
v2 = ones(2,1); v4 = ones(4,1); 
rfadj = rf; 
idip = (87:90)'; 
  
if highlow = = 1                         % High reading @ low SAT 
    % Interpolation for r(84:85) 
    x = (84:85)'; x2 = x.^2; 
    B = [rfadj(83);rfadj(89);sum(rfadj(84:88))]; 
    A = [83^2 83 1;86^2 86 1;sum(x2) sum(x) 2]; 
    c = A \ B; 
    rfadj(x) = [x2 x v2] * c; 
     
    rfadj(86:92) = rfadj(89:95); 
    rftemp = rfadj(idip); 
     
    % Interpolation (linear) for r(87:90)   
    x = (87:90)'; 
    A = [ 86 1; 91 1]; 
    B = [ rfadj(86); rfadj(91)]; 
    c = A \ B; 
    rfadj(x) = [x v4] * c; 
     
    rfadj(idip) = max([rfadj(idip) rftemp]')'; 
     
    % Interpolation for r(93:96) 
    x = (93:96)'; x2 = x.^2; 
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    B = [rfadj(92);rfadj(97);rfadj(96)]; 
    A = [92^2 92 1;97^2 97 1;sum(x2) sum(x) 4]; 
    c = A \ B; 
    rfadj(x) = [x2 x v4] * c; 
     
    Ineg = length(find(rfadj(x) <= 0));  
    if Ineg > 0 
        rfadj(x) = rfadj(96)/4; 
    end 
     
% Low reading @ high SAT 
elseif (highlow = = 0)                    
    % Interpolation for r(95:96) 
    x = (95:96)'; x2 = x.^2; 
    B = [rfadj(91);rfadj(97);sum(rfadj(92:96))]; 
    A = [94^2 94 1;97^2 97 1;sum(x2) sum(x) 2]; 
    c = A \ B; 
    rfadj(x) = [x2 x v2] * c; 
     
    rfadj(88:94) = rfadj(85:91); % Shift to get r(88:94) 
     
    % Interpolation for r(84:87) 
    x = (84:87)'; x2 = x.^2; 
    B = [rfadj(83);rfadj(88);rfadj(84)]; 
    A = [83^2 83 1;88^2 88 1;sum(x2) sum(x) 4]; 
    c = A \ B; 
    rfadj(x) = [x2 x v4] * c; 
     
    rftem = rfadj(idip); 
     
    % Interpolation (linear) for r(87:90) 
    x = (87:90)';  
    A = [ 86 1;91 1]; 
    B = [ rfadj(86);rfadj(91)]; 
    c = A \ B; 
    rfadj(x) = [x v4] * c; 
     
    rfadj(idip) = max([rfadj(idip) rftem]')'; 
     
else 
    error('highlow is 1 or 0') 
  
end 
  
adj = (84:96)'; 
rfadj(adj) = rfadj(adj) * (sum(rf(adj))/sum(rfadj(adj))); % Normalisation of rel. freq 
freqadj = rfadj * sumfreq/100; 
sumfadjx = freqadj'* ox; 
sumfadjx2 = freqadj'*(ox.^2); 
%ymax = max(max(rf),max(rfadj)) + 0.5;  
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%plot((1:1:100),rf,'-b.',(1:1:100),rfadj,'-
r.','LineWidth',2,'LineWidth',2,'MarkerSize',25); 
%switch colr 
%    case '-r.' 
%        plot((1:1:100),rf,'-b.',(1:1:100),rfadj,'-
r.','LineWidth',2,'LineWidth',2,'MarkerSize',25); 
%    case '-g.' 
%        plot((1:1:100),rfadj,'-g.','LineWidth',2,'LineWidth',2,'MarkerSize',25); 
%end 
%xlabel('Saturation','fontsize',16); ylabel('Relative frequency (%)','fontsize',16) 
%axis([60 100 0 ymax]) 
%title(['Saturation readings' ' ' inputname(1)],'fontsize',16); 
%h = legend('raw',adjusted',2); 
%set (h,'Location','NorthWest','fontsize',13); 
%grid on 
  
%x1=CHC5150(1:22000); x2=CHC5150(22001:44000); 
x3=CHC5150(44001:65536); 
%plot((1:1:100),rfadjSEG,'--g','LineWidth',2,'LineWidth',2,'MarkerSize',25); 
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